<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epilepsia Open</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia Open</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2470-9239</journal-id>
<journal-id journal-id-type="publisher-id">EPI4</journal-id>
<journal-title-group>
<journal-title>Epilepsia Open</journal-title>
</journal-title-group>
<issn pub-type="epub">2470-9239</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29881795</article-id>
<article-id pub-id-type="pmc">5983207</article-id>
<article-id pub-id-type="doi">10.1002/epi4.12102</article-id>
<article-id pub-id-type="publisher-id">EPI412102</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Critical Review and Invited Commentary</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Critical Review and Invited Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metabolic etiologies in West syndrome</article-title>
<alt-title alt-title-type="left-running-head">S. Salar et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="epi412102-cr-0001">
<name>
<surname>Salar</surname>
<given-names>Seda</given-names>
</name>
<xref ref-type="aff" rid="epi412102-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="epi412102-biog-0001">*</xref>
</contrib>
<contrib contrib-type="author" id="epi412102-cr-0002">
<name>
<surname>Moshé</surname>
<given-names>Solomon L.</given-names>
</name>
<xref ref-type="aff" rid="epi412102-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="epi412102-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="epi412102-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="epi412102-cr-0003">
<name>
<surname>Galanopoulou</surname>
<given-names>Aristea S.</given-names>
</name>
<address>
<email>aristea.galanopoulou@einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="epi412102-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="epi412102-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="epi412102-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Laboratory of Developmental Epilepsy</named-content>
<named-content content-type="organisation-division">Saul R. Korey Department of Neurology</named-content>
<named-content content-type="organisation-division">Montefiore/Einstein Epilepsy Center</named-content>
<institution>Albert Einstein College of Medicine</institution>
<named-content content-type="city">Bronx</named-content>
<named-content content-type="country-part">New York</named-content>
<country country="US">U.S.A.</country>
</aff>
<aff id="epi412102-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Dominick P. Purpura Department of Neuroscience</named-content>
<named-content content-type="organisation-division">Montefiore/Einstein Epilepsy Center</named-content>
<institution>Albert Einstein College of Medicine</institution>
<named-content content-type="city">Bronx</named-content>
<named-content content-type="country-part">New York</named-content>
<country country="US">U.S.A.</country>
</aff>
<aff id="epi412102-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<named-content content-type="organisation-division">Montefiore/Einstein Epilepsy Center</named-content>
<institution>Albert Einstein College of Medicine</institution>
<named-content content-type="city">Bronx</named-content>
<named-content content-type="country-part">New York</named-content>
<country country="US">U.S.A.</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Address correspondence to Aristea S. Galanopoulou, 1410 Pelham Parkway South, Kennedy Center Rm 306, Bronx NY 10461, U.S.A. E‐mail: <email>aristea.galanopoulou@einstein.yu.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2018</year>
</pub-date>
<volume>3</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1002/epi4.2018.3.issue-2</issue-id>
<fpage>134</fpage>
<lpage>166</lpage>
<history>
<date date-type="accepted">
<day>15</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 International League Against Epilepsy <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Epilepsia Open</italic> published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EPI4-3-134.pdf" xlink:type="simple"></self-uri>
<abstract id="epi412102-abs-0001">
<title>Summary</title>
<p>West syndrome (<styled-content style="fixed-case">WS</styled-content>) is an early life epileptic encephalopathy associated with infantile spasms, interictal electroencephalography (<styled-content style="fixed-case">EEG)</styled-content> abnormalities including high amplitude, disorganized background with multifocal epileptic spikes (hypsarrhythmia), and often neurodevelopmental impairments. Approximately 64% of the patients have structural, metabolic, genetic, or infectious etiologies and, in the rest, the etiology is unknown. Here we review the contribution of etiologies due to various metabolic disorders in the pathology of <styled-content style="fixed-case">WS</styled-content>. These may include metabolic errors in organic molecules involved in amino acid and glucose metabolism, fatty acid oxidation, metal metabolism, pyridoxine deficiency or dependency, or acidurias in organelles such as mitochondria and lysosomes. We discuss the biochemical, clinical, and <styled-content style="fixed-case">EEG</styled-content> features of these disorders as well as the evidence of how they may be implicated in the pathogenesis and treatment of <styled-content style="fixed-case">WS</styled-content>. The early recognition of these etiologies in some cases may permit early interventions that may improve the course of the disease.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="epi412102-kwd-0001">Metabolic disorder</kwd>
<kwd id="epi412102-kwd-0002">Early onset epileptic encephalopathy</kwd>
<kwd id="epi412102-kwd-0003">Infantile spasms</kwd>
<kwd id="epi412102-kwd-0004">Inborn errors of metabolism</kwd>
<kwd id="epi412102-kwd-0005">Hypsarrhythmia</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>NIH</funding-source>
<award-id>U54 NS100064</award-id>
<award-id>NS43209</award-id>
</award-group>
<award-group>
<funding-source>US Department of Defense</funding-source>
<award-id>W81XWH‐13‐1‐0180</award-id>
</award-group>
<award-group>
<funding-source>CURE Infantile Spasms Initiative</funding-source>
</award-group>
<award-group>
<funding-source>Heffer Family and the Segal Family Foundations</funding-source>
</award-group>
<award-group>
<funding-source>Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families</funding-source>
</award-group>
<award-group>
<funding-source>NINDS</funding-source>
<award-id>RO1 NS091170</award-id>
<award-id>U54 NS100064</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="3"></table-count>
<page-count count="33"></page-count>
<word-count count="25184"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>epi412102</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.0 mode:remove_FC converted:01.06.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>
<boxed-text content-type="box" id="epi412102-blkfxd-0001" orientation="portrait" position="anchor"><caption><title>Key Points</title></caption><p>
<list id="epi412102-list-0001" list-type="bullet"><list-item><p>Disorders with inborn errors of metabolism have been found in approximately 3%‐22% of infants with infantile spasms</p></list-item><list-item><p>Infantile spasms may be diagnosed in up to 12% of pediatric patients with phenylketonuria</p></list-item><list-item><p>Currently, in many cases, diagnosis of infantile spasms may precede the diagnosis of the metabolic disorders</p></list-item><list-item><p>Infantile spasms have been associated with numerous metabolic disorders, although the association with many of them can be sporadic</p></list-item><list-item><p>Early diagnosis of metabolic disorders may lead to early initiation of appropriate treatment</p></list-item></list>
</p></boxed-text>
</p>
<sec id="epi412102-sec-0002">
<p>Epileptic encephalopathies are a group of disorders for which epilepsy or epileptic activity plays the main role in disease phenotypes such as severe cognitive and behavioral impairments.<xref ref-type="ref" rid="epi412102-bib-0001">1</xref>, <xref ref-type="ref" rid="epi412102-bib-0002">2</xref>, <xref ref-type="ref" rid="epi412102-bib-0003">3</xref> As an early life encephalopathy with an average age of onset of 6 months, West syndrome (WS) is characterized by infantile spasms (IS), hypsarrhythmia, an interictal electroencephalography (EEG) pattern with irregular, high‐amplitude slow waves on a chaotic epileptic background, and neurodevelopmental decline; the presence of 2 of these symptoms confirms the diagnosis.<xref ref-type="ref" rid="epi412102-bib-0004">4</xref>, <xref ref-type="ref" rid="epi412102-bib-0005">5</xref>, <xref ref-type="ref" rid="epi412102-bib-0006">6</xref> IS is often used to describe the syndrome but can also be used in the literature to describe the characteristic flexion or extension spasms that manifest in this syndrome. More recently, and to also address the patients who have late‐onset spasms or continue to have spasms beyond the infantile age, it has been proposed that the term “epileptic spasms” be used when referring to these seizures. In patients with WS, IS disappear over time but are often replaced by various types of seizures. WS may also develop into Lennox‐Gastaut syndrome. Many of the infants with IS develop signs of autism spectrum disorders. Indeed, most patients with the disease show poor outcome, with neurodevelopmental or neuropsychiatric symptoms.<xref ref-type="ref" rid="epi412102-bib-0003">3</xref>, <xref ref-type="ref" rid="epi412102-bib-0005">5</xref>, <xref ref-type="ref" rid="epi412102-bib-0006">6</xref>, <xref ref-type="ref" rid="epi412102-bib-0007">7</xref>
</p>
<p>The incidence of IS is 2 to 3.5 infants per 10,000 live births, and the majority of affected infants (~64%), have structural, metabolic, infectious, or genetic etiologies, whereas in the remainder, no etiologies can be identified.<xref ref-type="ref" rid="epi412102-bib-0005">5</xref>, <xref ref-type="ref" rid="epi412102-bib-0008">8</xref>, <xref ref-type="ref" rid="epi412102-bib-0009">9</xref> In a cohort of 251 infants with IS,<xref ref-type="ref" rid="epi412102-bib-0009">9</xref> the breakdown of etiologies, according to the general classification scheme proposed by the International League Against Epilepsy (ILAE),<xref ref-type="ref" rid="epi412102-bib-0002">2</xref>, <xref ref-type="ref" rid="epi412102-bib-0010">10</xref> included metabolic (4.8%), genetic (14.4%), genetic‐structural (10%), structural‐congenital (10.8%), structural‐acquired (22.4%), and infectious (2%). Genetic examination of 356 trios consisting of parents and probands with IS and Lennox‐Gastaut syndrome revealed that 12% of the probands carried de novo genetic alterations.<xref ref-type="ref" rid="epi412102-bib-0011">11</xref> However, prognosis is better in infants with IS due to unknown etiology following early treatment compared to those with structural and metabolic etiologies.<xref ref-type="ref" rid="epi412102-bib-0005">5</xref>, <xref ref-type="ref" rid="epi412102-bib-0008">8</xref>, <xref ref-type="ref" rid="epi412102-bib-0012">12</xref>
</p>
<p>In this review, we discuss the contribution of metabolic etiologies in the pathology of WS in light of the recent literature. In addition, we describe in vitro and in vivo models of the metabolic disorders included in this review. We have included only articles in English language that were retrieved from PubMed using the search keywords “Infantile Spasms,” “West syndrome,” or “epileptic spasms” to identify relevance to IS. We used keywords “Inborn Errors of Metabolism” or “Metabolic Etiologies” or specific names for each syndrome or gene to retrieve articles on metabolic etiologies of spasms. In our review, we included all etiologies that manifested with IS, recognizing that, for rare diseases, it may be difficult to establish definite causative associations, since these are often based on case reports. Therefore, the level of evidence and strength of association of the various disorders with IS is not the same across these disorders. Articles describing work on both in vivo and in vitro models were accepted for review. Furthermore, separate searches for animal models (“rat” or “mouse” or “mice” or “animal model”) of specific metabolic syndromes were retrieved for review to determine if they produced a phenotype consistent with epilepsy or IS.</p>
<p>Inborn errors of metabolism may include metabolic errors in organic molecules involved in amino acid and glucose metabolism, fatty acid oxidation, metal metabolism, pyridoxine deficiency or dependency, or acidurias in organelles like mitochondria and lysosomes, as well as other rare diseases such as leukodystrophies<xref ref-type="ref" rid="epi412102-bib-0013">13</xref>, <xref ref-type="ref" rid="epi412102-bib-0014">14</xref>, <xref ref-type="ref" rid="epi412102-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412102-bib-0016">16</xref>, <xref ref-type="ref" rid="epi412102-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412102-bib-0018">18</xref>, <xref ref-type="ref" rid="epi412102-bib-0019">19</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0001">1</xref>). In a Chinese cohort of 60 patients with IS, metabolic disorders were found in 47%, among whom 22% had inborn errors of metabolism.<xref ref-type="ref" rid="epi412102-bib-0019">19</xref> In a retrospective study from Saudi Arabia consisting of 80 patients with IS, hereditary neurometabolic disorders were diagnosed in 12.5%, although the high rate of consanguinity (75% among IS patients with metabolic disorders) may have contributed to the high incidence in this population.<xref ref-type="ref" rid="epi412102-bib-0020">20</xref> In a larger U.S. cohort (251 infants with IS), metabolic etiologies were identified in 4.8%.<xref ref-type="ref" rid="epi412102-bib-0009">9</xref> In the United Kingdom Infantile Spasms Study (UKISS) study, metabolic etiologies were reported in 3.1% of IS patients: 2 newborns with hypoglycemia and 2 infants with pyridoxine dependency or mitochondrial disorder (n = 127 responders).<xref ref-type="ref" rid="epi412102-bib-0021">21</xref> The variability in the frequency of such metabolic etiologies may be due partially to the ethnic origin or to the different diagnostic batteries used for detection of such abnormalities. Early diagnosis of certain metabolic etiologies may permit the early initiation of appropriate treatments of WS, which, in certain cases, may ameliorate symptoms or may even lead to the resolution of the disease, such as in phenylketonuria (PKU)<xref ref-type="ref" rid="epi412102-bib-0022">22</xref> or cobalamin (vitamin B12) deficiency.<xref ref-type="ref" rid="epi412102-bib-0023">23</xref> Such cases emphasize the importance of genetic or metabolic screening of newborns when they are suspected to have metabolic diseases.<xref ref-type="ref" rid="epi412102-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412102-bib-0018">18</xref>, <xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0024">24</xref>, <xref ref-type="ref" rid="epi412102-bib-0025">25</xref>
</p>
<table-wrap id="epi412102-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Metabolic etiologies in IS</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Metabolic errors in organic molecules</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Amino acid metabolism</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">Phenylketonuria</td>
<td align="left" colspan="1" rowspan="1">Nonketotic hyperglycinemia</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Glucose metabolism &amp; transport</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">DEND</td>
<td align="left" colspan="1" rowspan="1">Persistent symptomatic hypoglycemia (specific syndromes)</td>
<td align="left" colspan="1" rowspan="1">GLUT1 deficiency</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Fatty acid oxidation</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">SCAD deficiency</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Metal metabolism</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">Menkes disease</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Vitamin B6‐, Pyridoxine dependency, &amp; pyridoxal 5′P deficiency</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Acidurias</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">
<sc>d</sc>‐Glyceric Aciduria</td>
<td align="left" colspan="1" rowspan="1">Methylmalonic acid &amp; cobalamin deficiencies</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">Homocysteinemia</td>
<td align="left" colspan="1" rowspan="1">Propionic acidemia</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Metabolic errors in organelles</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Mitochondrial disorders</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">PDHC deficiencies</td>
<td align="left" colspan="1" rowspan="1">Leigh syndrome</td>
<td align="left" colspan="1" rowspan="1">Alpers‐Huttenlocher disease</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Lysosomal storage diseases</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">Hurler syndrome</td>
<td align="left" colspan="1" rowspan="1">Niemann‐Pick disease</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other diseases</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Leukodystrophies</td>
<td align="left" colspan="1" rowspan="1">Biotinidase deficiency</td>
<td align="left" colspan="1" rowspan="1">DBP deficiency</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Biotinidase deficiency</td>
<td align="left" colspan="1" rowspan="1">Williams‐Beuren Syndrome</td>
<td align="left" colspan="1" rowspan="1">CDG</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Molybdenum cofactor deficiency</td>
<td align="left" colspan="1" rowspan="1">Primary carnitine deficiency</td>
<td align="left" colspan="1" rowspan="1">Isovaleric acidemia</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412102-note-0001">
<p>CDG, Congenital disorders of glycosylation; (DBP) D‐bifunctional protein; DEND, Developmental Delay, Epilepsy, and Neonatal Diabetes; GLUT1, Glucose Transporter 1; PDHC, Pyruvate dehydrogenase complex; SCAD, Short‐chain acyl‐coenzyme A dehydrogenase enzyme deficiency.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="epi412102-sec-0003">
<title>Metabolic Errors in Organic Molecules</title>
<sec id="epi412102-sec-0004">
<title>Deficiencies in amino acid metabolism</title>
<sec id="epi412102-sec-0005">
<title>Phenylketonuria and related disorders</title>
<p>Phenylketonuria (or PKU) is the most prevalent inborn error of metabolism, which is caused by autosomal recessive mutations in the phenylalanine hydroxylase (<italic>PAH</italic>) gene leading to mental retardation, seizures, and motor deficits if left untreated.<xref ref-type="ref" rid="epi412102-bib-0026">26</xref>, <xref ref-type="ref" rid="epi412102-bib-0027">27</xref>, <xref ref-type="ref" rid="epi412102-bib-0028">28</xref>
<italic>PAH</italic> mutations result in defect(s) in oxidation of phenylalanine (Phe) to tyrosine, a precursor of the catecholamines dopamine, norepinephrine, and epinephrine. Excess Phe metabolites inhibit dihydroxyphenylalanine (DOPA) decarboxylase, 5‐hydroxytryptophan decarboxylase, and glutamic acid decarboxylase (GAD), and interfere with myelin formation.<xref ref-type="ref" rid="epi412102-bib-0029">29</xref>, <xref ref-type="ref" rid="epi412102-bib-0030">30</xref> Increased Phe levels can be toxic to the brain, and untreated individuals develop irreversible mental dysfunction. A simple blood test can determine Phe levels and therefore PKU diagnosis.<xref ref-type="ref" rid="epi412102-bib-0031">31</xref> Although dietary restriction of Phe is the most common treatment for PKU and should be started immediately after its diagnosis, tetrahydrobiopterin (BH4) in mild cases and large neutral amino acids mainly for adult PKU cases are alternative therapies, although they are not as potent as dietary restriction; for review.<xref ref-type="ref" rid="epi412102-bib-0027">27</xref>, <xref ref-type="ref" rid="epi412102-bib-0028">28</xref>, <xref ref-type="ref" rid="epi412102-bib-0032">32</xref>
</p>
<p>In an adult population of 3,714 individuals with PKU, the prevalence of epilepsy was 5.2%.<xref ref-type="ref" rid="epi412102-bib-0033">33</xref> However, in a comprehensive retrospective study from China evaluating 503 PKU patients that included pediatric patients, seizures were found in 107 PKU patients (21.3%). 62 of them (12.3%) had WS with typical (76%) or modified (24%) hypsarrhythmic pattern recognized on EEG.<xref ref-type="ref" rid="epi412102-bib-0022">22</xref> Of interest, 82% of those patients manifested WS before PKU diagnosis could have been established. A positive correlation was present between the age of dietary restriction initiation and incidence of WS in patients, indicating that early diagnosis and treatment could prevent the evolution of WS. Supporting this, 5 patients receiving combined treatment showed amelioration in myelination on their follow‐up magnetic resonance imaging (MRI).<xref ref-type="ref" rid="epi412102-bib-0022">22</xref> Other studies also reported PKU patients presenting with hypsarrhythmic EEG and/or IS<xref ref-type="ref" rid="epi412102-bib-0034">34</xref>, <xref ref-type="ref" rid="epi412102-bib-0035">35</xref>, <xref ref-type="ref" rid="epi412102-bib-0036">36</xref>, <xref ref-type="ref" rid="epi412102-bib-0037">37</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<table-wrap id="epi412102-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Disorders of inborn errors in metabolism: clinicopathological findings and association with WS</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="6" rowspan="1" valign="top">Metabolic errors in West syndrome</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Metabolic disorder</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mode of inheritance—metabolic or gene defect</th>
<th align="left" colspan="1" rowspan="1" valign="top">Main clinical and laboratory abnormalities</th>
<th align="left" colspan="1" rowspan="1" valign="top">Brain pathology</th>
<th align="left" colspan="1" rowspan="1" valign="top">Association with IS</th>
<th align="left" colspan="1" rowspan="1" valign="top">Treatment effect on IS</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="6" rowspan="1">
<bold>Metabolic errors in organic molecules</bold>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Amino acid metabolism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Phenylketonuria (PKU)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0002" list-type="bullet"><list-item><p>AR – PAH<xref ref-type="ref" rid="epi412102-bib-0026">26</xref>, <xref ref-type="ref" rid="epi412102-bib-0027">27</xref>, <xref ref-type="ref" rid="epi412102-bib-0028">28</xref>
</p></list-item><list-item><p>AR ‐ DHPR Deficiency<xref ref-type="ref" rid="epi412102-bib-0039">39</xref>, <xref ref-type="ref" rid="epi412102-bib-0040">40</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0003" list-type="bullet"><list-item><p>↑ Phe<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>, <xref ref-type="ref" rid="epi412102-bib-0034">34</xref>, <xref ref-type="ref" rid="epi412102-bib-0035">35</xref>, <xref ref-type="ref" rid="epi412102-bib-0037">37</xref>
</p></list-item><list-item><p>Mental retardation<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>, <xref ref-type="ref" rid="epi412102-bib-0034">34</xref>, <xref ref-type="ref" rid="epi412102-bib-0035">35</xref>, <xref ref-type="ref" rid="epi412102-bib-0036">36</xref>
</p></list-item><list-item><p>*↑ Biopterin, ↓ DHPR activity<xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0036">36</xref>, <xref ref-type="ref" rid="epi412102-bib-0037">37</xref>, <xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0037">37</xref>, <xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0004" list-type="bullet"><list-item><p>Cerebral atrophy<xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p></list-item><list-item><p>Delayed myelination<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>, <xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p></list-item><list-item><p>Lesions in white matter, basal ganglia, cerebellum, brain stem<xref ref-type="ref" rid="epi412102-bib-0037">37</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0005" list-type="bullet"><list-item><p>IS with typical or modified hypsarrhythmia has been reported in up to 12% of PKU patients when pediatric population is included.<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>, <xref ref-type="ref" rid="epi412102-bib-0035">35</xref>, <xref ref-type="ref" rid="epi412102-bib-0036">36</xref>, <xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p></list-item><list-item><p>In a study, 82% of patients with PKU were diagnosed with IS prior to the diagnosis of PKU.<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>
</p></list-item><list-item><p>30.4% (7/23) of patients with PKU had hypsarrhythmia and 5 of them reported IS in.<xref ref-type="ref" rid="epi412102-bib-0035">35</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0006" list-type="bullet"><list-item><p>Protein restriction:</p><p>8/62 cases: trigger IS<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>
</p><p>17/62 cases: effective (with 77.8% relapse)<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>
</p></list-item></list>
<list id="epi412102-list-1006" list-type="bullet"><list-item><p>Protein restriction + VPA and/or NTZ: 
</p><p>11/62: effective (18.2% relapse)<xref ref-type="ref" rid="epi412102-bib-0022">22</xref>
</p></list-item></list>
<list id="epi412102-list-1007" list-type="bullet"><list-item><p>Protein restriction</p><p>effective in 2 cases, reduction in spasms in 1 case, not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0035">35</xref>
</p></list-item></list>
<list id="epi412102-list-1009" list-type="bullet"><list-item><p>(1) Corticotropin, (2) corticotropin + protein restriction
</p><p>(1) only reduction in spasms, (2) effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0036">36</xref>
</p></list-item></list>
<list id="epi412102-list-1010" list-type="bullet"><list-item><p>Protein restriction, VGB, VPA, Benzodiazepines and prednisolone: 
</p><p>no effect in 1 case<xref ref-type="ref" rid="epi412102-bib-0037">37</xref>
</p></list-item></list>
<list id="epi412102-list-1011" list-type="bullet"><list-item><p>(1) Protein restriction, L‐DOPA, 5‐HT, (2) Protein restriction, CZP (3) Protein restriction, hydrocortisone and neurotransmitter support
</p><p>(1) No effect, (2) Partial effect on myoclonus (3) effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nonketotic hyperglycinemia (NKH)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0013" list-type="bullet"><list-item><p>AR ‐ GLDC, AMT or GCSH<xref ref-type="ref" rid="epi412102-bib-0052">52</xref>, <xref ref-type="ref" rid="epi412102-bib-0053">53</xref>, <xref ref-type="ref" rid="epi412102-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412102-bib-0067">67</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0014" list-type="bullet"><list-item><p>↑ Glycine<xref ref-type="ref" rid="epi412102-bib-0067">67</xref>, <xref ref-type="ref" rid="epi412102-bib-0068">68</xref>
</p></list-item><list-item><p>Mental Retardation<xref ref-type="ref" rid="epi412102-bib-0068">68</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0067">67</xref>, <xref ref-type="ref" rid="epi412102-bib-0068">68</xref>
</p></list-item><list-item><p>Abnormal BAEP<xref ref-type="ref" rid="epi412102-bib-0066">66</xref>
</p></list-item><list-item><p>Abnormal visual responses<xref ref-type="ref" rid="epi412102-bib-0066">66</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0015" list-type="bullet"><list-item><p>Brain atrophy<xref ref-type="ref" rid="epi412102-bib-0067">67</xref>
</p></list-item><list-item><p>Bilateral subcortical heterotopia<xref ref-type="ref" rid="epi412102-bib-0067">67</xref>
</p></list-item><list-item><p>Choroid plexus cysts<xref ref-type="ref" rid="epi412102-bib-0068">68</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0016" list-type="bullet"><list-item><p>Case reports with IS, hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412102-bib-0065">65</xref>, <xref ref-type="ref" rid="epi412102-bib-0066">66</xref>, <xref ref-type="ref" rid="epi412102-bib-0067">67</xref>, <xref ref-type="ref" rid="epi412102-bib-0068">68</xref>, <xref ref-type="ref" rid="epi412102-bib-0343">343</xref>
</p></list-item><list-item><p>IS/hypsarrhythmia are considered common among neonatal NKH survivors beyond neonatal age.<xref ref-type="ref" rid="epi412102-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412102-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412102-bib-0064">64</xref>
</p></list-item><list-item><p>0.7% (1/134) of IS patients with metabolic screening in<xref ref-type="ref" rid="epi412102-bib-0009">9</xref> had NKH.</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0017" list-type="bullet"><list-item><p>NTZ &amp; PHT
</p><p>No effect in 2 cases<xref ref-type="ref" rid="epi412102-bib-0065">65</xref>
</p></list-item></list>
<list id="epi412102-list-0027" list-type="bullet"><list-item><p>AEDs (unmentioned)</p><p>No effect in 3 cases<xref ref-type="ref" rid="epi412102-bib-0067">67</xref>
</p></list-item></list>
<list id="epi412102-list-0217" list-type="bullet"><list-item><p>Sodium benzoate, ketamine, dextromethorphan, VGB, PHB, PHT, CZP, diazepam, ACTH 
</p><p>Only reduction in seizures, developmental delay persists in 1 case<xref ref-type="ref" rid="epi412102-bib-0068">68</xref>
</p><p>Case reports of vigabatrin‐induced acute encephalopathy reported in two infants with NKH<xref ref-type="ref" rid="epi412102-bib-0343">343</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Glucose metabolism and transport</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Developmental delay, epilepsy and neonatal diabetes (DEND)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0021" list-type="bullet"><list-item><p>AD ‐ KCNJ11<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0022" list-type="bullet"><list-item><p>Neonatal Diabetes<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>
</p></list-item><list-item><p>Ptosis<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>
</p></list-item><list-item><p>Dysmorphic features<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0023" list-type="bullet"><list-item><p>Normal<xref ref-type="ref" rid="epi412102-bib-0081">81</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0024" list-type="bullet"><list-item><p>Case reports of IS &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0025" list-type="bullet"><list-item><p>(1) Insulin, (2) PHB, VGB, PHT, ACTH (3) ACTH and glucocorticosteroids + Sulfonylurea
</p><p>(1) effective against DM, (2) not effective, (3) effective in 1 case but the patient died after initial amelioration<xref ref-type="ref" rid="epi412102-bib-0080">80</xref>
</p></list-item></list>
<list id="epi412102-list-0125" list-type="bullet"><list-item><p>(1) Insulin, (2) Pyridoxine, PHB, VGB, TPR, LEV, clobazam, VPA, (3) Sulfonylurea
</p><p>(1) effective against DM, (2) only transient and partial reduction of the seizures, (3) Effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0081">81</xref>
</p></list-item></list>
<list id="epi412102-list-0225" list-type="bullet"><list-item><p>Sulfonylurea
</p><p>effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0082">82</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Persistent symptomatic hypoglycemia probably associated with several underlying etiologies that may have contributed to the outcome</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0029" list-type="bullet"><list-item><p>↓Glucose<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0087">87</xref>, <xref ref-type="ref" rid="epi412102-bib-0088">88</xref>, <xref ref-type="ref" rid="epi412102-bib-0344">344</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item><list-item><p>Microcephaly<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0030" list-type="bullet"><list-item><p>Normal<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0087">87</xref>, <xref ref-type="ref" rid="epi412102-bib-0088">88</xref>
</p></list-item><list-item><p>Uni‐ or bilateral parietooccipital cyst<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>, <xref ref-type="ref" rid="epi412102-bib-0088">88</xref>
</p></list-item><list-item><p>Abnormal occipital/parietal signal<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0088">88</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0031" list-type="bullet"><list-item><p>IS &amp; Typical/modified hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0087">87</xref>, <xref ref-type="ref" rid="epi412102-bib-0088">88</xref>, <xref ref-type="ref" rid="epi412102-bib-0344">344</xref>
</p></list-item><list-item><p>IS<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item><list-item><p>IS &amp; bilateral epileptic activity<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0032" list-type="bullet"><list-item><p>(1) Glucose infusion and prednisolone, (2) +diazoxide and nifedipine, (3) +ACTH, (4) no effect ACTH, positive effect with PHB</p><p>1: No effect, 2: Effect on hypoglycemia, (3) Effect on spasms, (4) continued therapy in 1 case<xref ref-type="ref" rid="epi412102-bib-0344">344</xref>
</p></list-item></list>
<list id="epi412102-list-0033" list-type="bullet"><list-item><p>(1) Diazoxide, chlorothiazide, (2) +VPA, ACTH, prednisolone (3) VGB, Lamotrigine</p><p>(1) Effect on hypoglycemia, (2) No effect on spasms, (3) controlled seizures in 1 case<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item></list>
<list id="epi412102-list-0034" list-type="bullet"><list-item><p>(1) Diazoxide, (2) VGB, prednisolone (3) VPA, TPR (4) LEV</p><p>(1) Effect on hypoglycemia, (2) no effect on spasms (3) reduction in spasms, (4) reduction in seizures in 1 case<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item></list>
<list id="epi412102-list-0035" list-type="bullet"><list-item><p>(1) Diazoxide, chlorothiazide, (2) prednisolone, currently CBZ</p><p>(1) Effect on hypoglycemia, (2) reduction in spasms in 1 case<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item></list>
<list id="epi412102-list-0036" list-type="bullet"><list-item><p>(1) Pancreatectomy, (2) ACTH</p><p>(1) DM development (2) IS stopped, developmental delay persists in 1 case<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item></list>
<list id="epi412102-list-0037" list-type="bullet"><list-item><p>(1) Pancreatectomy, (2) VGB (1) DM development, (2) N/A<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>
</p></list-item></list>
<list id="epi412102-list-0038" list-type="bullet"><list-item><p>VGB</p><p>Spasms resolved but focal seizures continued in 1 case, not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLUT1 deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0039" list-type="bullet"><list-item><p>Deficiency in glucose transporter<xref ref-type="ref" rid="epi412102-bib-0104">104</xref>, <xref ref-type="ref" rid="epi412102-bib-0106">106</xref>
</p></list-item><list-item><p>SLC2A1 mutation<xref ref-type="ref" rid="epi412102-bib-0112">112</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0040" list-type="bullet"><list-item><p>↓Glucose<xref ref-type="ref" rid="epi412102-bib-0104">104</xref>, <xref ref-type="ref" rid="epi412102-bib-0111">111</xref>
</p></list-item><list-item><p>↓Lactate<xref ref-type="ref" rid="epi412102-bib-0104">104</xref>
</p></list-item><list-item><p>↓ CSF/blood glucose<xref ref-type="ref" rid="epi412102-bib-0104">104</xref>, <xref ref-type="ref" rid="epi412102-bib-0111">111</xref>, <xref ref-type="ref" rid="epi412102-bib-0112">112</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0111">111</xref>
</p></list-item><list-item><p>Microcephaly<xref ref-type="ref" rid="epi412102-bib-0111">111</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0041" list-type="bullet"><list-item><p>Normal<xref ref-type="ref" rid="epi412102-bib-0111">111</xref>, <xref ref-type="ref" rid="epi412102-bib-0112">112</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0042" list-type="bullet"><list-item><p>Convulsions, IS<xref ref-type="ref" rid="epi412102-bib-0111">111</xref>
</p></list-item><list-item><p>IS‐flexion &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0112">112</xref>
</p></list-item><list-item><p>Rare association with IS</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0242" list-type="bullet"><list-item><p>(1) ACTH, (2) Pyridoxine, biotin folinic acid, (3) Ketogenic diet</p><p>1&amp;2: no effect, 3: effect on IS and seizures in 1 case<xref ref-type="ref" rid="epi412102-bib-0111">111</xref>
</p></list-item><list-item><p>Ketogenic diet</p><p>Effect on seizures, developmental delay persists with slight improvement in 1 case<xref ref-type="ref" rid="epi412102-bib-0112">112</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Fatty acid oxidation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCAD deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0043" list-type="bullet"><list-item><p>AR‐ACADS<xref ref-type="ref" rid="epi412102-bib-0116">116</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0044" list-type="bullet"><list-item><p>↑ Ethylmalonic acid<xref ref-type="ref" rid="epi412102-bib-0117">117</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0117">117</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0045" list-type="bullet"><list-item><p>Hypoplastic corpus callosum without splenium and rostrum<xref ref-type="ref" rid="epi412102-bib-0117">117</xref>
</p></list-item><list-item><p>Abnormal cortical gyri<xref ref-type="ref" rid="epi412102-bib-0117">117</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0046" list-type="bullet"><list-item><p>One case report with generalized tonic‐clonic seizures, IS &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0117">117</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0243" list-type="bullet"><list-item><p>(1) ACTH, (2) NTZ, TPR, gamma globulin, ZNS</p><p>(1) partial effect, (2) no effect in 1 case<xref ref-type="ref" rid="epi412102-bib-0117">117</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Metal metabolism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Menkes disease</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0047" list-type="bullet"><list-item><p>XR ‐ATP7A<xref ref-type="ref" rid="epi412102-bib-0125">125</xref>, <xref ref-type="ref" rid="epi412102-bib-0127">127</xref>, <xref ref-type="ref" rid="epi412102-bib-0128">128</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref>, <xref ref-type="ref" rid="epi412102-bib-0131">131</xref>, <xref ref-type="ref" rid="epi412102-bib-0132">132</xref>, <xref ref-type="ref" rid="epi412102-bib-0133">133</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0048" list-type="bullet"><list-item><p>↓ Cu &amp; ↓ Ceruloplasmin<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412102-bib-0125">125</xref>, <xref ref-type="ref" rid="epi412102-bib-0128">128</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref>
</p></list-item><list-item><p>Mental retardation<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412102-bib-0125">125</xref>, <xref ref-type="ref" rid="epi412102-bib-0128">128</xref>
</p></list-item><list-item><p>Hypopigmentation in skin<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref>
</p></list-item><list-item><p>Fragile hair<xref ref-type="ref" rid="epi412102-bib-0125">125</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0049" list-type="bullet"><list-item><p>Ventricular dilatation<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>
</p></list-item><list-item><p>Abnormal cerebral vessels<xref ref-type="ref" rid="epi412102-bib-0125">125</xref>, <xref ref-type="ref" rid="epi412102-bib-0128">128</xref>, <xref ref-type="ref" rid="epi412102-bib-0129">129</xref>
</p></list-item><list-item><p>Cortical atrophy<sup>125,128</sup>,<xref ref-type="ref" rid="epi412102-bib-0129">129</xref>
</p></list-item><list-item><p>Delayed myelination<xref ref-type="ref" rid="epi412102-bib-0129">129</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0050" list-type="bullet"><list-item><p>IS are common in Menkes disease; all infants with Menkes disease had IS in<xref ref-type="ref" rid="epi412102-bib-0126">126</xref>
</p></list-item><list-item><p>IS, multifocal clonic seizures &amp; Hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>
</p></list-item><list-item><p>IS with/out slow and asymmetric background activity with multifocal spikes and slow wave discharges<xref ref-type="ref" rid="epi412102-bib-0125">125</xref>
</p></list-item><list-item><p>IS &amp; (modified) hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0127">127</xref>, <xref ref-type="ref" rid="epi412102-bib-0129">129</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref>
</p></list-item><list-item><p>IS &amp; diffuse irregular slow waves and spike waves<xref ref-type="ref" rid="epi412102-bib-0126">126</xref>
</p></list-item><list-item><p>IS, partial seizures &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0128">128</xref>
</p></list-item><list-item><p>IS, focal seizures &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0129">129</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0244" list-type="bullet"><list-item><p>(1) Cu‐His therapy (2) PHB, primidone, PHT, CZP, VPA</p><p>(1) Partial effect only initially, (2) Not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>
</p></list-item><list-item><p>Cu‐His, VGB/NTZ</p><p>Effect on Cu level but only partial effect on IS in 2 cases<xref ref-type="ref" rid="epi412102-bib-0125">125</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Vitamin B6, pyridoxine dependency and pyridoxal 5′P deficiency</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vitamin B6, Pyridoxine dependency and Pyridoxal 5′P deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0051" list-type="bullet"><list-item><p>AR – PNPO<xref ref-type="ref" rid="epi412102-bib-0164">164</xref>, <xref ref-type="ref" rid="epi412102-bib-0165">165</xref>
</p></list-item><list-item><p>AR ‐ ALDH7A1<xref ref-type="ref" rid="epi412102-bib-0166">166</xref>, <xref ref-type="ref" rid="epi412102-bib-0167">167</xref>, <xref ref-type="ref" rid="epi412102-bib-0168">168</xref>, <xref ref-type="ref" rid="epi412102-bib-0169">169</xref>, <xref ref-type="ref" rid="epi412102-bib-0170">170</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0052" list-type="bullet"><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0165">165</xref>, <xref ref-type="ref" rid="epi412102-bib-0169">169</xref>
</p></list-item><list-item><p>Mental retardation<xref ref-type="ref" rid="epi412102-bib-0168">168</xref>
</p></list-item><list-item><p>Tonic‐clonic convulsions, myoclonic jerks following pyridoxine withdrawal test<xref ref-type="ref" rid="epi412102-bib-0168">168</xref>
</p></list-item><list-item><p>↑ Pipecolic acid<xref ref-type="ref" rid="epi412102-bib-0169">169</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0053" list-type="bullet"><list-item><p>Atrophy<xref ref-type="ref" rid="epi412102-bib-0165">165</xref>
</p></list-item><list-item><p>Increased subarachnoidal space<xref ref-type="ref" rid="epi412102-bib-0165">165</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0054" list-type="bullet"><list-item><p>Myoclonic, multifocal seizures, IS‐flexion &amp; suppression‐burst activity<xref ref-type="ref" rid="epi412102-bib-0165">165</xref>
</p></list-item><list-item><p>Generalized tonic clonic seizures &amp; hypsarrhythmia in 3 cases<xref ref-type="ref" rid="epi412102-bib-0168">168</xref>
</p></list-item><list-item><p>IS, hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0169">169</xref>
</p></list-item><list-item><p>13% (7/53) of patients with pyridoxine‐dependent and/or responsive seizures had IS.<xref ref-type="ref" rid="epi412102-bib-0345">345</xref>
</p></list-item><list-item><p>64% of late‐onset patients with pyridoxine‐responsive and/or dependent seizures had IS.<xref ref-type="ref" rid="epi412102-bib-0345">345</xref>
</p></list-item><list-item><p>0.8% (1/127) of patients with IS had pyridoxine dependency.<xref ref-type="ref" rid="epi412102-bib-0192">192</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0245" list-type="bullet"><list-item><p>13% (7/53) of patients with pyridoxine‐dependent and/or responsive seizures had IS.<xref ref-type="ref" rid="epi412102-bib-0345">345</xref>
</p></list-item><list-item><p>Pyridoxine, benzodiazepine, VGB, TPR, ACTH, PHB, CZP, VPA, clobazam, pyridoxine, ketogenic diet</p><p>No effect in 1 case (PLP‐never tried)<xref ref-type="ref" rid="epi412102-bib-0165">165</xref>
</p></list-item><list-item><p>(1) VGB, (2) ACTH, (3) Pyridoxine</p><p>(1 &amp; 2) Not effective, (3) effective but autism spectrum disorder persists in 1 case<xref ref-type="ref" rid="epi412102-bib-0169">169</xref>
</p></list-item><list-item><p>Pyridoxine</p><p>Effective in 3 cases<xref ref-type="ref" rid="epi412102-bib-0169">169</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Acidurias</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">D‐Glyceric aciduria (D‐GA)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0055" list-type="bullet"><list-item><p>AR – GLYCTK<xref ref-type="ref" rid="epi412102-bib-0176">176</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0056" list-type="bullet"><list-item><p>↑ Glyceric Acid<xref ref-type="ref" rid="epi412102-bib-0176">176</xref>, <xref ref-type="ref" rid="epi412102-bib-0177">177</xref>, <xref ref-type="ref" rid="epi412102-bib-0178">178</xref>, <xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item><list-item><p>Autistic behavior<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item><list-item><p>Motor and mental retardation<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0057" list-type="bullet"><list-item><p>Delayed myelination<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item><list-item><p>Cerebral atrophy<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item><list-item><p>Increased T2 signal from mesencephalon, pontine tegmentum, bilateral dentate nuclei, globus pallidus and thalami<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0058" list-type="bullet"><list-item><p>One case report with IS.<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item><list-item><p>Epileptic fits &amp; multifocal generalized activity with hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0059" list-type="bullet"><list-item><p>(1) VGB, (2) ACTH, (3) fructose‐restricted diet + VGB + diazepam</p><p>(1) Not effective, (2 &amp; 3) partially effective, dietary restriction resolve MRI abnormalities in mesencephalon, thalami and globus pallidus, in 1 case<xref ref-type="ref" rid="epi412102-bib-0179">179</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Methylmalonic Aciduria &amp; B12 Deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0060" list-type="bullet"><list-item><p>AR – MUT<xref ref-type="ref" rid="epi412102-bib-0183">183</xref>, <xref ref-type="ref" rid="epi412102-bib-0186">186</xref>, <xref ref-type="ref" rid="epi412102-bib-0187">187</xref>, <xref ref-type="ref" rid="epi412102-bib-0188">188</xref>, <xref ref-type="ref" rid="epi412102-bib-0189">189</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0061" list-type="bullet"><list-item><p>↑ MMA<xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0189">189</xref>, <xref ref-type="ref" rid="epi412102-bib-0190">190</xref>
</p></list-item><list-item><p>↓ B12<xref ref-type="ref" rid="epi412102-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412102-bib-0190">190</xref>, <xref ref-type="ref" rid="epi412102-bib-0191">191</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412102-bib-0189">189</xref>
</p></list-item><list-item><p>Macrocytic anemia<xref ref-type="ref" rid="epi412102-bib-0190">190</xref>
</p></list-item><list-item><p>Pernicious anemia<xref ref-type="ref" rid="epi412102-bib-0191">191</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412102-bib-0189">189</xref>, <xref ref-type="ref" rid="epi412102-bib-0190">190</xref>
</p></list-item><list-item><p>Abnormal BAEP<xref ref-type="ref" rid="epi412102-bib-0019">19</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0062" list-type="bullet"><list-item><p>Abnormal signal from 2 globi pallidi<xref ref-type="ref" rid="epi412102-bib-0189">189</xref>
</p></list-item><list-item><p>Cerebral atrophy<xref ref-type="ref" rid="epi412102-bib-0191">191</xref>
</p></list-item><list-item><p>Delayed myelination<xref ref-type="ref" rid="epi412102-bib-0191">191</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0063" list-type="bullet"><list-item><p>IS &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412102-bib-0189">189</xref>, <xref ref-type="ref" rid="epi412102-bib-0190">190</xref>
</p></list-item><list-item><p>10% of IS patients in<xref ref-type="ref" rid="epi412102-bib-0019">19</xref> had methylmalonic aciduria</p></list-item><list-item><p>0.7% (1/134) of IS patients with metabolic screening in<xref ref-type="ref" rid="epi412102-bib-0009">9</xref> had methylmalonic aciduria</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0248" list-type="bullet"><list-item><p>Biotin, L‐carnitine, BH4, Vitamin B12, B1 and B2</p><p>Not effective in 1 case, partially effective on seizures in 2 cases, effective in 3 cases<xref ref-type="ref" rid="epi412102-bib-0019">19</xref>
</p></list-item><list-item><p>Low protein diet, L‐carnitine, hydroxycobalamin and VGB, lamotrigine, hydrocortisone</p><p>First 3 treatments are effective on MMA and the rest effective on IS, hypsarrhythmia resolves by time, developmental delay persists in 1 case<xref ref-type="ref" rid="epi412102-bib-0189">189</xref>
</p></list-item><list-item><p>Cyanocobalamin, PHB, ACTH</p><p>Effective in 2 cases<xref ref-type="ref" rid="epi412102-bib-0023">23</xref>
</p></list-item><list-item><p>ACTH and Vitamin B12</p><p>Effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0190">190</xref>
</p></list-item><list-item><p>B12</p><p>Triggered IS that is responsive to anti‐seizure treatment<xref ref-type="ref" rid="epi412102-bib-0191">191</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Homocysteinemias</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0064" list-type="bullet"><list-item><p>AR –MTHFR<xref ref-type="ref" rid="epi412102-bib-0200">200</xref>, <xref ref-type="ref" rid="epi412102-bib-0201">201</xref>, <xref ref-type="ref" rid="epi412102-bib-0202">202</xref>, <xref ref-type="ref" rid="epi412102-bib-0204">204</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0065" list-type="bullet"><list-item><p>↑Homocysteine (maybe also ↓ B12)<xref ref-type="ref" rid="epi412102-bib-0200">200</xref>, <xref ref-type="ref" rid="epi412102-bib-0201">201</xref>, <xref ref-type="ref" rid="epi412102-bib-0202">202</xref>, <xref ref-type="ref" rid="epi412102-bib-0204">204</xref>
</p></list-item><list-item><p>↓ CS activity<xref ref-type="ref" rid="epi412102-bib-0200">200</xref>, <xref ref-type="ref" rid="epi412102-bib-0201">201</xref>, <xref ref-type="ref" rid="epi412102-bib-0202">202</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0204">204</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0066" list-type="bullet"><list-item><p>Demyelination<xref ref-type="ref" rid="epi412102-bib-0204">204</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0067" list-type="bullet"><list-item><p>Case report with IS &amp; hypsarrhythmia and drug resistant epilepsy with episodes of status epilepticus.<xref ref-type="ref" rid="epi412102-bib-0204">204</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0249" list-type="bullet"><list-item><p>Betaine, methionine, folic acid, corpus callosotomy, vagal nerve stimulation</p><p>Not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0204">204</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Propionic Acidemia</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0068" list-type="bullet"><list-item><p>AR – PCC<xref ref-type="ref" rid="epi412102-bib-0215">215</xref>, <xref ref-type="ref" rid="epi412102-bib-0216">216</xref>, <xref ref-type="ref" rid="epi412102-bib-0217">217</xref>, <xref ref-type="ref" rid="epi412102-bib-0218">218</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0069" list-type="bullet"><list-item><p>Glycinuria<xref ref-type="ref" rid="epi412102-bib-0222">222</xref>
</p></list-item><list-item><p>Propionic academia<xref ref-type="ref" rid="epi412102-bib-0222">222</xref>
</p></list-item><list-item><p>Deficient propionyl CoA activity<xref ref-type="ref" rid="epi412102-bib-0222">222</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0070" list-type="bullet"><list-item><p>Case report with myoclonic seizures &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0222">222</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0071" list-type="bullet"><list-item><p>ACTH and later protein restriction Seizures stopped but developmental delay persisted in 1 case<xref ref-type="ref" rid="epi412102-bib-0222">222</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">
<bold><italic>Metabolic errors in organelles</italic></bold>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Mitochondrial disorders</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pyruvate dehydrogenase complex (PDHC) deficiencies</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0072" list-type="bullet"><list-item><p>PDHC deficiency</p></list-item><list-item><p>X‐linked‐PDHC E1α<xref ref-type="ref" rid="epi412102-bib-0001">1</xref>, <xref ref-type="ref" rid="epi412102-bib-0229">229</xref>, <xref ref-type="ref" rid="epi412102-bib-0230">230</xref>, <xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0232">232</xref>, <xref ref-type="ref" rid="epi412102-bib-0233">233</xref>, <xref ref-type="ref" rid="epi412102-bib-0234">234</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0073" list-type="bullet"><list-item><p>Lactic acidosis<xref ref-type="ref" rid="epi412102-bib-0233">233</xref>, <xref ref-type="ref" rid="epi412102-bib-0234">234</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0233">233</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref>
</p></list-item><list-item><p>Hydrocephalus<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0233">233</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref>
</p></list-item><list-item><p>Abnormal facies<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref>
</p></list-item><list-item><p>Microcephaly<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0233">233</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0074" list-type="bullet"><list-item><p>Cortical atrophy<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0233">233</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0075" list-type="bullet"><list-item><p>Seizures &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>
</p></list-item><list-item><p>IS &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0233">233</xref>, <xref ref-type="ref" rid="epi412102-bib-0234">234</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>
</p></list-item><list-item><p>IS‐flexion &amp; multiple spike and slow wave discharges<xref ref-type="ref" rid="epi412102-bib-0236">236</xref>
</p></list-item><list-item><p>30% (9/30) of female patients with PDHC had WS.<xref ref-type="ref" rid="epi412102-bib-0234">234</xref>
</p></list-item><list-item><p>3% (1/30) of male patients with PDHC had WS.<xref ref-type="ref" rid="epi412102-bib-0234">234</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0250" list-type="bullet"><list-item><p>High fat diet, biotin, lipoic acid, thiamine</p><p>Not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>
</p></list-item><list-item><p>Thiamine, bicarbonate, biotin, folic acid</p><p>Not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>
</p></list-item><list-item><p>Thiamine + ketogenic diet and Thiamine + DCA</p><p>Mildly effective in 1 case and effective in the same case, respectively, but developmental delay persists<xref ref-type="ref" rid="epi412102-bib-0233">233</xref>
</p></list-item><list-item><p>DCA + Vitamin B1</p><p>Effective in 3 cases, not effective in 3 cases<xref ref-type="ref" rid="epi412102-bib-0234">234</xref>
</p></list-item><list-item><p>DCA + Vitamin B1 + Vitamin b6 + ZNS</p><p>Effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0234">234</xref>
</p></list-item><list-item><p>Multiple therapies [Vitamin B6, VPA + CZP, Thiamine, DCA]</p><p>B6‐not effective, the rest‐mild effect in 1 case<xref ref-type="ref" rid="epi412102-bib-0235">235</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Leigh and Leigh‐like syndrome</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0076" list-type="bullet"><list-item><p>Nuclear (including PDHC) or mitochondrial variants of genes involved in cellular energy production<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0245">245</xref>, <xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0247">247</xref>, <xref ref-type="ref" rid="epi412102-bib-0248">248</xref>, <xref ref-type="ref" rid="epi412102-bib-0249">249</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0077" list-type="bullet"><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0248">248</xref>, <xref ref-type="ref" rid="epi412102-bib-0249">249</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>↑ Lactate or pyruvate<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>Spasticity<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>
</p></list-item><list-item><p>Optic atrophy/retinopathy<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>Cardiac problems<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>
</p></list-item><list-item><p>Cytochrome c oxidase deficiency<xref ref-type="ref" rid="epi412102-bib-0250">250</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0078" list-type="bullet"><list-item><p>Basal ganglia lesions [80%]<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>Thalamus lesions [40%]<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>
</p></list-item><list-item><p>SN lesions [40%]<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0249">249</xref>
</p></list-item><list-item><p>Putamen and brain stem lesions<xref ref-type="ref" rid="epi412102-bib-0248">248</xref>, <xref ref-type="ref" rid="epi412102-bib-0249">249</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>
</p></list-item><list-item><p>Cerebral white matter myelination abnormalities<xref ref-type="ref" rid="epi412102-bib-0249">249</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0079" list-type="bullet"><list-item><p>IS‐flexion or extensor &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0248">248</xref>, <xref ref-type="ref" rid="epi412102-bib-0249">249</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>Clonic convulsions, myoclonic seizures, apneic seizures, hemiconvulsions, opsoclonus‐myoclonus<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>Tonic seizures<xref ref-type="ref" rid="epi412102-bib-0249">249</xref>
</p></list-item><list-item><p>Tonic‐clonic convulsions<xref ref-type="ref" rid="epi412102-bib-0250">250</xref>
</p></list-item><list-item><p>0.7% (1/141) of IS patients with genetic testing had Leigh disease in<xref ref-type="ref" rid="epi412102-bib-0009">9</xref>
</p></list-item><list-item><p>2/80 (2.5%) of patients with IS had clinical Leigh‐like syndrome in<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0251" list-type="bullet"><list-item><p>VGB</p><p>Not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>ACTH</p><p>Effective in 2 cases, not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>
</p></list-item><list-item><p>CZP</p><p>Effective in 2 cases,<xref ref-type="ref" rid="epi412102-bib-0250">250</xref> Effective only in myoclonus in 1 case<xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item><list-item><p>Vitamin B6</p><p>Mildly effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0249">249</xref>
</p></list-item><list-item><p>CBZ and ACTH</p><p>Effective in seizures in 1 case, developmental delay persists<xref ref-type="ref" rid="epi412102-bib-0250">250</xref>
</p></list-item><list-item><p>VGB, +Hydrocortisone or +CZP</p><p>Effective on IS in 3 cases, developmental delay persisted in all<xref ref-type="ref" rid="epi412102-bib-0251">251</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Alpers‐Huttenlocher disease</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0080" list-type="bullet"><list-item><p>Respiratory chain complex 1 deficiency<xref ref-type="ref" rid="epi412102-bib-0260">260</xref>
</p></list-item><list-item><p>FARS2<xref ref-type="ref" rid="epi412102-bib-0262">262</xref>, <xref ref-type="ref" rid="epi412102-bib-0263">263</xref>
</p></list-item><list-item><p>POLG mutations<xref ref-type="ref" rid="epi412102-bib-0259">259</xref>, <xref ref-type="ref" rid="epi412102-bib-0260">260</xref>, <xref ref-type="ref" rid="epi412102-bib-0261">261</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0081" list-type="bullet"><list-item><p>Liver dysfunction<xref ref-type="ref" rid="epi412102-bib-0259">259</xref>, <xref ref-type="ref" rid="epi412102-bib-0260">260</xref>, <xref ref-type="ref" rid="epi412102-bib-0261">261</xref>
</p></list-item><list-item><p>Mental retardation<xref ref-type="ref" rid="epi412102-bib-0260">260</xref>
</p></list-item><list-item><p>Spasticity<xref ref-type="ref" rid="epi412102-bib-0260">260</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0082" list-type="bullet"><list-item><p>Generalized, symmetric cortical atrophy<xref ref-type="ref" rid="epi412102-bib-0260">260</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0083" list-type="bullet"><list-item><p>IS, hypsarrhythmia, myoclonic jerks (complex I deficiency)<xref ref-type="ref" rid="epi412102-bib-0260">260</xref>
</p></list-item><list-item><p>27% (3/11) reported patients with FARS2 mutations have IS and hypsarrhythmia, one also had focal seizures<xref ref-type="ref" rid="epi412102-bib-0262">262</xref>, <xref ref-type="ref" rid="epi412102-bib-0263">263</xref>
</p></list-item><list-item><p>No known cases of POLG mutations and IS</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Lysosomal storage diseases</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
Hurler Syndrome<break></break>
Niemann Pick Disease
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0084" list-type="bullet"><list-item><p>Low a‐L‐iduronidase (IDUA) activity)<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item><list-item><p>AR – SMPD1<xref ref-type="ref" rid="epi412102-bib-0270">270</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0085" list-type="bullet"><list-item><p>↓α‐L‐iduronidase activity (Hurler syndrome)<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item><list-item><p>↓ SMPD enzyme (NPD)<xref ref-type="ref" rid="epi412102-bib-0270">270</xref>
</p></list-item><list-item><p>Psychomotor retardation<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item><list-item><p>Opaque cornea<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item><list-item><p>Diminished bone density<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0086" list-type="bullet"><list-item><p>Dilatation of ventricles<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item><list-item><p>Hydrocephalus<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0087" list-type="bullet"><list-item><p>Case reports of IS &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>, <xref ref-type="ref" rid="epi412102-bib-0270">270</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0088" list-type="bullet"><list-item><p>VGB, TPR, Corticotrophin, VPA, surgical intervention</p><p>No effect in 1 case<xref ref-type="ref" rid="epi412102-bib-0269">269</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">
<bold>Other diseases</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
Leukodystrophies<break></break>
Alexander disease<break></break>
Krabbe Disease
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0089" list-type="bullet"><list-item><p>AD ‐ GFAP<xref ref-type="ref" rid="epi412102-bib-0282">282</xref>, <xref ref-type="ref" rid="epi412102-bib-0283">283</xref>
</p></list-item><list-item><p>AR ‐ GALC<xref ref-type="ref" rid="epi412102-bib-0284">284</xref>, <xref ref-type="ref" rid="epi412102-bib-0285">285</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0090" list-type="bullet"><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0282">282</xref>, <xref ref-type="ref" rid="epi412102-bib-0283">283</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0091" list-type="bullet"><list-item><p>Demyelination<xref ref-type="ref" rid="epi412102-bib-0282">282</xref>
</p></list-item><list-item><p>White matter degeneration<xref ref-type="ref" rid="epi412102-bib-0277">277</xref>, <xref ref-type="ref" rid="epi412102-bib-0278">278</xref>, <xref ref-type="ref" rid="epi412102-bib-0279">279</xref>, <xref ref-type="ref" rid="epi412102-bib-0280">280</xref>
</p></list-item><list-item><p>Spongy vacuolation<xref ref-type="ref" rid="epi412102-bib-0277">277</xref>, <xref ref-type="ref" rid="epi412102-bib-0278">278</xref>, <xref ref-type="ref" rid="epi412102-bib-0279">279</xref>, <xref ref-type="ref" rid="epi412102-bib-0280">280</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0092" list-type="bullet"><list-item><p>Case reports IS</p></list-item><list-item><p>IS‐flexion &amp; hysparrhythmia<xref ref-type="ref" rid="epi412102-bib-0282">282</xref>
</p></list-item><list-item><p>IS &amp; convulsions<xref ref-type="ref" rid="epi412102-bib-0283">283</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0252" list-type="bullet"><list-item><p>VGB</p><p>Effective on IS but developmental delay and other seizures persist in 1 case<xref ref-type="ref" rid="epi412102-bib-0282">282</xref>
</p></list-item><list-item><p>ACTH</p><p>Effective only on IS in 1 case but developmental delay persists<xref ref-type="ref" rid="epi412102-bib-0283">283</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Biotinidase deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0093" list-type="bullet"><list-item><p>AR ‐ BTD<xref ref-type="ref" rid="epi412102-bib-0291">291</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item><list-item><p>↓ BTD activity<xref ref-type="ref" rid="epi412102-bib-0289">289</xref>, <xref ref-type="ref" rid="epi412102-bib-0290">290</xref>, <xref ref-type="ref" rid="epi412102-bib-0291">291</xref>, <xref ref-type="ref" rid="epi412102-bib-0292">292</xref>, <xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0094" list-type="bullet"><list-item><p>Red skin rashes<xref ref-type="ref" rid="epi412102-bib-0290">290</xref>, <xref ref-type="ref" rid="epi412102-bib-0292">292</xref>
</p></list-item><list-item><p>Lactic aciduria<xref ref-type="ref" rid="epi412102-bib-0290">290</xref>, <xref ref-type="ref" rid="epi412102-bib-0292">292</xref>
</p></list-item><list-item><p>↑ alanine<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item><list-item><p>Alopecia<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item><list-item><p>Optic atrophy<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>BAEP abnormalities<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0095" list-type="bullet"><list-item><p>Normal<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>Atrophy<xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0096" list-type="bullet"><list-item><p>Case reports IS</p></list-item><list-item><p>IS &amp; burst suppression pattern<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>Only IS and convulsions<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>IS‐flexion spasms &amp;hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0253" list-type="bullet"><list-item><p>Corticotropin &amp; PHB</p><p>Partially effective on IS in 1<sup>st</sup> case<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>Biotin supplement</p><p>Effective on IS but persisting developmental delay in 1<sup>st</sup> and 2<sup>nd</sup> case<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>Corticotropin</p><p>Partial effect on IS in 2<sup>nd</sup> case<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>PHB +VPA</p><p>No effect on convulsions in 2<sup>nd</sup> case<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p></list-item><list-item><p>(1) PHB +VPA, (2) Phenytoin, (3) Biotin+VGB, (4) Biotin + VGB + TPR</p><p>(1) No effect on IS, (2) effective on IS, (3) Partial effect in 1 case (4) Effective in 1 case, developmental delay persists<xref ref-type="ref" rid="epi412102-bib-0294">294</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">D‐Bifunctional protein (DBP) deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0097" list-type="bullet"><list-item><p>AR ‐ HSD17B4<xref ref-type="ref" rid="epi412102-bib-0298">298</xref>, <xref ref-type="ref" rid="epi412102-bib-0299">299</xref>, <xref ref-type="ref" rid="epi412102-bib-0300">300</xref>
</p></list-item><list-item><p>↓ DBP activity<xref ref-type="ref" rid="epi412102-bib-0298">298</xref>, <xref ref-type="ref" rid="epi412102-bib-0299">299</xref>, <xref ref-type="ref" rid="epi412102-bib-0300">300</xref>, <xref ref-type="ref" rid="epi412102-bib-0301">301</xref>, <xref ref-type="ref" rid="epi412102-bib-0302">302</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0098" list-type="bullet"><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0302">302</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0099" list-type="bullet"><list-item><p>Abnormal periventricular white matter<xref ref-type="ref" rid="epi412102-bib-0302">302</xref>
</p></list-item><list-item><p>Septum pellucidum cyst<xref ref-type="ref" rid="epi412102-bib-0302">302</xref>
</p></list-item><list-item><p>Hypoplastic corpus callosum<xref ref-type="ref" rid="epi412102-bib-0302">302</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0100" list-type="bullet"><list-item><p>Case report of IS &amp; modified hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0302">302</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
• (1) Pyridoxine, (2) Clordemetildiazepam, (3) VPA, Clobazam, lamotrigine (4) VGB<break></break>
(1) no effect, (2) no effect, (3) no effect, (4) only reduction in spasms<xref ref-type="ref" rid="epi412102-bib-0302">302</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Williams Beuren syndrome (WBS)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0101" list-type="bullet"><list-item><p>AD, Deletion at WBS area of 7q<xref ref-type="ref" rid="epi412102-bib-0307">307</xref>, <xref ref-type="ref" rid="epi412102-bib-0308">308</xref>, <xref ref-type="ref" rid="epi412102-bib-0309">309</xref>, <xref ref-type="ref" rid="epi412102-bib-0310">310</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0102" list-type="bullet"><list-item><p>Facial elfin appearance<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>, <xref ref-type="ref" rid="epi412102-bib-0311">311</xref>
</p></list-item><list-item><p>Cardiac anomalies<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>, <xref ref-type="ref" rid="epi412102-bib-0311">311</xref>
</p></list-item><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>, <xref ref-type="ref" rid="epi412102-bib-0311">311</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0103" list-type="bullet"><list-item><p>Normal<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>, <xref ref-type="ref" rid="epi412102-bib-0311">311</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0104" list-type="bullet"><list-item><p>Case reports of IS &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>, <xref ref-type="ref" rid="epi412102-bib-0311">311</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0254" list-type="bullet"><list-item><p>ACTH, CLZ, VGB, VPA</p><p>Over 50% effect on IS in first case<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>
</p></list-item><list-item><p>ACTH, VPA</p><p>Effect on IS in second case<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>
</p></list-item><list-item><p>(1) Pyridoxine, VPA, (2) ACTH (3) ZNS, NTZ, PB (4) TRH (5) PHB, ZNS</p><p>(1) No effect (2) effective for IS, but progressive ventricular hypertrophy, (3 &amp; 4) partially effective, effect only on IS in 1 case<xref ref-type="ref" rid="epi412102-bib-0311">311</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="padding-left:10%">Congenital Disorders of Glycosylation (CDG), Molybdenum Cofactor Deficiency (MCD), Primary Carnitine Deficiency (PCD)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital Disorders of Glycosylation (CDG)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0105" list-type="bullet"><list-item><p>Deficient glycosylation<xref ref-type="ref" rid="epi412102-bib-0319">319</xref>, <xref ref-type="ref" rid="epi412102-bib-0320">320</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0106" list-type="bullet"><list-item><p>Abnormal vision<xref ref-type="ref" rid="epi412102-bib-0319">319</xref>
</p></list-item><list-item><p>Developmental and motor delay<xref ref-type="ref" rid="epi412102-bib-0319">319</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0107" list-type="bullet"><list-item><p>↓ white matter<xref ref-type="ref" rid="epi412102-bib-0319">319</xref>
</p></list-item><list-item><p>abnormal myelination<xref ref-type="ref" rid="epi412102-bib-0319">319</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0108" list-type="bullet"><list-item><p>Case report of IS &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0319">319</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Molybdenum cofactor deficiency (MCD)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0109" list-type="bullet"><list-item><p>AR ‐ MOCS 1 and 2<xref ref-type="ref" rid="epi412102-bib-0324">324</xref>
</p></list-item><list-item><p>AR‐GPHN<xref ref-type="ref" rid="epi412102-bib-0324">324</xref>
</p></list-item><list-item><p>Toxic sulfite accumulation<xref ref-type="ref" rid="epi412102-bib-0324">324</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0110" list-type="bullet"><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>Microcephaly<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>↑sulfocysteine<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>↓uric acid<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0111" list-type="bullet"><list-item><p>Delayed Myelination<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0112" list-type="bullet"><list-item><p>Case report of IS‐flexion spasms &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0113" list-type="bullet"><list-item><p>VGB, LEV, VPA</p><p>Not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Primary carnitine deficiency (PCD)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0114" list-type="bullet"><list-item><p>Defective fatty acid oxidation<xref ref-type="ref" rid="epi412102-bib-0323">323</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0115" list-type="bullet"><list-item><p>Developmental delay<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>Hypotonia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>↓carnitine<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item><list-item><p>↑ammonia<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0116" list-type="bullet"><list-item><p>Atrophy<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0117" list-type="bullet"><list-item><p>Case report of IS‐extension spasms &amp; asymmetric hypsarrhythmia, focal seizures<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0118" list-type="bullet"><list-item><p>VGB, CLZ, LEV</p><p>Not effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>
</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Isovaleric acidemia</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0119" list-type="bullet"><list-item><p>IVD enzyme deficiency<xref ref-type="ref" rid="epi412102-bib-0335">335</xref>, <xref ref-type="ref" rid="epi412102-bib-0336">336</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0120" list-type="bullet"><list-item><p>↑IVG<xref ref-type="ref" rid="epi412102-bib-0335">335</xref>, <xref ref-type="ref" rid="epi412102-bib-0336">336</xref>
</p></list-item><list-item><p>Lactic acidosis<xref ref-type="ref" rid="epi412102-bib-0335">335</xref>
</p></list-item><list-item><p>Hyperammonemia<xref ref-type="ref" rid="epi412102-bib-0336">336</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0121" list-type="bullet"><list-item><p>Normal<xref ref-type="ref" rid="epi412102-bib-0335">335</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0122" list-type="bullet"><list-item><p>Case report of IS‐flexion spasms &amp; hypsarrhythmia<xref ref-type="ref" rid="epi412102-bib-0335">335</xref>
</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0123" list-type="bullet"><list-item><p>(1) VGB (2) VGB + ACTH (for IS), Protein restricted diet + L‐carnitine + hydroxycobalamin supplement (for isovaleric acidemia)</p><p>(1) Not effective, (2) effective in 1 case<xref ref-type="ref" rid="epi412102-bib-0335">335</xref>
</p></list-item></list>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412102-note-0002">
<p>ACADS, Acyl‐CoA dehydrogenase C‐2 to C‐3 short chain; ACTH, Adrenocorticotropic hormone; AD, Autosomal dominant; AED, Antiepileptic drug; ALDH7A1, Alpha‐aminoadipic semialdehyde dehydrogenase; AR, Autosomal recessive; ATP7A, Adenosine triphosphatase; BAEP, Brainstem auditory evoked potentials; BH4, tetrahydrobiopterin; BTD, Biotinidase; CBZ, Carbamazepine; CDG, Congenital disorders of glycosylation; CS, Cystathionine synthase; CSF, Cerebrospinal fluid; CZP, Clonazepam; DCA, Dichloroacetate; DEND, Developmental Delay, Epilepsy, and Neonatal Diabetes; ?GA, ?‐Glyceric Aciduria; DM, Diabetes mellitus; FARS2, Phenylalanine‐tRNA synthetase; GALC, Galactosylceramidase; GFAP, Glial fibrillary acidic protein; GLUT1, Glucose Transporter 1; GLYCTK, D‐Glycerate Kinase; 5‐HT, 5‐Hydroxytryptamine; IDUA, Alpha‐L‐iduronidase; IS, Infantile spasms; KCNJ11, Potassium voltage‐gated channel subfamily J, member 11; L‐DOPA, Levodopa; LEV, Levetiracetam; MCD, Molybdenum cofactor deficiency; MRI, Magnetic resonance imaging; MTHFR, Methylene tetrahydrofolate reductase; MUT, Methylmalonyl mutase; NPD, Niemann‐Pick disease; NKH, Nonketotic hyperglycinemia; NTZ, Nitrazepam; PAH, Phenylalanine hydroxylase; PCC, Propionyl‐coenzyme A carboxylase; PCD, primary carnitine deficiency; PDHC, Pyruvate dehydrogenase complex; PHB, Phenobarbital; Phe, Phenylalanine; PHT, Phenytoin; PKU, Phenylketonuria; PNPO, Pyridoxine‐5'‐phosphate oxidase; POLG, catalytic subunit of mitochondrial DNA polymerase gamma; SCAD, Short‐chain acyl‐coenzyme A dehydrogenase enzyme deficiency; SLC2A1, Solute carrier family 2 member 1; SMPD1, Sphingomyelin phosphodiesterase 1; SN, Substantia nigra; TPR, Topiramate; TRH, Thyrotropin releasing hormone; VGB, Vigabatrin; VPA, Valproic Acid; WBS, Williams‐Beuren syndrome; WS, West Syndrome; ZNS, Zonisamide.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Another but rare cause of PKU is dihydropteridine reductase (DHPR) deficiency, where decreased or no enzyme activity leads to abnormalities in BH4 generation. DHPR deficiency has been associated with autosomal recessive <italic>guanosine triphosphate cyclohydrolase I (GCHI)</italic>,<italic> DHPR</italic>, or <italic>6‐pyruvoyl tetrahydropterin synthase (PTPS)</italic> gene deficits.<xref ref-type="ref" rid="epi412102-bib-0038">38</xref> BH4 is a cofactor of PAH and therefore deficiency of BH4 may lead to elevated Phe, despite normal PAH levels. In such cases, dietary Phe restriction may not suffice to correct the symptoms, and BH4 supplementation is required. BH4 is also involved in the tyrosine and tryptophan hydroxylation, and therefore BH4 deficiency results in reduced norepinephrine, dopamine, and serotonin synthesis, which may further contribute to the neurologic symptoms even if Phe levels are corrected.<xref ref-type="ref" rid="epi412102-bib-0038">38</xref>, <xref ref-type="ref" rid="epi412102-bib-0039">39</xref>, <xref ref-type="ref" rid="epi412102-bib-0040">40</xref> DHPR deficiency may further reduce the activity of folate.<xref ref-type="ref" rid="epi412102-bib-0038">38</xref> Therefore, the presence of normal PAH levels in patients with elevated Phe or the persistence or progression of neurologic symptoms despite the correction of Phe levels may suggest the need for diagnostic tests for DHPR deficiency. Diagnostic tests may then include DHPR activity levels; analysis of pterins in urine, blood, or cerebrospinal fluid (CSF); and CSF levels of metabolites of monoamines (homovallinic acid [HVA], 5‐hydroxyindoleacetic acid [HIAA]).<xref ref-type="ref" rid="epi412102-bib-0038">38</xref> If DHPR deficiency is documented, consideration of additional specific or supplemental treatments for this disease including BH4, folinic acid, or drugs that supplement the monoaminergic deficits should be considered, in addition to Phe dietary restriction.<xref ref-type="ref" rid="epi412102-bib-0038">38</xref>
</p>
<p>DHPR deficiency may also lead to IS and hypsarrhythmia, even though this is one of the rare etiologies<xref ref-type="ref" rid="epi412102-bib-0041">41</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Phe restriction and neurotransmitter supplement improved a patient's outcome<xref ref-type="ref" rid="epi412102-bib-0042">42</xref>; however, in a patient with IS, an additional therapy with steroids was needed to control spasms and hypsarrhythmia.<xref ref-type="ref" rid="epi412102-bib-0041">41</xref>
</p>
<p>Early neurological sequelae (ie, delayed myelination) may be overlooked depending on the onset of Phe accumulation<xref ref-type="ref" rid="epi412102-bib-0037">37</xref> since myelination is a continuous process starting from the last days of gestation and reaching through adulthood (for review<xref ref-type="ref" rid="epi412102-bib-0043">43</xref>). In addition, the results of the PKU newborn screenings need to be interpreted cautiously, considering that false‐positive or, rarely, false‐negative results may also be seen.<xref ref-type="ref" rid="epi412102-bib-0037">37</xref>, <xref ref-type="ref" rid="epi412102-bib-0044">44</xref>, <xref ref-type="ref" rid="epi412102-bib-0045">45</xref>
</p>
<p>In vitro and in vivo experimental PKU models have provided significant insights (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0046">46</xref>, <xref ref-type="ref" rid="epi412102-bib-0047">47</xref>, <xref ref-type="ref" rid="epi412102-bib-0048">48</xref>, <xref ref-type="ref" rid="epi412102-bib-0049">49</xref>, <xref ref-type="ref" rid="epi412102-bib-0050">50</xref>, <xref ref-type="ref" rid="epi412102-bib-0051">51</xref>
<sc>l</sc>‐Phe competes both for the glutamate binding region of the alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) and kainate receptors, and the glycine‐binding site of the <italic>N</italic>‐methyl‐<sc>d</sc>‐aspartate (NMDA) receptors in rat neuronal hippocampal cultures, depressing glutamatergic transmission in the presence of very high Phe levels.<xref ref-type="ref" rid="epi412102-bib-0047">47</xref> This effect may precipitate seizures, in certain situations, when Phe levels are normalized after its dietary restriction reversing the depressed glutamatergic transmission.<xref ref-type="ref" rid="epi412102-bib-0047">47</xref>, <xref ref-type="ref" rid="epi412102-bib-0049">49</xref> In vivo models induced by increasing the Phe levels and/or the use of Phe hydroxylase inhibitors have been used but their phenotype resembles more to BH4 deficiency. Therefore, models such as <italic>Pah</italic>
<sup>enu2</sup> mice, which carry chemically induced mutations in the <italic>PAH</italic> gene, through the administration of ethylnitrosourea (enu), have provided an alternative option to model PKU of genetic etiology.<xref ref-type="ref" rid="epi412102-bib-0046">46</xref>, <xref ref-type="ref" rid="epi412102-bib-0050">50</xref>, <xref ref-type="ref" rid="epi412102-bib-0051">51</xref> The adult <italic>Pah</italic>
<sup>enu2</sup> model mimics the clinical pathology as well as presents with a decreased threshold to audiogenic seizures.<xref ref-type="ref" rid="epi412102-bib-0046">46</xref>, <xref ref-type="ref" rid="epi412102-bib-0049">49</xref>, <xref ref-type="ref" rid="epi412102-bib-0050">50</xref> Expression studies from these mice also show NMDA receptor subtype–specific changes in glutamate receptors, with increases in NMDA receptor subtype 2A (NR2A) and decreases in NR2B, as well as increased expression of AMPA receptor subunits glutamate receptor 1 (GluR1) and GluR2/3.<xref ref-type="ref" rid="epi412102-bib-0048">48</xref>
</p>
<table-wrap id="epi412102-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>In vivo and in vitro models of metabolic diseases associated with WS</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Metabolic disease</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease model and main features</th>
<th align="left" colspan="1" rowspan="1" valign="top">Spontaneous seizures or spasms</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Phenylketonuria (PKU)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0124" list-type="bullet"><list-item><p>Rat hippocampal neuronal cultures exposed to high Phe</p></list-item></list>
<break></break>
depression of glutamatergic transmission<xref ref-type="ref" rid="epi412102-bib-0047">47</xref>
<list id="epi412102-list-1125" list-type="bullet"><list-item><p>Pah<sup>enu</sup> mice</p></list-item></list>
<break></break>
↓ threshold to audiogenic seizures<xref ref-type="ref" rid="epi412102-bib-0046">46</xref>, <xref ref-type="ref" rid="epi412102-bib-0049">49</xref>, <xref ref-type="ref" rid="epi412102-bib-0050">50</xref>
<break></break>
↑expression of NR2A&amp;B, GluR1&amp;2/3<xref ref-type="ref" rid="epi412102-bib-0048">48</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nonketotic hyperglycinemia (NKH)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0126" list-type="bullet"><list-item><p>Glycine on cultured hippocampal rat slices</p></list-item></list>
<break></break>
↑ excitability &amp; neurotoxicity<xref ref-type="ref" rid="epi412102-bib-0055">55</xref>
<list id="epi412102-list-0127" list-type="bullet"><list-item><p>Glycine on auditory brain stem rat slices</p></list-item></list>
<break></break>
↑ transmitter release<xref ref-type="ref" rid="epi412102-bib-0056">56</xref>
<list id="epi412102-list-0128" list-type="bullet"><list-item><p>95% ↓ Gcs mice &amp; <italic>Amt</italic> deletion in mice</p></list-item></list>
<break></break>
Neural tube defects<xref ref-type="ref" rid="epi412102-bib-0069">69</xref>, <xref ref-type="ref" rid="epi412102-bib-0070">70</xref>
<list id="epi412102-list-0129" list-type="bullet"><list-item><p>29% ↓ GCS mice</p></list-item></list>
<break></break>
Longer electroshock induced tonic–clonic seizures<xref ref-type="ref" rid="epi412102-bib-0071">71</xref>
<break></break>
High locomotor activity and anxiety behavior<xref ref-type="ref" rid="epi412102-bib-0071">71</xref>
<list list-type="simple"><list-item><p>Severe neuronal injury after focal cerebral ischemia<xref ref-type="ref" rid="epi412102-bib-0072">72</xref>
</p></list-item></list>
<list id="epi412102-list-0130" list-type="bullet"><list-item><p>Glyt1 KO mice</p></list-item></list>
<break></break>
abnormal respiration reversed by strychnine<xref ref-type="ref" rid="epi412102-bib-0073">73</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DEND</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0131" list-type="bullet"><list-item><p>Expression of KCNJ11 mutations in Xenopus oocytes</p></list-item></list>
<break></break>
Interfere with K<sub>ATP</sub> sensitivity or sulfonylurea efficacy<xref ref-type="ref" rid="epi412102-bib-0078">78</xref>
<list id="epi412102-list-0132" list-type="bullet"><list-item><p>Kir<sub>6.2</sub> KO mice</p></list-item></list>
<break></break>
Myoclonic jerks, tonic convulsions, &amp; death in response to hypoxia<xref ref-type="ref" rid="epi412102-bib-0084">84</xref>
<break></break>
SNr firing rates increase during hypoxia in vitro<xref ref-type="ref" rid="epi412102-bib-0084">84</xref>
<list id="epi412102-list-0133" list-type="bullet"><list-item><p>Overexpression of SUR1 in mice</p></list-item></list>
<break></break>
Protective against kainic acid–induced seizures<xref ref-type="ref" rid="epi412102-bib-0085">85</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Symptomatic hypoglycemia</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0134" list-type="bullet"><list-item><p>Insulin‐induced hypoglycemia in rats</p></list-item></list>
<break></break>
Neuronal damage in the hippocampus, caudate nucleus, spinal cord, and cerebellar Purkinje cells<xref ref-type="ref" rid="epi412102-bib-0096">96</xref>
<break></break>
In immature rats: neuronal damage in cortex, DG, thalamus, and hypothalamus<xref ref-type="ref" rid="epi412102-bib-0097">97</xref>
<list list-type="simple"><list-item><p>In PN25 rats ketogenic diet protects against neuronal damage if started at PN21<xref ref-type="ref" rid="epi412102-bib-0099">99</xref>
</p></list-item></list>
<list list-type="simple"><list-item><p>In fasting rats: decreased latency to seizures<xref ref-type="ref" rid="epi412102-bib-0103">103</xref>
</p></list-item></list>
<list id="epi412102-list-0135" list-type="bullet"><list-item><p>Insulin &amp; SEZ‐induced hypoglycemia in juvenile rats</p></list-item></list>Seizures<xref ref-type="ref" rid="epi412102-bib-0100">100</xref>
<list id="epi412102-list-0136" list-type="bullet"><list-item><p>Hypoglycemia in hippocampal slices from juvenile mice</p></list-item></list>Seizures responsive to NMDA &amp; non‐NMDA antagonists &amp; midazolam, decreased synaptic transmission, spreading depolarizations<xref ref-type="ref" rid="epi412102-bib-0101">101</xref>
<list id="epi412102-list-0137" list-type="bullet"><list-item><p>Slices from developing rats exposed to repetitive hypoglycemia</p></list-item></list>
<break></break>
decreased LTP<xref ref-type="ref" rid="epi412102-bib-0102">102</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
seizures<break></break>
seizures
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLUT1 deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0138" list-type="bullet"><list-item><p>Heterozygous Glut1 mice</p></list-item></list>
<break></break>
Generalized/focal onset electrographic seizures, rhythmic or polyspikes, SWDs, no behavioral change<xref ref-type="ref" rid="epi412102-bib-0113">113</xref>
<break></break>
Behavioral arrests during fasting<xref ref-type="ref" rid="epi412102-bib-0113">113</xref>
<list id="epi412102-list-0139" list-type="bullet"><list-item><p>Expression of SLC2A1 variants in Xenopus oocytes</p></list-item></list>
<break></break>
Mild to dramatic glucose transport changes<xref ref-type="ref" rid="epi412102-bib-0115">115</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Seizures<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCAD deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0140" list-type="bullet"><list-item><p>BALB/cByJ mice</p></list-item></list>
<break></break>
impaired thermoregulation in cold<xref ref-type="ref" rid="epi412102-bib-0121">121</xref>
<list id="epi412102-list-0141" list-type="bullet"><list-item><p>Slices from BALB/cByJ mice</p></list-item></list>
<break></break>
Cerebral edema, astrocytic swelling, neuronal mitochondrial injury<xref ref-type="ref" rid="epi412102-bib-0120">120</xref>
<list id="epi412102-list-0142" list-type="bullet"><list-item><p>Strial slices from ethylmalonic acid–administered rats</p></list-item></list>
<break></break>
Deficient redox homeostasis &amp; ↓ Na<sup>+</sup>/K<sup>+</sup>ATPase activity<xref ref-type="ref" rid="epi412102-bib-0122">122</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Menkes disease</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0143" list-type="bullet"><list-item><p>Mo<sup>br</sup> mice</p></list-item></list>
<break></break>
impaired axonal development &amp; synaptogenesis in the cerebral cortex and the hippocampus, ↓ peptidylglycine alpha‐amidating monooxygenase activity in slices<xref ref-type="ref" rid="epi412102-bib-0137">137</xref>
<break></break>
Phenotype partially reversed by human Menkes transgene<xref ref-type="ref" rid="epi412102-bib-0139">139</xref>
<list id="epi412102-list-0144" list-type="bullet"><list-item><p>Inhibition of atp7a expression in <italic>Drosophila</italic>
</p></list-item></list>
<break></break>
cell–specific amidation impairments<xref ref-type="ref" rid="epi412102-bib-0141">141</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vitamin B6‐, Pyridoxine dependency &amp; pyridoxal‐5′‐phosphate deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0145" list-type="bullet"><list-item><p>TNAP KO mice</p></list-item></list>
<break></break>
seizures, ↑ PLP, ↓ GABA that are reversible by PLP but not pyridoxine depending on the mice background<xref ref-type="ref" rid="epi412102-bib-0172">172</xref>
<list id="epi412102-list-0146" list-type="bullet"><list-item><p>TNAP+/+ and heterozygous mice</p></list-item></list>
<break></break>
Pyridoxine‐deficient diet‐induced seizures<xref ref-type="ref" rid="epi412102-bib-0173">173</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Seizures<break></break>
Seizures
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ᴅ‐Glyceric aciduria (DGA)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0147" list-type="bullet"><list-item><p>Rats with high fructose &amp; fat diet</p></list-item></list>
<break></break>
type II diabetes<xref ref-type="ref" rid="epi412102-bib-0180">180</xref>
<list id="epi412102-list-0148" list-type="bullet"><list-item><p>Glyctk KO mice</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Methylmalonic aciduria &amp; B12 deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0149" list-type="bullet"><list-item><p>Intrastriatal MMA injection in rats</p></list-item></list>
<break></break>
Clonic &amp; tonic–clonic seizures, ↓duration of seizures with preadministration of MK‐801, alpha‐tocopherol or ascorbic acid<xref ref-type="ref" rid="epi412102-bib-0193">193</xref>, <xref ref-type="ref" rid="epi412102-bib-0194">194</xref>
<list id="epi412102-list-0150" list-type="bullet"><list-item><p>ICV MMA in rats</p></list-item></list>
<break></break>
clonic convulsions that can be reduced by pyridoxine, baclofen, and muscimol; ↓GAD activity that can be prevented by pyridoxine &amp; MK‐801<xref ref-type="ref" rid="epi412102-bib-0196">196</xref>
<list id="epi412102-list-0151" list-type="bullet"><list-item><p>CD320/TCbIR KO mice</p></list-item></list>
<break></break>
cognitive deficits &amp; anxiety<xref ref-type="ref" rid="epi412102-bib-0198">198</xref>
<break></break>
smaller pyramidal cells, impaired LTP in CA1, ↓ GluR1<xref ref-type="ref" rid="epi412102-bib-0198">198</xref>
<list id="epi412102-list-0152" list-type="bullet"><list-item><p>Membrane preparations from MMA‐treated rat cortex/brain homogenates preincubated with MMA</p></list-item></list>
<break></break>
↓Na<sup>+</sup>/K<sup>+</sup>ATPase activity, prevented by glutathione<xref ref-type="ref" rid="epi412102-bib-0195">195</xref>
</td>
<td align="left" colspan="1" rowspan="1">
Seizures<break></break>
Seizures<break></break>
NR<break></break>
No
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Homocysteinemias</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0153" list-type="bullet"><list-item><p>Heterozygous Mthfr KO mice</p></list-item></list>
<break></break>
Impaired short‐term memory in WT animals born to this phenotype &amp; apoptosis in the hippocampus<xref ref-type="ref" rid="epi412102-bib-0213">213</xref>, <xref ref-type="ref" rid="epi412102-bib-0214">214</xref>
<list id="epi412102-list-0154" list-type="bullet"><list-item><p>Systemic administration homocyteine in rats &amp; mice</p></list-item></list>
<break></break>
convulsive seizures<xref ref-type="ref" rid="epi412102-bib-0205">205</xref>, <xref ref-type="ref" rid="epi412102-bib-0206">206</xref>
<list id="epi412102-list-0155" list-type="bullet"><list-item><p>Intraperitoneal homocysteine injection</p></list-item></list>
<break></break>
status epilepticus &amp; flexion seizures in immature rats<xref ref-type="ref" rid="epi412102-bib-0210">210</xref>
<break></break>
Spikes &amp; spike waves without behavioral correlation in adults rats<xref ref-type="ref" rid="epi412102-bib-0210">210</xref>
<list id="epi412102-list-0156" list-type="bullet"><list-item><p>ICV application of homocysteic acid in PN12 rats</p></list-item></list>
<break></break>
Generalized tonic–clonic seizures, prevented by pre‐NBQX &amp; AP7 application<xref ref-type="ref" rid="epi412102-bib-0211">211</xref>
<list id="epi412102-list-0157" list-type="bullet"><list-item><p>Subcutaneous chronic homocysteine injection in rats</p></list-item></list>
<break></break>
↓ Na+/K+ATPase activity in hippocampal synaptic membrane preparations<xref ref-type="ref" rid="epi412102-bib-0212">212</xref>
<list id="epi412102-list-0158" list-type="bullet"><list-item><p>Homocysteine application on rat organotypic cortical &amp; hippocampal slice cultures</p></list-item></list>
<break></break>
Excitotoxicity<xref ref-type="ref" rid="epi412102-bib-0207">207</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
Seizures<break></break>
Seizures<break></break>
Seizures<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Propionic acidemia</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0159" list-type="bullet"><list-item><p>ICV propionic acid injection in adult rats</p></list-item></list>
<break></break>
Dystonia, hyperactivity, caudate spiking, ↑ severity of kindling‐induced seizures<xref ref-type="ref" rid="epi412102-bib-0223">223</xref>
<break></break>
↑ oxidative stress, ↓glutathione &amp; glutathione peroxidase activity &amp; neuroinflammation ex vivo<xref ref-type="ref" rid="epi412102-bib-0223">223</xref>
<list id="epi412102-list-0160" list-type="bullet"><list-item><p>Oral propionic acid application in PN 21 rats</p></list-item></list>
<break></break>
↓ glutathione &amp; glutathione peroxidase activity, ↑ IL6, TNFα, HSP70 &amp; caspase 3, DNA fragmentation, ↓GABA, serotonin &amp; dopamine<xref ref-type="ref" rid="epi412102-bib-0226">226</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PDHC deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0161" list-type="bullet"><list-item><p>PDHC E1 α null mutation in mice</p></list-item></list>
<break></break>
Low PDC activity, reduced litter size<xref ref-type="ref" rid="epi412102-bib-0238">238</xref>
<break></break>
All males die &amp; 50% females survive after only brain‐targeted mutation, females show ↓neuronal density &amp; neuropil fibers, abnormal neuronal localization in the gray matter, ↓lipid synthesis &amp; irregular myelination, adult females have neurological deficits<xref ref-type="ref" rid="epi412102-bib-0239">239</xref>
<list id="epi412102-list-0162" list-type="bullet"><list-item><p>PDHC E1 α knockdown in striatum &amp; SN in rats</p></list-item></list>
<break></break>
abnormal amphetamine‐induced rotation<xref ref-type="ref" rid="epi412102-bib-0240">240</xref>
<list id="epi412102-list-0163" list-type="bullet"><list-item><p>Systemic deletion of exon 8 from PDHC E1 α</p></list-item></list>
<break></break>
↓ brain weight, de novo lipid synthesis, ↓ proliferation, differentiation and migration of newly generated neuronal precursor cells in cerebellum, impaired dendritic development of Purkinje cells ex vivo<break></break>
Impaired acoustic startle reflex<xref ref-type="ref" rid="epi412102-bib-0242">242</xref>
<list id="epi412102-list-0164" list-type="bullet"><list-item><p>E2 impairment in zebrafish</p></list-item></list>
<break></break>
Ketogenic diet reversed abnormal vision, lactic acidosis &amp; lethargy<xref ref-type="ref" rid="epi412102-bib-0243">243</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Leigh syndrome</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0165" list-type="bullet"><list-item><p>Ndufs4 KO mice</p></list-item></list>
<break></break>
Delayed growth, progressive lethargy, ataxia, blindness, progressive loss of startle response &amp; death at week 7 due to systemic KO, hypoxia reversed neurodegenerative changes &amp; ↑ life span, rapamycin also extended life span, prevented brain injury, ↑ GABA, dopamine and free fatty acid levels, ↓glycolytic intermediates<xref ref-type="ref" rid="epi412102-bib-0254">254</xref>, <xref ref-type="ref" rid="epi412102-bib-0256">256</xref>, <xref ref-type="ref" rid="epi412102-bib-0257">257</xref>
<break></break>
Similar outcome as in the systemic knockout, in addition, gliosis &amp; microglial activation due to KO only in glial cells and neurons<xref ref-type="ref" rid="epi412102-bib-0255">255</xref>
<list id="epi412102-list-0166" list-type="bullet"><list-item><p>ND2 deletion in <italic>Drosophila</italic>
</p></list-item></list>
<break></break>
Rapamycin increases the life span but leads to fat storage impairments<xref ref-type="ref" rid="epi412102-bib-0258">258</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Alpers‐Huttenlocher disease</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0167" list-type="bullet"><list-item><p>D257A knockin mice (PolyA<sup>mut/mut</sup>)</p></list-item></list>
<break></break>
Early aging, ↓ body size &amp; weight, death<xref ref-type="ref" rid="epi412102-bib-0264">264</xref>, <xref ref-type="ref" rid="epi412102-bib-0265">265</xref>
<break></break>
Early lethality &amp; mtDNA depletion if KO at preimplantation stage<xref ref-type="ref" rid="epi412102-bib-0267">267</xref>
<list id="epi412102-list-0168" list-type="bullet"><list-item><p>Polg−/− zebrafish</p></list-item></list>
<break></break>
larvae survive till juvenile age<xref ref-type="ref" rid="epi412102-bib-0266">266</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lysosomal storage diseases</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0169" list-type="bullet"><list-item><p>Idua KO mice</p></list-item></list>
<break></break>
High glycosaminoglycan in urine, flat face, abnormal lysosomal storage in glial cells, vacuolation in Purkinje cells, neurons in the cortex, no behavioral alterations<xref ref-type="ref" rid="epi412102-bib-0272">272</xref>
<break></break>
Human IDUA injection into putamen reverses brain pathology<xref ref-type="ref" rid="epi412102-bib-0273">273</xref>
<break></break>
ICV human IDUA injection prevents brain pathology &amp; spatial learning deficits<xref ref-type="ref" rid="epi412102-bib-0274">274</xref>
<list id="epi412102-list-0170" list-type="bullet"><list-item><p>ASM KO mice</p></list-item></list>
<break></break>
High sphingomyelin, no ASM activity, ↓body weight &amp; death<xref ref-type="ref" rid="epi412102-bib-0272">272</xref>
<break></break>
Mutations expressed in this background show high level of expression in brain &amp; higher residual ASM activity than ASM KOs<xref ref-type="ref" rid="epi412102-bib-0272">272</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Leukodystrophies</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0171" list-type="bullet"><list-item><p>Mice carrying WT+1 mutated hGFAP</p></list-item></list>
<break></break>
No Rosenthal fibers<xref ref-type="ref" rid="epi412102-bib-0286">286</xref>
<list id="epi412102-list-0172" list-type="bullet"><list-item><p>Mice carrying WT + multiple mutated hGFAP</p></list-item></list>
<break></break>
Rosenthal fibers in adult age, severe convulsions &amp; high mortality rate when challenged with kainate<xref ref-type="ref" rid="epi412102-bib-0286">286</xref>
<list id="epi412102-list-0173" list-type="bullet"><list-item><p>Mice with hGFAP</p></list-item></list>
<break></break>
Hypertrophic astrocytes, Rosenthal fiber‐like inclusions, upregulation of small HSPs<xref ref-type="ref" rid="epi412102-bib-0287">287</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BTD deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0174" list-type="bullet"><list-item><p>Rats fed with biotin‐deficient diet</p></list-item></list>
<break></break>
Alopecia of lower back, delayed growth, longer BAEP latency<xref ref-type="ref" rid="epi412102-bib-0295">295</xref>
<list id="epi412102-list-0175" list-type="bullet"><list-item><p>BTD KO mice fed with biotin‐deficient diet</p></list-item></list>
<break></break>
Hypotonia, demyelination, axonal degeneration, impaired motor neuron function, lethargy, limping, ventriculomegaly, slow growth, weight loss reversed with biotin supplement<xref ref-type="ref" rid="epi412102-bib-0296">296</xref>, <xref ref-type="ref" rid="epi412102-bib-0297">297</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DBP deficiency</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0176" list-type="bullet"><list-item><p>MFP2 KO mice</p></list-item></list>
<break></break>
Failure to thrive, astrogliosis &amp; microglial activation in gray matter, death<xref ref-type="ref" rid="epi412102-bib-0300">300</xref>, <xref ref-type="ref" rid="epi412102-bib-0303">303</xref>
<list id="epi412102-list-0177" list-type="bullet"><list-item><p>Nestin‐Mfp2−/− mice</p></list-item></list>
<break></break>
mild neuroinflammation &amp; axonal impairments in Purkinje cells, motor deficits<xref ref-type="ref" rid="epi412102-bib-0305">305</xref>
<list id="epi412102-list-0178" list-type="bullet"><list-item><p>dbp knockdown in zebrafish</p></list-item></list>
<break></break>
Rescue by murine Dbp<xref ref-type="ref" rid="epi412102-bib-0306">306</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Williams‐Beuren syndrome (WBS)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0179" list-type="bullet"><list-item><p>Fzd9 deletions in mice</p></list-item></list>
<break></break>
both heterozygous &amp; homozygous deletions lead to ↓ threshold of pentylenetetrazole‐induced seizures &amp; abnormalities in hippocampal structure, only homozygous deletions lead to spatial learning impairments<xref ref-type="ref" rid="epi412102-bib-0315">315</xref>
<list id="epi412102-list-0180" list-type="bullet"><list-item><p>WBS distal deletions in mice</p></list-item></list>
<break></break>
cognitive impairment<xref ref-type="ref" rid="epi412102-bib-0316">316</xref>
<list id="epi412102-list-0181" list-type="bullet"><list-item><p>WBS distal &amp; proximal deletions in mice</p></list-item></list>
<break></break>
defective motor skills<xref ref-type="ref" rid="epi412102-bib-0316">316</xref>
<list id="epi412102-list-0182" list-type="bullet"><list-item><p>Heterozygous WBS complete deletions in mice</p></list-item></list>
<break></break>
↓ brain weight, dendritic length &amp; spine density in the hippocampus, GFAP+ cells in amygdala, ↑ immature cells in DG, craniofacial and cardiac abnormalities, spatial learning deficits<xref ref-type="ref" rid="epi412102-bib-0317">317</xref>
<break></break>
Slices from these mice show unstable LTP in CA1, ↓ BDNF in CA1‐CA3<xref ref-type="ref" rid="epi412102-bib-0318">318</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital disorder of glycosylation (CDG)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0183" list-type="bullet"><list-item><p>Mgat2‐null mice</p></list-item></list>
<break></break>
20% of the animals show transient paralysis &amp; tremors resembling epileptic seizures<xref ref-type="ref" rid="epi412102-bib-0322">322</xref>
</td>
<td align="left" colspan="1" rowspan="1">Seizure mimics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Molybdenum cofactor deficiency (MCD)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0184" list-type="bullet"><list-item><p>Mocs1 KO mice</p></list-item></list>
<break></break>
survival 1 to 11 days, human MOCS1 &amp; cPMP injections ↑life span<xref ref-type="ref" rid="epi412102-bib-0325">325</xref>, <xref ref-type="ref" rid="epi412102-bib-0326">326</xref>
<list id="epi412102-list-0185" list-type="bullet"><list-item><p>Mocs2 KO mice</p></list-item></list>
<break></break>
Survival for 11 days, apoptosis in the hippocampus<xref ref-type="ref" rid="epi412102-bib-0327">327</xref>
<break></break>
Cortex &amp; brainstem, inactivation of all molybdenum cofactor‐dependent enzymes, accumulation of hypoxanthine, xanthine &amp; S‐sulfocysteine ex vivo<xref ref-type="ref" rid="epi412102-bib-0327">327</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Primary carnitine deficiency (PCD)</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0186" list-type="bullet"><list-item><p>Dietary restriction of carnitine in rats</p></list-item></list>
<break></break>
50% reduction of carnitine, no other changes<xref ref-type="ref" rid="epi412102-bib-0328">328</xref>
<list id="epi412102-list-0187" list-type="bullet"><list-item><p>Dietary restriction of carnitine with butyrobetaine hydroxylase inhibitor in rats</p></list-item></list>
<break></break>
Liver anomalies<xref ref-type="ref" rid="epi412102-bib-0329">329</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Isovaleric acidemia</td>
<td align="left" colspan="1" rowspan="1">
<list id="epi412102-list-0188" list-type="bullet"><list-item><p>Isovaleric acid application onto rat cortical synaptic membrane preparations</p></list-item></list>
<break></break>
↓ Na<sup>+</sup>/K<sup>+</sup> ATPase activity<xref ref-type="ref" rid="epi412102-bib-0337">337</xref>
<list id="epi412102-list-0189" list-type="bullet"><list-item><p>Isovaleric acid application onto rat brain homogenates &amp; mitochondrial preparations</p></list-item></list>
<break></break>
↑ protein oxidation<xref ref-type="ref" rid="epi412102-bib-0338">338</xref>
<list id="epi412102-list-0190" list-type="bullet"><list-item><p>IVG application onto rat brain homogenates &amp; mitochondrial preparations</p></list-item></list>
<break></break>
Lipid peroxidation &amp; ↓GSH levels<xref ref-type="ref" rid="epi412102-bib-0338">338</xref>
</td>
<td align="left" colspan="1" rowspan="1">
NR<break></break>
NR<break></break>
NR
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412102-note-0003">
<p>AMT, Aminomethyltransferase; AP7, 2‐amino‐7 phosphonoheptanoic acid; ASM, acid sphingomyelinase; ATP7A, Adenosine triphosphatase; BAEP, Brainstem auditory evoked potentials; BNDF, Brain‐derived neurotrophic factor; BTD, Biotinidase; DG, Dentate gyrus; Fzd9, Frizzled 9; GABA, Gamma‐aminobutryric acid; GAD, Glutamic acid decarboxylase; GFAP, Glial fibrillary acidic protein; GLYT1, Glycine transporter 1; GCS, Glycine cleavage system; GluR1,2,3, AMPA receptor subunits glutamate receptor 1,2,3; GLUT1, Glucose Transporter 1; GLYCTK, D‐Glycerate Kinase; GCSH, Glycine cleavage system H protein; HSP, Heat shock protein; ICV, Intracerebroventricular; IDUA, Alpha‐L‐iduronidase; IL6, Interleukin 6; IVG, Isovalerylglycine; KATP, Adenosine triphosphate (ATP)‐sensitive inward‐rectifier potassium channels; KCNJ11, Potassium voltage‐gated channel subfamily J, member 11; Kir, Inward rectifier potassium channel; KO, Knockout; MFP‐2, multifunctional protein‐2; Mgat2, Mannosyl (Alpha‐1,6)‐Glycoprotein Beta‐1,2‐N‐Acetylglucosaminyltransferase; MMA, Methylmalonic acid; Moblo , Mobr and Modp, Murine mottled blotchy, brindled and dappled; MOCS1 and MOCS2, Molybdenum cofactor synthesis protein 1 and 2; mtDNA, Mitochondrial DNA; MTHFR, Methylene tetrahydrofolate reductase; NBQX, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzoquinoxaline‐2,3‐dione; ND2, NADH dehydrogenease 2; NDUFS4, NADH : ubiquinone oxidoreductase subunit S4; NMDA, N‐methyl D‐aspartate; NR2A and NR2B, NMDA receptor subtype 2A and 2B; LTP, Long‐term potentiation; PAH, Phenylalanine hydroxylase; PDHC, Pyruvate dehydrogenase complex; Phe, Phenylalanine; PLP, Pyridoxal phosphate; POLG, catalytic subunit of mitochondrial DNA polymerase gamma; PN, Postnatal day; SEZ, Streptozotocin; SLC2A1, Solute carrier family 2 member 1; SLC6A9, Solute carrier family 6 member 9; SN, Substantia nigra; SNr, Substantia nigra pars reticulata; SUR1, Sulfonylurea 1; SWDs, Slow wave discharges; CD320/TCblR, Transcobalamin II receptor; TNAP, Tissue non‐specific alkaline phosphatase; TNF? ,Tumor Necrosis Factor ?; WBS, Williams‐Beuren syndrome; WT, Wild type.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="epi412102-sec-0006">
<title>Glycine Encephalopathy or Nonketotic Hyperglycinemia</title>
<p>Glycine encephalopathy or nonketotic hyperglycinemia (NKH) is caused by autosomal recessive mutations in mostly P‐protein (a pyridoxal phosphate‐dependent glycine decarboxylase, GLDC) and/or T protein (a tetrahydrofolate‐requiring enzyme, aminomethyltransferase, AMT) and very rarely H‐protein (hydrogen carrier protein, GCSH), which are components of the mitochondrial glycine cleavage system (GCS).<xref ref-type="ref" rid="epi412102-bib-0052">52</xref>, <xref ref-type="ref" rid="epi412102-bib-0053">53</xref>, <xref ref-type="ref" rid="epi412102-bib-0054">54</xref> As a result, glycine levels increase. Glycine is an inhibitory neurotransmitter, especially in the spinal cord, but also acts as a positive regulator of NMDA receptors in central neurons, and is shown to increase excitability and lead to neurotoxicity in cultured hippocampal rat slices,<xref ref-type="ref" rid="epi412102-bib-0055">55</xref> as well as to enhance transmitter release in rat auditory brainstem slices.<xref ref-type="ref" rid="epi412102-bib-0056">56</xref> Mutational screening of NKH‐related genes in 69 families with NKH patients identified mutations in <italic>GLDC</italic> and <italic>AMT</italic> genes in 75% to 83% individuals with neonatal or infantile onset NKH but in none of those with late‐onset NKH.<xref ref-type="ref" rid="epi412102-bib-0054">54</xref>
</p>
<p>NKH symptoms may start to appear in neonatal, infantile, or a later period, with a better prognosis in the latter.<xref ref-type="ref" rid="epi412102-bib-0053">53</xref>, <xref ref-type="ref" rid="epi412102-bib-0054">54</xref> Transient NKH was also reported with a good prognosis.<xref ref-type="ref" rid="epi412102-bib-0057">57</xref>, <xref ref-type="ref" rid="epi412102-bib-0058">58</xref>, <xref ref-type="ref" rid="epi412102-bib-0059">59</xref> The affected individuals show elevated plasma and CSF glycine levels, and present with hypotonia, seizures, and developmental delay.<xref ref-type="ref" rid="epi412102-bib-0060">60</xref>, <xref ref-type="ref" rid="epi412102-bib-0061">61</xref>, <xref ref-type="ref" rid="epi412102-bib-0062">62</xref> In a retrospective study reporting on the natural history of 65 patients with NKH, seizures were reported in ~90% of patients, most (68%) of whom had neonatal‐onset seizures.<xref ref-type="ref" rid="epi412102-bib-0063">63</xref> Among the patients with NKH who manifested seizures, 29% had burst suppression on EEG and 5% had hypsarrhythmia.<xref ref-type="ref" rid="epi412102-bib-0063">63</xref> Most of the literature on IS in NKH is in the format of case reports, with very few reports on larger cohorts of patients with NKH. In general, expert reviews of the clinical course of neonatal NKH and a cohort of 56 families with neonatal NKH described the emergence of IS and/or hypsarrhythmia as a common feature of NKH among infants who survive beyond the neonatal period.<xref ref-type="ref" rid="epi412102-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412102-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412102-bib-0064">64</xref>
</p>
<p>NKH patients manifesting with WS have been reported<xref ref-type="ref" rid="epi412102-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412102-bib-0065">65</xref>, <xref ref-type="ref" rid="epi412102-bib-0066">66</xref>, <xref ref-type="ref" rid="epi412102-bib-0067">67</xref>, <xref ref-type="ref" rid="epi412102-bib-0068">68</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Because the prognosis is very poor in neonatal‐onset NKH, Korman et al.<xref ref-type="ref" rid="epi412102-bib-0068">68</xref> treated, immediately after birth, a prenatally diagnosed male newborn carrier of a <italic>GLDC</italic> mutation with sodium benzoate and ketamine (NMDA receptor antagonist; Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Although the treatment prevented the neonatal hypotonia and apnea it did not ameliorate the long‐term epilepsy and neurocognitive outcomes.</p>
<p>To create a model for NKH, Pai et al.<xref ref-type="ref" rid="epi412102-bib-0069">69</xref> used mice with 95% decreased <italic>Gldc</italic> expression with dramatically reduced GCS activity that led to neural tube defects in homozygote mice (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>). Similar defects are also reported from use of mice lacking GCS activity through deletions in the <italic>Amt</italic> gene.<xref ref-type="ref" rid="epi412102-bib-0070">70</xref> However, neither report mentions any seizure phenotype. On the other hand, in a model of mild‐type glycine encephalopathy, mice with 29% reduced GCS activity (low GCS) show a longer duration of tonic or clonic seizures induced by electroshock, and higher locomotor activity and anxiety‐related behavior, which can be partially reversed by NMDA antagonists specific to the glycine‐binding site of the receptor.<xref ref-type="ref" rid="epi412102-bib-0071">71</xref> Likewise, after focal cerebral ischemia, mice with low GCS activity demonstrate greater neuronal injury compared to wild‐type (WT) animals.<xref ref-type="ref" rid="epi412102-bib-0072">72</xref>
</p>
<p>The glycine transporter 1 (<italic>Glyt1</italic>) knockout (KO) mice have been used to model features of glycine encephalopathy.<xref ref-type="ref" rid="epi412102-bib-0073">73</xref>, <xref ref-type="ref" rid="epi412102-bib-0074">74</xref> Homozygous mutations in solute carrier family 6 member 9 (Slc6A9) encoding <italic>Glyt1</italic> are lethal within the first postnatal day (PN), mostly due to respiratory deficits, but strychnine, a glycine receptor antagonist, reverses the abnormal respiratory activity in brainstem slices from these mice.<xref ref-type="ref" rid="epi412102-bib-0073">73</xref> An association between NKH and GLYT1 was suspected in a patient with no GCS abnormality but absence of glycine transport system on autopsy.<xref ref-type="ref" rid="epi412102-bib-0075">75</xref> A homozygous <italic>SLC6A9</italic> mutation has recently been identified in an atypical NKH patient, a 15‐month‐old girl presenting with normal EEG and most of the disease symptoms except encephalopathy.<xref ref-type="ref" rid="epi412102-bib-0076">76</xref>
</p>
</sec>
</sec>
<sec id="epi412102-sec-0007">
<title>Deficiencies in glucose metabolism and transport</title>
<sec id="epi412102-sec-0008">
<title>Developmental delay, epilepsy, and neonatal diabetes</title>
<p>Permanent neonatal diabetes mellitus has been associated with autosomal‐dominant mutations in the potassium voltage‐gated channel subfamily J, member 11 (<italic>KCNJ11</italic>) gene encoding the pore‐forming subunit (K<sub>ir</sub>6.2) of the adenosine triphosphate (ATP)–sensitive inward‐rectifier potassium channels (K<sub>ATP</sub>). In the presence of ATP, K<sub>ATP</sub> channels close and trigger insulin secretion from pancreatic beta cells.<xref ref-type="ref" rid="epi412102-bib-0077">77</xref> Closure of these channels leads to membrane depolarization and opening of <sc>l</sc>‐type voltage‐dependent calcium (Ca<sup>2+</sup>) channels that subsequently increase intracellular Ca<sup>2+</sup> and therefore insulin exocytosis. Some of the diabetic neonates present also with developmental delay and epilepsy,<xref ref-type="ref" rid="epi412102-bib-0077">77</xref> a syndrome that is known as DEND (developmental delay, epilepsy, neonatal diabetes).<xref ref-type="ref" rid="epi412102-bib-0078">78</xref>, <xref ref-type="ref" rid="epi412102-bib-0079">79</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref> Hypsarrhythmia has been reported in a total of 4 DEND patients<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>), 3 of whom presented with IS and one with tonic–clonic seizures.<xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref> Sulfonylurea therapy (acting by binding to the sulfonylurea receptor part of the K<sub>ATP</sub> and closing them—leading to insulin secretion) mitigated neurological symptoms and psychomotor development in these patients.<xref ref-type="ref" rid="epi412102-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412102-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412102-bib-0082">82</xref> However, one patient died following initial amelioration.<xref ref-type="ref" rid="epi412102-bib-0080">80</xref>
</p>
<p>K<sub>ATP</sub> channels are expressed not only in pancreas but also in skeletal muscle, cardiac muscle, and brain tissue (for review: ref <xref ref-type="ref" rid="epi412102-bib-0083">83</xref>). Therefore, epilepsy, including IS when present, was suggested to be linked to the genetic defect in DEND syndrome, rather than the outcome of neonatal diabetes.<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0079">79</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref> The rarity of reported cases of IS in DEND and the lack of cohorts exploring the incidence of IS in patients with DEND do not allow for strong arguments that there is a specific association of this syndrome with IS rather than epilepsy in general. However, not all patients carrying mutations have neurologic features.<xref ref-type="ref" rid="epi412102-bib-0079">79</xref> Despite the fact that the location of <italic>K</italic>
<sub><italic>ir</italic></sub>
<italic>6.2</italic> mutations has a strong influence on the severity of symptoms,<xref ref-type="ref" rid="epi412102-bib-0078">78</xref> DEND is a rare disease and more information is needed to confirm these findings.</p>
<p>In vitro functional analyses of different mutations leading to neonatal diabetes and DEND using Xenopus oocytes indicate that although a mutation (R201C) in <italic>KCNJ11</italic> directly acts on ATP sensitivity of K<sub>ATP</sub>, 2 other mutations linked with DEND (Q52R and V59G) lead to conformational change that keeps channels in an open state and therefore interferes with the sulfonylurea efficacy (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0078">78</xref> In vivo EEG and electromyography (EMG) recordings from <italic>K</italic>
<sub><italic>ir</italic></sub>
<italic>6.2</italic> KO mice show myoclonic jerks, severe tonic convulsions, and death when challenged with hypoxia, whereas WT animals recover normally.<xref ref-type="ref" rid="epi412102-bib-0084">84</xref> In vitro recordings from SNr neurons from the same model displayed no difference in firing rates of the neurons compared to the neurons from WT animals; however, the firing rates increased during hypoxia in the former, whereas they decreased in slices from WT animals, indicating the inhibitory effect of these channels in SNr.<xref ref-type="ref" rid="epi412102-bib-0084">84</xref> Likewise, overexpression of the other subunit of K<sub>ATP</sub> channels, sulfonylurea 1 (<italic>Sur1</italic>), in mice protects against kainic acid–induced seizures and the neuronal damage.<xref ref-type="ref" rid="epi412102-bib-0085">85</xref> Although the protective role of these channels in different parts of the brain during hypoxia is known,<xref ref-type="ref" rid="epi412102-bib-0086">86</xref> there are no known reports of spontaneous seizures in these models.</p>
</sec>
<sec id="epi412102-sec-0009">
<title>Persistent symptomatic hypoglycemia</title>
<p>Patients with persistent neonatal hypoglycemia and specific syndromic etiology such as those that may require pancreatectomy for persistent hyperinsulinemia may develop IS following variable latent time.<xref ref-type="ref" rid="epi412102-bib-0087">87</xref>, <xref ref-type="ref" rid="epi412102-bib-0088">88</xref> In earlier studies, neonatal hypoglycemia (low blood glucose levels, &lt;2.6 mmol/L) was reported in some of the IS patients in 2 long‐term population studies in Finland.<xref ref-type="ref" rid="epi412102-bib-0089">89</xref>, <xref ref-type="ref" rid="epi412102-bib-0090">90</xref> However, at the time these studies were carried out, there were limited diagnostic tools to determine the reason behind the persistent hypoglycemia while limited treatment options existed, such as since diazoxide administration and pancreatectomy were developed later. In almost all cases in which IS occurred, there were structural brain abnormalities, indicating that the abnormal MRI finding was the entry criterion in the available retrospective study<xref ref-type="ref" rid="epi412102-bib-0091">91</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>Increased awareness of the significance of identifying the causes of hypoglycemia and the institution of targeted treatments helped to decrease the incidence of persistent symptomatic hypoglycemia as an etiologic factor in IS.<xref ref-type="ref" rid="epi412102-bib-0089">89</xref>, <xref ref-type="ref" rid="epi412102-bib-0092">92</xref>
</p>
<p>Hypoglycemia may have profound effects on the brain where it is used as a primary energy source, even though the exact mechanism leading to IS has yet to be discovered. The effects may include but are not limited to mitochondrial energy deficiencies and increased susceptibility to hypoxic‐ischemic brain injuries,<xref ref-type="ref" rid="epi412102-bib-0088">88</xref>, <xref ref-type="ref" rid="epi412102-bib-0093">93</xref> and may interfere with any of the proposed mechanisms of IS/WS development.<xref ref-type="ref" rid="epi412102-bib-0007">7</xref> The effects of hypoglycemia may be age specific. Experimental data from immature rats and dogs point out that immature animals are more resistant to induced hypoglycemia if there are no other underlying abnormalities, owing to their decreased energy dependence, higher endogenous carbohydrate storage and use of alternative energy sources, as well as compensatory mechanisms such as increased cerebral blood flow and glucose transport into the brain. However, hypoglycemia in the presence of hypoxia‐ischemia may be detrimental (for review<xref ref-type="ref" rid="epi412102-bib-0094">94</xref>).</p>
<p>A number of models, both in vitro and in vivo, that mimic the hypoglycemic condition are studied in different animals (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0095">95</xref> Results of one of the studies that evaluated insulin‐induced hypoglycemia in rats indicate that neuronal damage is triggered when EEG becomes isoelectric EEG, regardless of the glucose level.<xref ref-type="ref" rid="epi412102-bib-0096">96</xref> The damage is correlated with the duration of the isoelectric time, in that the longer the time spent in the isoelectric state, the greater the brain injury.<xref ref-type="ref" rid="epi412102-bib-0096">96</xref> In an attempt to establish an animal model for brain injury caused by neonatal hypoglycemia, Zhou et al.<xref ref-type="ref" rid="epi412102-bib-0097">97</xref> later showed that immature rats exposed to prolonged insulin‐induced hypoglycemia had neuronal death and that the damage was seen mainly in cortex, dentate gyrus (DG), thalamus, and hypothalamus but not in the CA1 and CA3 regions of the hippocampus. In contrast, a previous study that used mature animals showed damage in the hippocampus, caudate nucleus, spinal cord, and cerebellar Purkinje cells.<xref ref-type="ref" rid="epi412102-bib-0096">96</xref> These findings underscore the impact of age when animals are exposed to hypoglycemia on both neuronal injury and its location.<xref ref-type="ref" rid="epi412102-bib-0098">98</xref> In addition, the ketogenic diet provides the brain with an alternative energy source in the absence of glucose, and decreases the neuronal injury when started at the weaning age (PN21) in rats exposed to insulin‐induced hypoglycemia at PN25.<xref ref-type="ref" rid="epi412102-bib-0099">99</xref> In juvenile rats with insulin‐ and streptozotocin‐ (SEZ, an antibiotic that is toxic to the pancreatic beta cells) induced hypoglycemia, seizures and neuronal damage were found to be similar to that in nondiabetic rats treated with only insulin, indicating the relation of seizures to decreased levels of glucose.<xref ref-type="ref" rid="epi412102-bib-0100">100</xref> Slices from juvenile mice exposed to hypoglycemia showed seizures and subsequent decline in synaptic transmission that were accompanied by spreading depolarizations in the hippocampus, and only seizures could be abolished by NMDA and non‐NMDA‐receptor antagonists and midazolam.<xref ref-type="ref" rid="epi412102-bib-0101">101</xref> Likewise, following repetitive hypoglycemia, slices from developing rats showed decreased long‐term potentiation (LTP) in the hippocampus, suggesting a cognitive impairment, even though the basal synaptic transmission was intact in these animals.<xref ref-type="ref" rid="epi412102-bib-0102">102</xref> On the other hand, adult rats that had free or limited access to food 14–16 h before the insulin‐induced hypoglycemia, had decreased latency to seizure development in the fasting group, although this effect was related to the reduced expression of K<sub>ATP</sub> channels in SNr due to fasting.<xref ref-type="ref" rid="epi412102-bib-0103">103</xref>
</p>
</sec>
<sec id="epi412102-sec-0010">
<title>Glucose transporter 1 deficiency</title>
<p>Deficiency of glucose transporter 1 GLUT1, the primary transporter in the blood–brain barrier allowing glucose entrance to the brain, was first reported by De Vivo et al.<xref ref-type="ref" rid="epi412102-bib-0104">104</xref> in 2 infants having drug‐resistant epilepsy, developmental delay, hypoglycorrhachia (a very low CSF glucose level), and low lactate level. No genetic analysis is performed but western blot analysis of erythrocytic glucose transporters (EGTs) showed decreased interaction with cytochalasin B, a mycotoxin that binds to GLUTs and inhibits glucose transport. EGTs show close homology to brain vascular endothelial cell GLUTs and are therefore suggested to represent the activity of brain GLUTs.<xref ref-type="ref" rid="epi412102-bib-0105">105</xref> Mutations in <italic>GLUT1</italic> (<italic>SLC2A1</italic>, solute carrier family 2 member 1) underlie the pathology of the GLUT1 deficiency syndrome, which comprises infantile‐onset epilepsy, developmental delay, movement disorders, and acquired microcephaly.<xref ref-type="ref" rid="epi412102-bib-0106">106</xref>, <xref ref-type="ref" rid="epi412102-bib-0107">107</xref>, <xref ref-type="ref" rid="epi412102-bib-0108">108</xref> Various seizure types may occur, including generalized tonic or clonic, atypical absences, atonic, myoclonic, myoclonic astatic, or focal. <xref ref-type="ref" rid="epi412102-bib-0108">108</xref>, <xref ref-type="ref" rid="epi412102-bib-0109">109</xref>, <xref ref-type="ref" rid="epi412102-bib-0110">110</xref> GLUT1 deficiency syndrome has rarely been reported in IS patients who responded to the ketogenic diet fully or partially,<xref ref-type="ref" rid="epi412102-bib-0110">110</xref>, <xref ref-type="ref" rid="epi412102-bib-0111">111</xref>, <xref ref-type="ref" rid="epi412102-bib-0112">112</xref> including a patient with a missense mutation in <italic>SLC2A1</italic>
<xref ref-type="ref" rid="epi412102-bib-0112">112</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>Heterozygous haploinsufficiency of the <italic>Glut1</italic> gene in mice (heterozygous <italic>Glut1</italic> mice) mimics most of the clinical phenotype of GLUT1 deficiency without the histopathological changes, whereas homozygous deletion of the gene is lethal during embryonic development (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0113">113</xref> In heterozygous <italic>Glut1</italic> mice, generalized or focal‐onset electrographic seizures with rhythmic spikes or polyspikes and slow wave discharges or bursts of 2‐3 Hz spike and slow‐wave discharges (SWDs) were noted with no apparent disruption of the animal's behavior. During fasting, however, 1‐4 seconds of 6 Hz SWDs associated with behavioral arrests were also seen.<xref ref-type="ref" rid="epi412102-bib-0113">113</xref> The authors conclude that lactate deprivation is the main reason for pathology in the presence of GLUT1 deficiency<xref ref-type="ref" rid="epi412102-bib-0113">113</xref> since glucose is used mainly by astrocytes to maintain the glutamate‐glycine cycle and is converted into lactate, which is in turn used by the neurons as a main energy source.<xref ref-type="ref" rid="epi412102-bib-0114">114</xref> In Xenopus oocytes, functional testing of 7 variants in the <italic>SLC2A1</italic> gene, which is also associated with 1% of the genetic generalized epilepsies, shows mild to dramatic glucose transport changes that are not always correlated with the phenotypes seen in the patients, indicating that in some cases, modifier genes and environmental factors also play a role in GLUT1 deficiency.<xref ref-type="ref" rid="epi412102-bib-0115">115</xref> These models have already shown a predisposition to spontaneous seizures, even though no IS have been reported, and the possible presence of disease modifiers.</p>
</sec>
</sec>
<sec id="epi412102-sec-0011">
<title>Deficiencies in fatty acid oxidation</title>
<sec id="epi412102-sec-0012">
<title>Short‐chain acyl‐coenzyme A dehydrogenase enzyme deficiency</title>
<p>Short‐chain acyl‐coenzyme A (CoA) dehydrogenase enzyme deficiency (SCAD) is an autosomal recessive disorder with mutations in the acyl‐CoA dehydrogenase C‐2 to C‐3 short chain (ACADS) gene wherein infants' increased levels of butyrylcarnitine and urinary ethylmalonic acid are accompanied by heterogeneous clinical symptoms such as hypotonia, hypoglycemia, and lethargy, and later in life by developmental delay and seizures.<xref ref-type="ref" rid="epi412102-bib-0116">116</xref> To our knowledge, there is one WS case with SCAD resistant to treatment in the literature<xref ref-type="ref" rid="epi412102-bib-0117">117</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>The BALB/cByJ mouse is described as a model for human SCAD during routine screening of mutated mice for metabolic disorders (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0118">118</xref>, <xref ref-type="ref" rid="epi412102-bib-0119">119</xref> Histopathologically, cerebral edema, astrocytic swelling, and neuronal mitochondrial injury<xref ref-type="ref" rid="epi412102-bib-0120">120</xref> and clinically, impaired thermoregulation in cold conditions are reported<xref ref-type="ref" rid="epi412102-bib-0121">121</xref>; however, no seizure phenotype is mentioned. Because it was known that the ethylmalonic acid accumulates in SCAD deficiency, a study investigated the effects of its direct administration into striatum in young rats and found that striatal slices from these rats have deficient redox homeostasis and decreased sodium potassium ATPase (Na<sup>+</sup>/K<sup>+</sup>ATPase) activity, both of which may lead to neuronal impairment in neurotransmission.<xref ref-type="ref" rid="epi412102-bib-0122">122</xref>
</p>
</sec>
</sec>
<sec id="epi412102-sec-0013">
<title>Deficiencies in metal metabolism</title>
<sec id="epi412102-sec-0014">
<title>Menkes disease</title>
<p>IS have been commonly reported in patients presenting with Menkes disease<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412102-bib-0124">124</xref>, <xref ref-type="ref" rid="epi412102-bib-0125">125</xref>, <xref ref-type="ref" rid="epi412102-bib-0126">126</xref>, <xref ref-type="ref" rid="epi412102-bib-0127">127</xref>, <xref ref-type="ref" rid="epi412102-bib-0128">128</xref>, <xref ref-type="ref" rid="epi412102-bib-0129">129</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Bahi‐Buisson et al.<xref ref-type="ref" rid="epi412102-bib-0126">126</xref> reported that IS manifested during the intermediate stage of Menkes disease in all their patients. Menkes disease is an X‐linked recessive disease with low serum copper (Cu) levels due to mutations in an adenosine triphosphatase (ATP7A) gene encoding P‐type ATPase, which transports nutritional Cu into organelles.<xref ref-type="ref" rid="epi412102-bib-0131">131</xref>, <xref ref-type="ref" rid="epi412102-bib-0132">132</xref>, <xref ref-type="ref" rid="epi412102-bib-0133">133</xref> In the absence of Cu, dysfunctional Cu‐dependent enzymes involved in blood clotting, superoxide removal, myelin, and dopamine/melanin and norepinephrine synthesis (ie, blood clotting factors V and VII, superoxide dismutase and ceramide galactosyl transferase, lysyl oxidase, and dopamine beta hydroxylase) lead to variable outcomes such as anemia, vessel abnormalities, muscle weakness, and neurologic effects.<xref ref-type="ref" rid="epi412102-bib-0127">127</xref>, <xref ref-type="ref" rid="epi412102-bib-0134">134</xref> Nevertheless, Cu supplementation is inefficient as a therapy in Menkes disease.<xref ref-type="ref" rid="epi412102-bib-0125">125</xref>, <xref ref-type="ref" rid="epi412102-bib-0129">129</xref> Even when the disease was first described in 1962, severe neurological symptoms and seizures were observed in 5 related patients.<xref ref-type="ref" rid="epi412102-bib-0131">131</xref> However, the main mechanism leading to IS is still unknown (for review<xref ref-type="ref" rid="epi412102-bib-0135">135</xref>).</p>
<p>Variations in the murine mottled (blotchy and dappled, <italic>Mo</italic>
<sup>blo</sup> and <italic>Mo</italic>
<sup>dp</sup>) locus are suggested to be the homolog of the human Menkes disease–causing <italic>ATP7A</italic> gene.<xref ref-type="ref" rid="epi412102-bib-0136">136</xref>, <xref ref-type="ref" rid="epi412102-bib-0137">137</xref> Neurological aspects of Menkes disease, including seizures, are reflected at most by the brindled mottled mouse (Mo<sup>br</sup>), although no spasms were reported (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0137">137</xref> In these mice, axonal development and synaptogenesis are impaired in the cerebral cortex and the hippocampus, and in addition, peptidylglycine alpha–amidating monooxygenase activity is reduced, indicating an impaired amidation that is important for functioning of neuropeptides as glycine, cholecystokinin, and neuropeptide Y.<xref ref-type="ref" rid="epi412102-bib-0137">137</xref>, <xref ref-type="ref" rid="epi412102-bib-0138">138</xref> Some of these changes in the brindled Mo<sup>br</sup> can be rescued by the human Menkes transgene, although the Cu concentrations are not fully reversed to normal.<xref ref-type="ref" rid="epi412102-bib-0139">139</xref> In addition, recently, non‐mammalian models of Menkes disease have also been established. The normal brain expression of <italic>atp7a</italic> in a zebrafish model is very low,<xref ref-type="ref" rid="epi412102-bib-0140">140</xref> whereas amidation impairments in a <italic>Drosophila</italic> model are similar to the murine model.<xref ref-type="ref" rid="epi412102-bib-0141">141</xref> These findings from animal models already indicate the global alterations that lead to the Menkes disease phenotype and pathology similarities in different organisms.</p>
</sec>
</sec>
<sec id="epi412102-sec-0015">
<title>Vitamin B<sub>6</sub>‐, pyridoxine dependency, and pyridoxal‐5′‐phosphate deficiency</title>
<p>Reports of nervous system symptoms, epileptiform activities, or seizures induced by pyridoxine (vitamin B<sub>6</sub>) deficiency and of the seizure‐suppressing effect of pyridoxine have been described for rats and humans.<xref ref-type="ref" rid="epi412102-bib-0142">142</xref>, <xref ref-type="ref" rid="epi412102-bib-0143">143</xref>, <xref ref-type="ref" rid="epi412102-bib-0144">144</xref>, <xref ref-type="ref" rid="epi412102-bib-0145">145</xref>, <xref ref-type="ref" rid="epi412102-bib-0146">146</xref> A Japanese study testing pyridoxal phosphate (PLP, active form of pyridoxine) as a treatment in WS showed efficacy in 12.7% of patients including the ones with no underlying metabolic defect, prompting a treatment trial with high‐dose PLP in all WS infants.<xref ref-type="ref" rid="epi412102-bib-0147">147</xref> Similarly, Ohtahara et al.<xref ref-type="ref" rid="epi412102-bib-0148">148</xref> and Pietz et al.<xref ref-type="ref" rid="epi412102-bib-0149">149</xref> report successful use of PLP in 11.8% of WS patients and of high‐dose pyridoxine in 30% of IS patients, respectively, regardless of the prenatal etiology (ie, tuberous sclerosis complex [TSC], chromosome abnormalities, or brain malformations; symptomatic or idiopathic). Pyridoxine is still one of the first treatment choices in WS in Japan due to its safety and because of the side effects of other treatments.<xref ref-type="ref" rid="epi412102-bib-0150">150</xref>, <xref ref-type="ref" rid="epi412102-bib-0151">151</xref>, <xref ref-type="ref" rid="epi412102-bib-0152">152</xref> However, new reports implement the use of first‐line treatments (eg, adrenocorticotropic hormone [ACTH] or vigabatrin [VGB]), as there is no significant difference in efficacy of pyridoxine treatment compared to other medications.<xref ref-type="ref" rid="epi412102-bib-0153">153</xref>
</p>
<p>The exact mechanisms of pyridoxine or PLP deficiency and vitamin B<sub>6</sub> dependency, as well as therapeutic action of these compounds, are still unknown in seizure generation considering that even in certain patients with unknown etiology epilepsy,<xref ref-type="ref" rid="epi412102-bib-0146">146</xref> pyridoxine or PLP treatment can be effective. Vitamin B<sub>6</sub> is converted into pyridoxine and its active coenzyme form, PLP, which is a cofactor of a number of enzymes including GAD catalyzing the conversion of glutamate to γ‐aminobutyric acid (GABA).<xref ref-type="ref" rid="epi412102-bib-0154">154</xref> Low GABA levels are seen in some patients with neonatal seizures that were responsive to vitamin B6 and pyridoxine.<xref ref-type="ref" rid="epi412102-bib-0155">155</xref>, <xref ref-type="ref" rid="epi412102-bib-0156">156</xref> GABA is the main inhibitory neurotransmitter in the central nervous system (CNS), but also plays a role in oxidative energy metabolism.<xref ref-type="ref" rid="epi412102-bib-0157">157</xref> Due to this relation, seizures are attributed to functional deficiencies in GAD1 and GAD2 genes and GABA synthesis<xref ref-type="ref" rid="epi412102-bib-0158">158</xref>, <xref ref-type="ref" rid="epi412102-bib-0159">159</xref>, <xref ref-type="ref" rid="epi412102-bib-0160">160</xref> but no significant linkage has been found in affected families.<xref ref-type="ref" rid="epi412102-bib-0161">161</xref>, <xref ref-type="ref" rid="epi412102-bib-0162">162</xref>, <xref ref-type="ref" rid="epi412102-bib-0163">163</xref>
</p>
<p>Autosomal recessive mutations in the pyridoxine‐5′‐phosphate oxidase (<italic>PNPO</italic>) gene that expresses the enzyme that converts pyridoxine and pyridoxamine to active PLP underlie PLP‐responsive (but pyridoxine‐unresponsive) neonatal epileptic encephalopathy in 5 patients.<xref ref-type="ref" rid="epi412102-bib-0164">164</xref> A patient with IS of unknown etiology who had normal CSF pyridoxal‐5′‐phosphate, carried a <italic>PNPO</italic> mutation that resided in a conserved sequence with damaging effects, as determined by 2 functional online analysis programs, polymorphism phenotyping v2 (PolyPhen) and sorting tolerant from intolerant (SIFT). <xref ref-type="ref" rid="epi412102-bib-0165">165</xref> DNA sequencing from 13 individuals between 17 months and 15 years of age who had pyridoxine‐dependent seizures revealed mutations in the α‐aminoadipic semialdehyde dehydrogenase (ALDH7A1) gene that encodes antiquitin which is involved in lysine catabolism.<xref ref-type="ref" rid="epi412102-bib-0166">166</xref> The location of the mutations in the <italic>ALDH7A1</italic> gene contributes to the phenotype of the patients.<xref ref-type="ref" rid="epi412102-bib-0167">167</xref> In addition, unlike patients carrying <italic>PNPO</italic> mutations or having PNPO deficiency, in patients with ALDH deficiency, no increases in threonine or glycine in serum or CSF are found.</p>
<p>There are patients with <italic>ALDH7A1</italic> mutations and IS although there is a patient with antiquitin dysfunction but without a mutation suggesting an unknown mechanism in this deficiency<xref ref-type="ref" rid="epi412102-bib-0168">168</xref>, <xref ref-type="ref" rid="epi412102-bib-0169">169</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Of interest, patients with folinic acid deficiency, also a known but rare cause of seizures, may carry <italic>ALDH7A1</italic> mutations.<xref ref-type="ref" rid="epi412102-bib-0170">170</xref> Although this condition is seen mostly with neonatal seizures, urine antiquitin measurement is advised when no underlying cause is present for IS.<xref ref-type="ref" rid="epi412102-bib-0171">171</xref>
</p>
<p>KO mice for tissue‐nonspecific alkaline phosphatase (TNAP) show seizures, elevated PLP and reduced levels of GABA all of which can be reversed by the application of PLP but not pyridoxine (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0172">172</xref> Interestingly, pyridoxal treatment is influenced by the genetic background of the mice, being effective fully only in C57BL/6 mice, not effective in inbred 129/Sv and partially effective in hybrid B6129.<xref ref-type="ref" rid="epi412102-bib-0172">172</xref> Litters born to both TNAP+/+ mice and heterozygous mice who are fed by pyridoxine‐deficient diet also show epileptic seizures.<xref ref-type="ref" rid="epi412102-bib-0173">173</xref> PLP and primidone suppress zebrafish seizures induced by Ginkgo biloba, leading to PLP and GABA reductions despite the fact that this model is not a specific model for PLP deficiency.<xref ref-type="ref" rid="epi412102-bib-0174">174</xref>
</p>
</sec>
<sec id="epi412102-sec-0016">
<title>Acidurias</title>
<sec id="epi412102-sec-0017">
<title>
<sc>d</sc>‐Glyceric aciduria</title>
<p>ᴅ‐Glyceric Aciduria (ᴅGA) was first described in a 2‐year old boy having symptoms similar to NKH such as high urinary glycine, myoclonic jerks, and motor and developmental retardation, but also with hyperglyceric acidemia and hyperglycericaciduria.<xref ref-type="ref" rid="epi412102-bib-0175">175</xref> Autosomal recessive mutations in the <sc>d</sc>‐glycerate kinase (<italic>GLYCTK</italic>) gene were identified in 3 patients including the ᴅGA patient first described.<xref ref-type="ref" rid="epi412102-bib-0176">176</xref> Regardless of the high urinary ᴅ‐glyceric acid content, individuals that are fully healthy or present with only mildly affected fructose metabolism have been reported.<xref ref-type="ref" rid="epi412102-bib-0176">176</xref>, <xref ref-type="ref" rid="epi412102-bib-0177">177</xref>, <xref ref-type="ref" rid="epi412102-bib-0178">178</xref>
</p>
<p>A 6‐month‐old boy with healthy sisters from first‐degree, consanguineous parents was diagnosed with WS and was followed until 3 years of age<xref ref-type="ref" rid="epi412102-bib-0179">179</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). A fructose‐free diet provided partial amelioration, with decreases in autistic behavior and resolution of abnormal signal intensity in mesencephalon, thalami, and globus pallidum on MRI; however, it is not clear how defects in fructose metabolism led to neuronal symptoms, and particularly WS.</p>
<p>No seizures are reported in rats that are exposed to a high‐fructose and high‐fat diet (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0180">180</xref>
<italic>Glyctk KOs</italic> that are created by the clustered regularly interspaced short palindromic repeats (CRISPR) and <italic>Glyctk</italic> small interfering RNAs (siRNAs) to silence the gene are available; however, no model with a seizure phenotype has been identified to date.</p>
</sec>
<sec id="epi412102-sec-0018">
<title>Methylmalonic aciduria and cobalamin (B12) deficiencies</title>
<p>Deficient methylmalonyl CoA mutase (MUT) that converts propionyl‐CoA from amino and fatty acids into a Krebs cycle component, succinyl‐CoA, leads to accumulation of methylmalonic acid (MMA) and its derivatives. These derivatives are toxic to kidneys and brain where they affect particularly the basal ganglia.<xref ref-type="ref" rid="epi412102-bib-0181">181</xref>, <xref ref-type="ref" rid="epi412102-bib-0182">182</xref>, <xref ref-type="ref" rid="epi412102-bib-0183">183</xref> 5′‐Deoxyadenosylcobalamin is a cofactor of MUT; therefore its absence or deficient synthesis may also result in methylmalonic aciduria.<xref ref-type="ref" rid="epi412102-bib-0183">183</xref>, <xref ref-type="ref" rid="epi412102-bib-0184">184</xref>, <xref ref-type="ref" rid="epi412102-bib-0185">185</xref> The disease progression, and treatment options and their success may differ depending on the location of autosomal recessive mutations affecting either the synthesis pathway of the apoenzyme or the cofactor.<xref ref-type="ref" rid="epi412102-bib-0183">183</xref>, <xref ref-type="ref" rid="epi412102-bib-0186">186</xref>, <xref ref-type="ref" rid="epi412102-bib-0187">187</xref>, <xref ref-type="ref" rid="epi412102-bib-0188">188</xref> IS due to MMA accumulation or B12 deficiency is reported in several patients with various responses to vitamin supplements<xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412102-bib-0189">189</xref>, <xref ref-type="ref" rid="epi412102-bib-0190">190</xref>, <xref ref-type="ref" rid="epi412102-bib-0191">191</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). In bigger cohorts, the frequency of methylmalonic aciduria among the reported underlying etiologies in infants with IS varies between 0 and10%.<xref ref-type="ref" rid="epi412102-bib-0009">9</xref>, <xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0192">192</xref>
</p>
<p>Rats show clonic and tonic–clonic seizures after intrastriatal MMA injection, and the duration of these seizures are reduced by preadministration of MK‐801, alpha‐tocopherol, or ascorbic acid, indicating the possible role of NMDA receptors and free radicals in the MMA‐induced phenotype (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0193">193</xref>, <xref ref-type="ref" rid="epi412102-bib-0194">194</xref> Membrane preparations from both cerebral cortex of the subcutaneously MMA‐treated rats and brain homogenates of untreated rats that are preincubated with MMA indicate decreased Na<sup>+</sup>/K<sup>+</sup>ATPase activity, which is prevented by ex vivo simultaneous glutathione application.<xref ref-type="ref" rid="epi412102-bib-0195">195</xref> On the other hand, intracerebroventricular (ICV) injection of MMA leads to clonic convulsions and lower GAD activity in rats, and although the duration of convulsions can be reduced by pyridoxine, baclofen, and muscimol, decrease in GAD activity can be prevented by pyridoxine and MK‐801.<xref ref-type="ref" rid="epi412102-bib-0196">196</xref>
</p>
<p>Of the few mice models that mimic cobalamin deficiency, transcobalamin receptor (<italic>CD320/TCbIR</italic>) KOs present with neurological impairments that are similar to the human cobalamin deficiency.<xref ref-type="ref" rid="epi412102-bib-0197">197</xref>, <xref ref-type="ref" rid="epi412102-bib-0198">198</xref>, <xref ref-type="ref" rid="epi412102-bib-0199">199</xref> These mice show cognitive deficits and anxiety behaviorally, whereas in vitro examination indicates smaller pyramidal cells and impaired in the CA1 region of the hippocampus together with lower GluR1 expression, indicating an AMPA receptor–mediated LTP deficit.<xref ref-type="ref" rid="epi412102-bib-0198">198</xref> However, seizures have not been observed.</p>
</sec>
<sec id="epi412102-sec-0019">
<title>Homocysteinemias</title>
<p>Increased levels of homocysteine in blood and urine in patients presenting with neurological symptoms were reported to be due to cystathionine synthase (CS) deficiency or decreased activity of methylene tetrahydrofolate reductase (MTHFR) enzyme due to autosomal‐recessive <italic>MTHFR</italic> mutations.<xref ref-type="ref" rid="epi412102-bib-0200">200</xref>, <xref ref-type="ref" rid="epi412102-bib-0201">201</xref>, <xref ref-type="ref" rid="epi412102-bib-0202">202</xref> Insufficiency of cobalamin (or vitamin B12), a cofactor of MTHFR, may also result in homocysteinemia. When homocysteine is not converted to cystathione via CS or not reduced to methionine via MTHFR, it accumulates in many tissues and interacts with a number of molecules including cytochrome C, hemoglobin, and immune mediators. Therefore, homocysteine affects a range of functions including energy metabolism, oxidative reactions, and immunity (for review see<xref ref-type="ref" rid="epi412102-bib-0203">203</xref>).<xref ref-type="ref" rid="epi412102-bib-0204">204</xref> Although the direct link between homocysteinemia and seizures or spasms is not clear, it is known that systemic administration of homocysteine leads to convulsive seizures in adult rats and adult mice and excitotoxicity in organotypic cortical and hippocampal slice cultures from rat brain.<xref ref-type="ref" rid="epi412102-bib-0205">205</xref>, <xref ref-type="ref" rid="epi412102-bib-0206">206</xref>, <xref ref-type="ref" rid="epi412102-bib-0207">207</xref> In addition, homocysteine accumulation is associated with vascular and neurodegenerative diseases, and also with epilepsy (for review<xref ref-type="ref" rid="epi412102-bib-0208">208</xref>). Folic acid and cobalamin supplements are known to decrease blood homocysteine levels.<xref ref-type="ref" rid="epi412102-bib-0209">209</xref>
</p>
<p>A 14‐month‐old girl from a nonconsanguineous parents presenting with IS, hypsarrhythmia, and developmental delay was shown to have MTHFR deficiency. None of the interventions including betaine, methionine, vitamin supplements, various antiseizure drug combinations, corpus callosotomy, and vagus nerve stimulator implantation blocked her seizures<xref ref-type="ref" rid="epi412102-bib-0204">204</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>Intraperitoneal homocysteine injection of rats of different age groups ranging between 7 and 90 days show age‐specific seizures (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0210">210</xref> In immature rats, status epilepticus and flexion seizures are apparent, whereas in adult rats, spikes and spike waves without a behavioral correlation are observed. Intracerebroventricular administration of homocysteic acid in 12‐day‐old rats leads to generalized tonic–clonic seizures that are completely prevented when NMDA nonselective and selective 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzoquinoxaline‐2,3‐dione (NBQX) and 2‐amino‐7‐phosphonoheptanoic acid (AP7), respectively, are administered before homocysteic acid.<xref ref-type="ref" rid="epi412102-bib-0211">211</xref> Likewise, subcutaneous chronic injection of homocysteine in rats from PN6 to PN28 decreases Na<sup>+</sup>/K<sup>+</sup>ATPase activity in the synaptic membrane preparations from the hippocampus ex vivo.<xref ref-type="ref" rid="epi412102-bib-0212">212</xref> Few animal models present with homocysteinemia but the <italic>Mthfr</italic> KO mouse is the closest phenotype to the one seen in humans.<xref ref-type="ref" rid="epi412102-bib-0197">197</xref> Heterozygote mice show a moderate increase in homocysteine, whereas homozygotes have a 10‐fold increase and they have developmental retardation.<xref ref-type="ref" rid="epi412102-bib-0213">213</xref> Of interest, WT animals from heterozygote hyperhomocysteinemic mothers show impaired short‐term memory assessed by a behavioral test, and slices from these mice indicate apoptosis in the hippocampus.<xref ref-type="ref" rid="epi412102-bib-0214">214</xref>
</p>
</sec>
<sec id="epi412102-sec-0020">
<title>Propionic acidemia</title>
<p>Autosomal recessively inherited mutations in propionyl‐coenzyme A carboxylase (<italic>PCC</italic>) genes resulted in PCC deficiencies, leading to deficient catabolism of various amino and fatty acids and cholesterol.<xref ref-type="ref" rid="epi412102-bib-0215">215</xref>, <xref ref-type="ref" rid="epi412102-bib-0216">216</xref>, <xref ref-type="ref" rid="epi412102-bib-0217">217</xref>, <xref ref-type="ref" rid="epi412102-bib-0218">218</xref> Due to the resulting accumulation of propionyl‐CoA, secondary hypoglycemia, hyperammonemia, and hyperglycinemia, it is considered as a form of ketotic hyperglycinemia<xref ref-type="ref" rid="epi412102-bib-0216">216</xref> but can also manifest without metabolic symptoms.<xref ref-type="ref" rid="epi412102-bib-0219">219</xref> Patients are presenting with failure to thrive, vomiting, ketoacidosis, lethargy, and neurological symptoms ranging from developmental delay to seizures and stroke‐like episodes. Treatment involves protein‐restricted diet and carnitine load to help propionylcarnitine excretion, although interventions may not prevent or reverse all the neurological symptoms.<xref ref-type="ref" rid="epi412102-bib-0220">220</xref>, <xref ref-type="ref" rid="epi412102-bib-0221">221</xref>
</p>
<p>In a 4‐month‐old girl with hypsarrhythmia and propionic acidemia associated with deficient PCC activity in her leukocytes and cultured skin fibroblasts, ACTH treatment stopped her seizures and normalized her EEG. Dietary protein restriction also was reported as beneficial, but she developed ketoacidosis triggered by poor feeding at 11 months of age and developmental delay<xref ref-type="ref" rid="epi412102-bib-0222">222</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>ICV administration of propionic acid in adult rats led to dystonia, hyperactivity, spiking in the caudate, and worsening of kindling‐induced seizures; in vitro analysis showed increased oxidative stress and reduced glutathione and glutathione peroxidase activity along with neuroinflammation (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0223">223</xref> Of interest, the authors suggest that this model may serve as a model for autism spectrum disorder (ASD), as it shows impairments of social behavior, social cognition, and sensorimotor ability.<xref ref-type="ref" rid="epi412102-bib-0224">224</xref>, <xref ref-type="ref" rid="epi412102-bib-0225">225</xref> In addition, in vitro evaluation of the brains from 21‐day‐old rats that received oral propionic acid show decreased glutathione and glutathione peroxidase activity, elevated levels of neuroinflammatory markers, interleukin 6 (IL‐6), tumor necrosis factor alpha (TNF‐α), interferon gamma (IFN‐γ), and heat shock protein 70 (HSP17), and proapoptotic marker caspase 3, along with DNA fragmentation as well as decreased levels of GABA, serotonin, and dopamine.<xref ref-type="ref" rid="epi412102-bib-0226">226</xref> Despite the fact that IS, especially due to symptomatic origin, is also a known risk factor for ASD,<xref ref-type="ref" rid="epi412102-bib-0005">5</xref>, <xref ref-type="ref" rid="epi412102-bib-0227">227</xref> no seizures are reported in this model.</p>
</sec>
</sec>
</sec>
<sec id="epi412102-sec-0021">
<title>Metabolic Errors in Organelles</title>
<sec id="epi412102-sec-0022">
<title>Mitochondrial disorders</title>
<sec id="epi412102-sec-0023">
<title>Pyruvate dehydrogenase complex deficiency</title>
<p>Pyruvate dehydrogenase complex (PDHC) comprises multiple enzymes that catalyze oxidative decarboxylation of pyruvate to acetyl‐CoA, an irreversible and rate‐limiting reaction in the aerobic glucose metabolism in mitochondria.<xref ref-type="ref" rid="epi412102-bib-0228">228</xref> PDHC enzymes are expressed in many cell types, and deficiency of the enzymes leads to lactic acidemia as well as neurological complications, since the brain is a highly energy dependent organ.<xref ref-type="ref" rid="epi412102-bib-0228">228</xref>, <xref ref-type="ref" rid="epi412102-bib-0229">229</xref> Lactic acidosis was found to be due to the mutations in the pyrophosphate‐dependent pyruvate decarboxylase (E1) α subunit of the PDHC,<xref ref-type="ref" rid="epi412102-bib-0230">230</xref> and these mutations were shown to be the most prominent ones in patients with mild to severe neurological symptoms.<xref ref-type="ref" rid="epi412102-bib-0229">229</xref>, <xref ref-type="ref" rid="epi412102-bib-0231">231</xref> Depending on the genomic localization of the mutations on the X chromosome and also the random X inactivation in different tissues, PDHC E1 α subunit deficiency may have variable effects on tissues with sexually dimorphic features.<xref ref-type="ref" rid="epi412102-bib-0229">229</xref>, <xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0232">232</xref>
</p>
<p>There are several reports of patients presenting both PDHC deficiency and WS with variable responses to treatment<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0233">233</xref>, <xref ref-type="ref" rid="epi412102-bib-0234">234</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). A preference for female patients with PDHC to develop WS has been reported.<xref ref-type="ref" rid="epi412102-bib-0234">234</xref> Genotype‐phenotype variability has been observed in patients with PDHC deficiency receiving similar treatments, which could be due to different genetic substrates or variable developmental effects of PDHC deficiency and its treatments.<xref ref-type="ref" rid="epi412102-bib-0237">237</xref>
</p>
<p>Mice with a null mutation of PDHC E1 α subunit, which removed exon 8 (<italic>Pdha1 (Deltaex8</italic>)) from the gene globally, have low PDC activity and reduced litter size, whereas developmental delay was reported in the mice that had the <italic>Pdha1 (Deltaex8)</italic> allele predominantly (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0238">238</xref> When the same mutation was targeted only to the developing nervous system, using a nestin‐cre promoter, male mice died prenatally and only 50% of female mice survived.<xref ref-type="ref" rid="epi412102-bib-0239">239</xref> These female mice had decreased neuronal density and neuropil fibers, abnormal localization of the neurons in the gray matter, reduced lipid synthesis, and irregular myelination. Of interest, the affected female mice survived into adulthood without discernible neurological deficits. Knockdown of the PDHC E1 α subunit via the delivery of siRNAs into striatum and substantia nigra of rats led to abnormal amphetamine‐induced rotation<xref ref-type="ref" rid="epi412102-bib-0240">240</xref> indicating degenerative changes in the nigrostriatal system.<xref ref-type="ref" rid="epi412102-bib-0241">241</xref> A recent investigation of a systemic deletion of exon 8 from PDHC E1 α subunit in mice showed general decrease in brain weight, de novo lipid synthesis, reduced proliferation, differentiation, and migration of newly generated neuronal precursor cells in prenatal and postnatal periods in cerebellum and impaired dendritic development of Purkinje cells.<xref ref-type="ref" rid="epi412102-bib-0242">242</xref> The locomotor activity was normal in these mice; however, they had impaired acoustic startle reflex indicating mild motor abnormalities. In a zebrafish model of PDH deficiency via the impairment of the E2 subunit, ketogenic diet reversed the abnormal vision, lactic acidosis, and lethargic swimming behavior.<xref ref-type="ref" rid="epi412102-bib-0243">243</xref>
</p>
</sec>
<sec id="epi412102-sec-0024">
<title>Leigh syndrome (subacute necrotizing encephalomyopathy)</title>
<p>Leigh syndrome was first described in 1951 based on the autopsy findings of focal, bilateral subacute necrotic white matter lesions in a boy presenting with somnolence, deafness, blindness, and spastic limbs.<xref ref-type="ref" rid="epi412102-bib-0244">244</xref> The lesions are now known to include basal ganglia, thalamus, cerebellum, and brainstem; the symptoms and signs include hypotonia, feeding problems, and psychomotor delay.<xref ref-type="ref" rid="epi412102-bib-0245">245</xref> Mutations leading to this phenotype can be autosomal or X‐linked, as in the case of mitochondrial PDHC or respiratory chain mutations, although patients without these mutations were also reported.<xref ref-type="ref" rid="epi412102-bib-0245">245</xref>, <xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0247">247</xref>
</p>
<p>Leigh and Leigh‐like syndromes presenting with IS/WS were described in several patients due to PDHC mutations<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0248">248</xref>, <xref ref-type="ref" rid="epi412102-bib-0249">249</xref>, <xref ref-type="ref" rid="epi412102-bib-0250">250</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Of interest, Tsuji et al.<xref ref-type="ref" rid="epi412102-bib-0246">246</xref> reported 2 sisters with Leigh syndrome, where only one developed WS and in another family both brothers with Leigh syndrome had WS later, adding further to the complexity of pathology in Leigh syndrome with WS patients.</p>
<p>Because mutations in the NADH:ubiquinone oxidoreductase subunit S4 (NDUFS4), encoding a mitochondrial complex I protein, are also related to Leigh and Leigh‐like syndromes,<xref ref-type="ref" rid="epi412102-bib-0252">252</xref>, <xref ref-type="ref" rid="epi412102-bib-0253">253</xref>
<italic>Ndufs4</italic> KO mice were generated (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0254">254</xref> These mice were behaviorally normal during the first 4 postnatal weeks but their growth was delayed; they progressively became lethargic, ataxic, and blind; lost their startle response; and died by week 7.<xref ref-type="ref" rid="epi412102-bib-0254">254</xref> Selective KO of Ndufs4 in neurons and glia present with similar phenotype as complete KO; however, slices from these mice also showed gliosis and microglial activation in brainstem and cerebellum.<xref ref-type="ref" rid="epi412102-bib-0255">255</xref> Of interest, hypoxia (11% O<sub>2</sub>) reversed neurodegenerative changes and increased the life span of <italic>Ndufs4</italic> KO mice.<xref ref-type="ref" rid="epi412102-bib-0256">256</xref> In addition, rapamycin (an inhibitor of mechanistic target of rapamycin [mTOR]) extended the life span, prevented brain injury, increased the low levels of GABA, dopamine, and free fatty acids, and decreased the glycolytic intermediates without having an effect on oxidative stress markers in <italic>Ndfus4</italic> KO mice.<xref ref-type="ref" rid="epi412102-bib-0257">257</xref> Likewise, rapamycin also increased the life span of animals but led to fat storage impairments in a <italic>Drosophila</italic> model of Leigh syndrome via the complex I subunit NADH dehydrogenase 2 (<italic>ND2</italic>) deletion.<xref ref-type="ref" rid="epi412102-bib-0258">258</xref> Alterations in glycolytic intermediates and fat storage in these models suggest that rapamycin exerts its effects via the changing metabolism, a hypothesis that is yet to be proven.<xref ref-type="ref" rid="epi412102-bib-0257">257</xref>, <xref ref-type="ref" rid="epi412102-bib-0258">258</xref>
</p>
</sec>
<sec id="epi412102-sec-0025">
<title>Alpers‐Huttenlocher disease</title>
<p>Alpers‐Huttenlocher disease is a rare disorder characterized by microcephaly, refractory seizures, and liver dysfunction that may result from deficiencies in the PDH enzyme in citric acid cycle or respiratory chain or mutations in mitochondrial DNA polymerase gamma (<italic>POLG</italic>) of <italic>FARS2</italic> gene (Phe‐tRNA synthetase 2).<xref ref-type="ref" rid="epi412102-bib-0259">259</xref>, <xref ref-type="ref" rid="epi412102-bib-0260">260</xref>, <xref ref-type="ref" rid="epi412102-bib-0261">261</xref> Three patients with Alpers‐Huttenlocher disease and WS were identified in a study examining the etiological factors in 20 patients with mitochondrial dysfunction confirmed by biochemical and morphologic examinations<xref ref-type="ref" rid="epi412102-bib-0260">260</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Despite all 3 Alpers‐Huttenlocher disease patients having mitochondrial complex I deficiency, it was not inherited in any of them. Among 11 reported cases with <italic>FARS2</italic> mutations, 3 (27%) had WS and hypsarrhythmia.<xref ref-type="ref" rid="epi412102-bib-0262">262</xref>, <xref ref-type="ref" rid="epi412102-bib-0263">263</xref> No reports of patients with <italic>POLG</italic> mutations and IS are known to the authors.</p>
<p>The mitochondrial mutator mice, carrying a D257A knockin mutation at the catalytic subunit A of the <italic>Polg</italic> gene that removes the proofreading ability of the enzyme, show instability of the mitochondrial DNA (mtDNA) with increased mutation rate and deletions in the mitochondrial DNA (mtDNA), leading to early aging (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0264">264</xref>, <xref ref-type="ref" rid="epi412102-bib-0265">265</xref> Homozygous <italic>PolgA</italic>
<sup><italic>mut/mut</italic></sup> mice manifest reduced body size and weight around the 20th week, prematurely age at around 48 weeks, and die by 61 weeks of life.<xref ref-type="ref" rid="epi412102-bib-0264">264</xref>, <xref ref-type="ref" rid="epi412102-bib-0265">265</xref> Heterozygous <italic>PolgA</italic>
<sup><italic>mut/wt</italic></sup> mice do not show abnormalities in aging.<xref ref-type="ref" rid="epi412102-bib-0264">264</xref> A zebrafish model was developed where <italic>Polg−/−</italic> larvae survived until juvenile age (4 weeks after fertilization).<xref ref-type="ref" rid="epi412102-bib-0266">266</xref> A different study suggested that early KO of <italic>PolgA</italic> at the preimplantation stage results in early lethality by embryonic day 11 and depletion of mtDNA in mice.<xref ref-type="ref" rid="epi412102-bib-0267">267</xref>
</p>
</sec>
</sec>
<sec id="epi412102-sec-0026">
<title>Lysosomal storage diseases</title>
<p>Lysosomal storage diseases comprise a group of disorders including neuronal ceroid lipofuscinosis (NCL), Gaucher disease, Tay‐Sachs disease, Hurler syndrome, Niemann‐Pick disease, and a few others resulting from deficiencies in lysosomal metabolic enzyme(s) (for review<xref ref-type="ref" rid="epi412102-bib-0016">16</xref>, <xref ref-type="ref" rid="epi412102-bib-0268">268</xref>). These diseases may feature neuromuscular, respiratory, endocrine, cardiovascular, and morphological symptoms, although most patients may appear normal neonatally because the excess, harmful metabolites that are produced by the dysfunctional enzymes can be removed via the placenta during gestation.<xref ref-type="ref" rid="epi412102-bib-0268">268</xref> Mutations in the lysosomal enzymes are mostly autosomal recessive, or in few exceptions such as Fabry disease, Hunter syndrome and Danon disease, are X‐linked.<xref ref-type="ref" rid="epi412102-bib-0268">268</xref>
</p>
<p>There is a report of a 5‐month‐old boy with IS and a low α‐<sc>l</sc>‐iduronidase (IDUA) activity confirmed to have a severe type of mucopolysaccharidosis I, a lysosomal storage disease called Hurler syndrome<xref ref-type="ref" rid="epi412102-bib-0269">269</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Another recent study reported a 5‐month‐old patient with IS having a form of Niemann‐Pick disease (NPD) due to sphingomyelin phosphodiesterase enzyme deficiency caused by compound heterozygous mutations in sphingomyelin phosphodiesterase 1 (<italic>SMPD1</italic>), also known as the acid sphingomyelinase (<italic>ASM</italic>) gene<xref ref-type="ref" rid="epi412102-bib-0270">270</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>There are different experimental models for various types of lysosomal storage diseases (for review<xref ref-type="ref" rid="epi412102-bib-0271">271</xref>) (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>). For instance, <italic>Idua</italic> KO mice generated by targeted disruption of exon 5 of the gene in mice embryonic stem cells that are injected later into blastocysts have deficient IDUA activity.<xref ref-type="ref" rid="epi412102-bib-0272">272</xref> These mice show some phenotypic features such as flat face and increase in glycosaminoglycan in urine, which are similar to those seen in human patients with Hurler syndrome. Abnormal lysosomal storage is detected only in glial cells at 4 weeks, but as the KO mice age, vacuolation in Purkinje cells and also neurons in the cortex are prominent without behavioral alterations.<xref ref-type="ref" rid="epi412102-bib-0272">272</xref> When 6 to 7 week old <italic>Idua</italic> KO mice are injected with viruses containing human <italic>IDUA</italic> only into their putamen, the brain pathology is reversed.<xref ref-type="ref" rid="epi412102-bib-0273">273</xref> Furthermore, ICV injection of a similar viral construct into 4‐ to 6‐day‐old mice brains also results in widespread expression that prevents the brain pathology and also spatial learning deficits in <italic>Idua</italic> KO mice.<xref ref-type="ref" rid="epi412102-bib-0274">274</xref>
<italic>Asm</italic> KO mice, on the other hand, show high levels of sphingomyelin accumulation and no detectable ASM activity, and die after 6 to 8 months with half of the body weight of controls and heterozygotes at the same age.<xref ref-type="ref" rid="epi412102-bib-0275">275</xref> Also described is a transgenic model for NPD in mice with mutations in complete ASM KO background that may allow evaluation of the effects of different mutations.<xref ref-type="ref" rid="epi412102-bib-0276">276</xref>
</p>
</sec>
</sec>
<sec id="epi412102-sec-0027">
<title>Other Diseases</title>
<sec id="epi412102-sec-0028">
<title>Leukodystrophies</title>
<p>Leukodystrophies present with white matter degeneration, spongy vacuolation, loss of myelin, and resulting motor dysfunction in the early stages of the diseases. Some of these diseases namely Alexander disease, Krabbe disease, X‐linked adrenoleukodystrophy, hereditary diffuse leukoencephalopathy with spheroids, and metachromatic leukodystrophy also feature seizures and epilepsy.<xref ref-type="ref" rid="epi412102-bib-0016">16</xref>
</p>
<p>Autopsy investigations of brain specimens from patients with IS and cognitive dysfunction show spongy dystrophies or leukodystrophies.<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0277">277</xref>, <xref ref-type="ref" rid="epi412102-bib-0278">278</xref>, <xref ref-type="ref" rid="epi412102-bib-0279">279</xref>, <xref ref-type="ref" rid="epi412102-bib-0280">280</xref> Some patients with Alexander and Krabbe disease were reported to have IS/WS<xref ref-type="ref" rid="epi412102-bib-0281">281</xref>, <xref ref-type="ref" rid="epi412102-bib-0282">282</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Autosomal dominant mutations in glial fibrillary acidic protein (GFAP) resulting in build‐up of Rosenthal fibers in astrocytes may be associated with Alexander disease,<xref ref-type="ref" rid="epi412102-bib-0283">283</xref> whereas autosomal recessive mutations in galactosylceramidase gene (GALC) leading to lysosomal glycosphingolipid accumulation was shown to lead to Krabbe disease.<xref ref-type="ref" rid="epi412102-bib-0284">284</xref>, <xref ref-type="ref" rid="epi412102-bib-0285">285</xref>
</p>
<p>Mice expressing WT and only one copy of the human <italic>GFAP</italic> (<italic>hGFAP</italic>) mutation (R239H) causing Alexander disease showed no Rosenthal fiber formation (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0286">286</xref> However, mice expressing WT and multiple copies of the transgene do show Rosenthal fibers only in adult age, have severe convulsions and a high mortality rate when challenged with kainate but show no spontaneous seizures and leukodystrophy.<xref ref-type="ref" rid="epi412102-bib-0286">286</xref> Hypertrophic astrocytes, Rosenthal fiber‐like inclusions, and upregulation of small HSPs are seen in mice carrying the hGFAP transgene without mutations but overexpressed GFAP.<xref ref-type="ref" rid="epi412102-bib-0287">287</xref> In a similar model, microarray analysis show increased immune and stress response, neuronal death, and dysfunction.<xref ref-type="ref" rid="epi412102-bib-0288">288</xref>
</p>
</sec>
<sec id="epi412102-sec-0029">
<title>Biotinidase deficiency</title>
<p>As an inherited disorder in an autosomal recessive manner, biotinidase (BTD) enzyme deficiency leads to abnormalities in the recycling of the vitamin biotin, which is an important cofactor of carboxylase enzymes that help in the catabolism of complex organic acids, fatty acid synthesis, and gluconeogenesis.<xref ref-type="ref" rid="epi412102-bib-0289">289</xref>, <xref ref-type="ref" rid="epi412102-bib-0290">290</xref>, <xref ref-type="ref" rid="epi412102-bib-0291">291</xref> The resulting metabolic dysfunction clinically presents with red skin rash, lactic aciduria, hearing loss, hypotonia, seizures, and developmental delay, and biotin supplements can be used to treat the symptoms.<xref ref-type="ref" rid="epi412102-bib-0290">290</xref>, <xref ref-type="ref" rid="epi412102-bib-0292">292</xref>
</p>
<p>Three patients with full or partial BTD deficiency and IS partially responsive to biotin supplement have been reported; however, mild to moderate developmental delay persisted in all patients<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Rats fed with a biotin‐deficient diet have alopecia of the lower back, delayed growth, and longer latencies in brainstem auditory evoked potentials (BAEPs), indicating an alteration in the auditory system (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0295">295</xref>
<italic>BTD</italic> KO mice, fed with a biotin‐deficient diet show hypotonia, demyelination, axonal degeneration, impaired motor neuron function, lethargy, limping, and ventriculomegaly, in addition to slower growth and weight loss, and these symptoms are reversed with biotin supplement.<xref ref-type="ref" rid="epi412102-bib-0296">296</xref>, <xref ref-type="ref" rid="epi412102-bib-0297">297</xref>
</p>
</sec>
<sec id="epi412102-sec-0030">
<title>D‐bifunctional protein deficiency</title>
<p>D‐bifunctional protein (DBP) deficiency is one of the peroxisomal disorders with poor prognosis, leading to defective oxidation of fatty acids and synthesis of bile salts due to mutations in the DBP gene also known as paroxysmal multifunctional enzyme type 2 (HSD17B4) or multifunctional protein‐2 (MFP‐2).<xref ref-type="ref" rid="epi412102-bib-0298">298</xref>, <xref ref-type="ref" rid="epi412102-bib-0299">299</xref>, <xref ref-type="ref" rid="epi412102-bib-0300">300</xref> High levels of very long chain fatty acids in the plasma and cultured fibroblasts, hypotonia, facial dysmorphism, neuronal migration defects, demyelination, developmental delay, and seizures may be present (for review<xref ref-type="ref" rid="epi412102-bib-0301">301</xref>). A patient with drug‐resistant WS having DBP deficiency has been reported<xref ref-type="ref" rid="epi412102-bib-0302">302</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>Multifunctional protein (<italic>MFP2</italic>) KO mice mimic the metabolic disturbances at birth leading to failure to thrive and death, but they are not hypotonic and do not show any neuronal migration defects (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0300">300</xref>, <xref ref-type="ref" rid="epi412102-bib-0303">303</xref> The surviving <italic>MFP2</italic> KO mice, however, have astrogliosis and microglial activation in the gray matter, which is not seen in humans.<xref ref-type="ref" rid="epi412102-bib-0304">304</xref> In mice, the selective <italic>MFP2</italic> deletion either from all neuronal cells (Nestin‐Mfp2−/−) or only from oligodendrocytes (Cnp‐Mfp2−/−) lead to mild neuroinflammation and axonal impairments in Purkinje cells correlated with motor deficits only in Nestin‐Mfp2−/− mice, indicating no oligodendrocytic involvement in this brain pathology.<xref ref-type="ref" rid="epi412102-bib-0305">305</xref> Complete <italic>MFP2</italic> KO mice also show severe proneuroinflammatory activation. More recently, morphological impairments, delayed growth, and abnormal neuronal development in the <italic>dbp</italic> knockdown zebrafish model is rescued by murine <italic>Dbp</italic>, indicating the benefit of modeling the disease in different organisms.<xref ref-type="ref" rid="epi412102-bib-0306">306</xref>
</p>
</sec>
<sec id="epi412102-sec-0031">
<title>Williams‐Beuren syndrome</title>
<p>Williams‐Beuren syndrome (WBS) also known as Williams syndrome is due to variable microdeletions within the WBS area on the long arm of chromosome 7 containing 26 to 28 genes such as, Elastin (<italic>ELN</italic>) and Syntaxin 1A (<italic>STX1A</italic>), and may present with various features as hypercalcemia, hypothyroidism, impaired glucose tolerance, growth abnormalities, characteristic facial appearance, mental retardation, and cardiac anomalies.<xref ref-type="ref" rid="epi412102-bib-0307">307</xref>, <xref ref-type="ref" rid="epi412102-bib-0308">308</xref>, <xref ref-type="ref" rid="epi412102-bib-0309">309</xref> The exact contribution of the involved deleted genes to the WBS phenotype is yet to be elucidated. Treatment is only symptomatic, directed toward the specific clinical presentation of the disease.<xref ref-type="ref" rid="epi412102-bib-0307">307</xref>
</p>
<p>In WBS, due to deletions in the WBS area of the 7th chromosome, WS has been reported in 3 children whose spasms were fully or partially treated with ACTH and anti‐seizure drugs, although the developmental impairment is progressive<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>, <xref ref-type="ref" rid="epi412102-bib-0311">311</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). Of interest, the deletions in the membrane‐associated guanylate kinase inverted‐2 (MAGI2) gene in the very same region of chromosome 7 were previously shown to be associated with IS.<xref ref-type="ref" rid="epi412102-bib-0312">312</xref> The scaffolding protein encoded by MAGI2 is also associated with Stargazin protein. <italic>MAGI2</italic> mutations are the cause of epilepsy in the stargazer epilepsy model, which presents with generalized cortical spike and wave discharges accompanied by behavioral arrest and complex bilateral neocortical discharges.<xref ref-type="ref" rid="epi412102-bib-0312">312</xref>, <xref ref-type="ref" rid="epi412102-bib-0313">313</xref> A recent study evaluating the candidate genes residing on chromosome 7 in a zebrafish knockdown model reported haploinsufficiency of <italic>ywag</italic> gene, residing in the telomeric region of the chromosome and encoding 14‐3‐3 protein gamma, and related this gene with IS and cardiomegaly seen in WBS patients.<xref ref-type="ref" rid="epi412102-bib-0314">314</xref> Because the WBS area encompasses a number of genes, the first experiments focused on both hetero‐ and homozygous single gene deletions in this region to elucidate the contribution of each gene to the phenotype (for review<xref ref-type="ref" rid="epi412102-bib-0192">192</xref>). Of these modeled genes, both heterozygous and homozygous deletions of one of the Wnt receptor–coding frizzled 9 (<italic>Fzd9</italic>) gene, involving in the neurotrophic processes, led to decreased pentylenetetrazole‐induced seizure threshold and abnormalities in hippocampal structure, whereas the homozygous deletions also result in spatial learning impairments in mice (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).<xref ref-type="ref" rid="epi412102-bib-0315">315</xref> The large‐scale deletions in proximal and/or distal regions in the mouse WBS area present with cognitive impairments in distal deletions and defective motor skills in double, heterozygotes (proximal and distal deletions), showing a closer relation to the human phenotype.<xref ref-type="ref" rid="epi412102-bib-0192">192</xref>, <xref ref-type="ref" rid="epi412102-bib-0316">316</xref> Heterozygous, almost‐complete deletions of the WBS region in mice reduce brain weight and dendritic length and spine density in the hippocampus and GFAP‐positive cells in the amygdala; increase the number of immature cells in the DG; and lead to craniofacial and cardiac abnormalities.<xref ref-type="ref" rid="epi412102-bib-0317">317</xref> In addition, complete deletion mice show spatial learning deficits, and slices from these mice indicate unstable LTP with no changes in presynaptic function or AMPA and NMDA receptor activity in CA1 but low brain‐derived neurotrophic factor (BNDF) levels in CA1‐CA3 regions.<xref ref-type="ref" rid="epi412102-bib-0318">318</xref>
</p>
</sec>
<sec id="epi412102-sec-0032">
<title>Congenital disorders of glycosylation, molybdenum cofactor deficiency, and primary carnitine deficiency</title>
<p>Several disorders such as congenital disorders of glycosylation (CDG), molybdenum cofactor deficiency (MCD), primary carnitine deficiency (PCD), and isovaleric acidemia (IVA) were also reported in patients with WS.</p>
<p>CDG is a group of disorders with deficient glycosylation of proteins and lipids, leading to their abnormal folding, transport, stability, and activity.<xref ref-type="ref" rid="epi412102-bib-0319">319</xref>, <xref ref-type="ref" rid="epi412102-bib-0320">320</xref> A patient with abnormal vision, IS, hypsarrhythmia, abnormal myelination, reduced white matter, and developmental and motor delay was shown to have a deficient glycosylation, classified as CDG‐li, as investigated by serum transferrin isoelectric focusing<xref ref-type="ref" rid="epi412102-bib-0319">319</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). This defect impairs the transfer of mannosyl residues at the cytosolic side of endoplasmic reticulum, leading to deficient oligosaccharide biosynthesis. Mouse models for 2 different groups of CDGs (CDGI and CDG II) are currently available (for review<xref ref-type="ref" rid="epi412102-bib-0321">321</xref>). However, transient paralysis and tremors that resemble the epileptic seizures are reported only from 20% of mannosyl (alpha‐1,6)‐glycoprotein beta‐1,2‐N‐acetylglucosaminyltransferase (<italic>Mgat2</italic>)–null mice modeling the CDG type IIa (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0322">322</xref> A further evaluation is needed to understand the pathology in this model. MCD and PCD were reported in 2 different WS patients in a study that investigated the metabolic etiologies in 80 children.<xref ref-type="ref" rid="epi412102-bib-0020">20</xref> Both patients were nonresponsive to antiseizure drugs and showed severe developmental delay (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).</p>
<p>Molybdenum is a cofactor of xanthine dehydrogenase, sulfite oxidase, and aldehyde oxidase and in the absence of it, all these enzymes are affected leading mainly to toxic accumulation of sulfite.<xref ref-type="ref" rid="epi412102-bib-0017">17</xref> Carnitine is involved in the transport of long‐chain fatty acids and peroxisomal oxidation products, such as acetyl‐CoA, into mitochondria for oxidation. Deficiency in carnitine transport leads to PCD with defective fatty acid oxidation and fatty acid accumulation. <xref ref-type="ref" rid="epi412102-bib-0323">323</xref>
</p>
<p>Because few mutations in molybdenum cofactor synthesis protein 1 and 2 (<italic>MOCS1</italic> and <italic>MOCS2</italic>) genes and one mutation in gephyrin (<italic>GPHN</italic>) gene leading to MCD are reported, several animal KO models are described (for review<xref ref-type="ref" rid="epi412102-bib-0324">324</xref>). <italic>Mocs1</italic> KO mice survive 1 to 11 days with no convulsions, ataxia, or structural changes in the brain (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0325">325</xref> Systemic injection of adenoviruses carrying human <italic>MOCS1</italic> cDNA increases the life span of the <italic>Mocs</italic>1 KO mice that are treated via hepatic injections of cyclic pyranopterin monophosphatase (cPMP), a precursor in the molybdenum cofactor synthesis, until they are old enough to get a systemic injection.<xref ref-type="ref" rid="epi412102-bib-0326">326</xref>
<italic>Mocs2</italic> KO mice also survive for 11 days on average; pathological and biochemical studies show apoptosis in the hippocampus, cortex, and brainstem; inactivation of all molybdenum cofactor‐dependent enzymes; and accumulation of hypoxanthine, xanthine, and S‐sulfocysteine.<xref ref-type="ref" rid="epi412102-bib-0327">327</xref>
</p>
<p>Dietary restriction of carnitine in rats leads to 50% of reduction in its physiological levels, indicating an ongoing endogenous synthesis but induces no major anatomical or behavioral changes (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0328">328</xref> Dietary restriction, together with supplement of butyrobetaine hydroxylase inhibitor that blocks the last step of the carnitine synthesis results in carnitine deficiency within 3 weeks in rats; however, only liver anomalies are reported.<xref ref-type="ref" rid="epi412102-bib-0329">329</xref> Of interest, when combined with acyl‐CoA, acylcarnitines, including acetyl‐<sc>l</sc>‐carnitine, have neuroprotective effects in various disorders such as<xref ref-type="ref" rid="epi412102-bib-0330">330</xref> Alzheimer's disease<xref ref-type="ref" rid="epi412102-bib-0331">331</xref> and ischemia‐hypoxia–induced brain injury<xref ref-type="ref" rid="epi412102-bib-0332">332</xref> (for review<xref ref-type="ref" rid="epi412102-bib-0333">333</xref>). Carnitine deficiency may result in loss of these protective effects. In addition, the link between PCD and autism is investigated.<xref ref-type="ref" rid="epi412102-bib-0334">334</xref>
</p>
<p>Isovaleric acidemia due to deficient isovaleryl‐CoA dehydrogenase (or IVD) enzyme was confirmed in cultured fibroblasts from a boy in presenting with vomiting, lethargy, and WS<xref ref-type="ref" rid="epi412102-bib-0335">335</xref> (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). IVD is involved in the catabolism of leucine, and in IVD deficiency, this amino acid cannot be degraded, leading to excess excretion of isovalerylglycine (IVG).<xref ref-type="ref" rid="epi412102-bib-0336">336</xref> To our knowledge, currently there is no model mimicking isovaleric acidemia; however, application of isovaleric acid or IVG onto cortical homogenates of 30‐day‐old rats indicates no changes in citric acid cycle or creatine kinase activity, whereas synaptic membrane preparations from these homogenates show that IA decreases Na<sup>+</sup>/K<sup>+</sup>ATPase activity via peroxide radicals (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412102-bib-0337">337</xref> In a similar in vitro experiment using brain homogenates and mitochondrial preparations, IVG but not IA leads to lipid peroxidation and reduced GSH levels in a mitochondria‐independent way. On the other hand, IA triggers protein oxidation.<xref ref-type="ref" rid="epi412102-bib-0338">338</xref> Despite the fact that no other phenotype is defined in these experiments, in vitro alterations are suggestive of neurodegenerative transformations.</p>
</sec>
</sec>
<sec id="epi412102-sec-0033">
<title>Diagnosis of Metabolic Etiologies</title>
<p>As discussed earlier, the frequency of metabolic disorders in the diagnostic evaluation of infants with IS varies among studies, ranging between 3% and 47%, depending on the cohort, the type, and extent of diagnostic investigation for such causes, and the criteria used in each study to distinguish “metabolic disorders” from “genetic etiologies” or “inborn errors of metabolism.”<xref ref-type="ref" rid="epi412102-bib-0009">9</xref>, <xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0020">20</xref> In infants with IS, metabolic disorders for which we have more evidence for a higher association with IS include PKU, NKH, Menkes disease, pyridoxine responsive or dependent seizures, methylmalonic aciduria, and mitochondrial disorders (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>). In general, such diagnostic tests may include routine clinical chemistry (eg, electrolytes, glucose, ammonia, lactate, liver function, or creatine kinase), amino acids, monoamines, or organic acids in blood, urine, or cerebrospinal fluid, specific assays for the activity of certain enzymes, genetic testing for nuclear or mitochondrial DNA defects, or biopsy. Especially newborn screenings from a basic biochemical test to rapid tandem mass spectrometry or genetic tests if indicated may lead to early detection of these abnormalities even before the appearance of the symptoms.<xref ref-type="ref" rid="epi412102-bib-0339">339</xref>, <xref ref-type="ref" rid="epi412102-bib-0340">340</xref> Early identification may also assist in the fast clearance of toxic metabolites (ie, hyperammonemia) and could improve the course of the disease, as in PKU,<xref ref-type="ref" rid="epi412102-bib-0022">22</xref> cobalamin deficiency,<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412102-bib-0339">339</xref>, <xref ref-type="ref" rid="epi412102-bib-0340">340</xref>, <xref ref-type="ref" rid="epi412102-bib-0341">341</xref> or pyridoxine‐responsive seizures. It is beyond the scope of this review to detail the diagnostic workup indicated for each condition or provide guidelines for the physician. The clinical suspicion for an underlying metabolic or genetic etiology plays a significant role in initiating the specific workup, particularly in regions where cost and availability may be a prohibiting factor, which could also affect the reported incidence of such etiologies. Clinicians are therefore guided by other features, symptoms, or signs of these disorders, including neuroimaging findings or expected rate of specific metabolic disorders in the relevant population to direct the diagnostic workup by assessing the cost‐benefit relationship of each test before ordering extensive diagnostic metabolic workups. We refer the readers to textbooks or specific reviews that address the diagnostic features and findings of such disorders.<xref ref-type="ref" rid="epi412102-bib-0016">16</xref>, <xref ref-type="ref" rid="epi412102-bib-0017">17</xref> MRI or routine metabolic studies, including glucose and lactate/pyruvate, or organic and amino acids analysis, may help guide further diagnostic decisions. Genetic testing with specific epilepsy panels or whole‐exome sequencing, which may also identify defects in certain neurometabolic genes, are increasingly available. More specific diagnostic tests for metabolic disorders may be requested based on clinical suspicion and available diagnostic workup.</p>
<p>Associated features that may help the diagnostic evaluation include the neurological exam (eg, hypotonia or hyperreflexia) or presence of movement disorders (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>)<xref ref-type="ref" rid="epi412102-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0339">339</xref> Clinical examination may give hints such as dysmorphic features and neonatal diabetes (eg, DEND),<xref ref-type="ref" rid="epi412102-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412102-bib-0080">80</xref> skin hypopigmentation (eg, Menkes disease),<xref ref-type="ref" rid="epi412102-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412102-bib-0130">130</xref> facial elfin appearance (eg, Williams‐Beuren syndrome),<xref ref-type="ref" rid="epi412102-bib-0310">310</xref>, <xref ref-type="ref" rid="epi412102-bib-0311">311</xref> abnormal facies (eg, PDHC deficiencies),<xref ref-type="ref" rid="epi412102-bib-0231">231</xref>, <xref ref-type="ref" rid="epi412102-bib-0235">235</xref>, <xref ref-type="ref" rid="epi412102-bib-0236">236</xref> alopecia (eg, biotinidase deficiency),<xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref> abnormal visual responses (eg, NKH)<xref ref-type="ref" rid="epi412102-bib-0066">66</xref> or alterations in auditory‐evoked potentials (eg, NKH, methylmalonic aciduria, and biotinidase deficiency),<xref ref-type="ref" rid="epi412102-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412102-bib-0066">66</xref>, <xref ref-type="ref" rid="epi412102-bib-0293">293</xref>, <xref ref-type="ref" rid="epi412102-bib-0294">294</xref> optic atrophy (eg, Leigh syndrome and biotinidase deficiency).<xref ref-type="ref" rid="epi412102-bib-0246">246</xref>, <xref ref-type="ref" rid="epi412102-bib-0251">251</xref>, <xref ref-type="ref" rid="epi412102-bib-0293">293</xref>
</p>
<p>Biochemical screening is typically the first approach to diagnose the metabolic abnormalities. In blood—increased Phe (PKU), glycine (NKH, propionic acidemia), homocysteine (homocysteinemia), propionate (propionic acidemia), lactate (Leigh syndrome, biotinidase deficiency, isovaleric acidemia), ammonia (PCD, isovaleric acidemia) or lactate; or decreased glucose (GLUT1 deficiency), Cu and ceruloplasmin (Menkes disease), B12 (B12 deficiency), carnitine (PCD); in urine—increased ethylmalonic acid (SCAD deficiency), glyceric acid (D‐GA), methylmalonic acid (methylmalonic aciduria), propionate (slightly propionic acidemia), sulfocysteine or decreased uric acid (MCD), isovalerylglycine (isovaleric acidemia); and in CSF—increased pipecolic acid (pyridoxine dependency) give hints about respective diseases. Decreased DHPR (DHPR deficiency), cystathionine synthase (homocysteinemia), alpha‐<sc>l</sc>‐iduronidase (Hurler syndrome), SMPD (Niemann‐Pick disease) or abnormal propionyl CoA (propionic acidemia), cytochrome c oxidase (Leigh syndrome), and enzymatic activities can also be used as confirmatory analyses. Anemia (B12 deficiency) and neonatal diabetes (DEND), cardiac problems (Leigh syndrome, Williams‐Beuren disease), and liver dysfunction (Alpers‐Huttenlocher disease) are also some symptoms of the respective diseases (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0339">339</xref>, <xref ref-type="ref" rid="epi412102-bib-0340">340</xref>, <xref ref-type="ref" rid="epi412102-bib-0341">341</xref>
</p>
<p>MRI findings may be normal in some cases as DEND, GLUT1 deficiency, or isovaleric acidemia, or provide either nonspecific features (atrophy, delayed myelination, white matter abnormalities) or specific alterations such as in acidurias (abnormal signals from globus pallidi) or Leigh syndrome (basal ganglia and SN lesions) (Table <xref ref-type="table-wrap" rid="epi412102-tbl-0002">2</xref>).<xref ref-type="ref" rid="epi412102-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412102-bib-0339">339</xref>, <xref ref-type="ref" rid="epi412102-bib-0340">340</xref>, <xref ref-type="ref" rid="epi412102-bib-0341">341</xref> Dysgenesis of corpus callosum and gyral abnormalities may also be present in certain patients with NKH.<xref ref-type="ref" rid="epi412102-bib-0342">342</xref>
</p>
</sec>
<sec id="epi412102-sec-0034">
<title>Conclusions</title>
<p>Metabolic etiologies are one of the major contributors to the evolution of WS pathology. Because WS presents in early ages when most of the developmental changes are occurring, where both temporal and spatial coherence are critical, especially for the brain maturation, the presentation and progression of the symptoms and responses to the treatment are variable in patients having inborn errors of metabolism together with WS. The IS/WS phenotype has not been reported yet in several of the existing experimental models for metabolic diseases; nevertheless, these models provide invaluable information about putative pathogenesis and prevention as well as development and fine tuning of newer and better models. Despite the lack of knowledge in the exact pathology of many metabolic errors leading to IS/WS, diagnosis of the metabolic deficiency may decelerate the progression of WS, ameliorate patients' symptoms, and in some cases even treat WS patients. Therefore, screening for disorders of inborn metabolic pathways including physical and neurological examination, biochemical and/or genetic investigations, and MRI (where possible), are helpful in diagnosis. The development of animal models is critical not only for diagnosis but also for improving our knowledge about the pathways involved in WS generation.</p>
</sec>
<sec id="epi412102-sec-0036">
<title>Conflict of Interest</title>
<p>S.S. has no conflicts of interest. S.L.M. has no conflicts of interest with regard to this review. He is serving as Associate Editor of <italic>Neurobiology of Disease</italic> and is on the editorial boards of <italic>Brain and Development</italic>,<italic> Pediatric Neurology</italic>, and <italic>Physiological Research</italic>. He receives from Elsevier an annual compensation for his work as Associate Editor on <italic>Neurobiology of Disease</italic> and royalties from 2 books that he coedited. He received a consultant fee from UCB for participation in a Data Safety Monitoring Board. He has also received honorarium for participation in an advisory board meeting of Mallinckrodt, but there is no conflict of interest with regard to the contents of this review. A.S.G. has no conflicts of interest with regard to this article. She is co‐Editor in Chief of <italic>Epilepsia Open</italic> and has received royalties for publications from Elsevier. She has also received honorarium for participation in an advisory board meeting of Mallinckrodt, but there is no conflict of interest with regard to the contents of this review. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p>
</sec>
</body>
<back>
<ack id="epi412102-sec-0035">
<title>Acknowledgments</title>
<p>Dr Salar completed her PhD studies with Prof. Heinemann and would like to acknowledge his great support in independence in scientific thinking and work. Drs Moshé and Galanopoulou would like to acknowledge Dr Heinemann's input in setting up metabolic studies in their lab, his valuable insight in scientific discussions on epilepsy research, the freely offered mentoring of younger investigators, and his valuable contributions as a member of the working groups of the AES/ILAE Translational Research Task Force of the ILAE. Solomon L. Moshé is the Charles Frost Chair in Neurosurgery and Neurology and partially funded by grants from NIH U54 NS100064 and NS43209, US Department of Defense (W81XWH‐13‐1‐0180), CURE Infantile Spasms Initiative and the Heffer Family and the Segal Family Foundations, and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. Aristea S. Galanopoulou acknowledges grant support from NINDS RO1 NS091170, U54 NS100064, the US Department of Defense (W81XWH‐13‐1‐0180), the CURE Infantile Spasms Initiative, and research funding from the Heffer Family and the Segal Family Foundations and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families.</p>
</ack>
<bio id="epi412102-biog-0001">
<p>Dr. <bold>Seda Salar</bold> was a postdoctoral research fellow at the Albert Einstein College of Medicine.</p>
<graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="EPI4-3-134-g001.gif"></graphic>
</bio>
<ref-list content-type="cited-references" id="epi412102-bibl-0001">
<title>References</title>
<ref id="epi412102-bib-0001">
<label>1</label>
<mixed-citation id="epi412102-cit-0001" publication-type="journal">
<string-name>
<surname>Berg</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Brodie</surname>
<given-names>MJ</given-names>
</string-name>, et al. <article-title>Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009</article-title>. <source xml:lang="en"/>Epilepsia
<year>2010</year>;<volume>51</volume>:<fpage>676</fpage>–<lpage>685</lpage>.<pub-id pub-id-type="pmid">20196795</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0002">
<label>2</label>
<mixed-citation id="epi412102-cit-0002" publication-type="journal">
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Capovilla</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology</article-title>. <source xml:lang="en"/>Epilepsia
<year>2017</year>;<volume>58</volume>:<fpage>512</fpage>–<lpage>521</lpage>.<pub-id pub-id-type="pmid">28276062</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0003">
<label>3</label>
<mixed-citation id="epi412102-cit-0003" publication-type="journal">
<string-name>
<surname>Lado</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Rubboli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Capovilla</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Pathophysiology of epileptic encephalopathies</article-title>. <source xml:lang="en"/>Epilepsia
<year>2013</year>;<volume>54</volume>(<issue>Suppl. 8</issue>):<fpage>6</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">24571111</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0004">
<label>4</label>
<mixed-citation id="epi412102-cit-0004" publication-type="journal">
<string-name>
<surname>West</surname>
<given-names>WJ</given-names>
</string-name>. <article-title>On a peculiar form of infantile convulsions</article-title>. <source xml:lang="en"/>Lancet
<year>1841</year>;<volume>35</volume>:<fpage>724</fpage>–<lpage>725</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0005">
<label>5</label>
<mixed-citation id="epi412102-cit-0005" publication-type="journal">
<string-name>
<surname>Pellock</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Hrachovy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Shinnar</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Infantile spasms: a U.S. consensus report</article-title>. <source xml:lang="en"/>Epilepsia
<year>2010</year>;<volume>51</volume>:<fpage>2175</fpage>–<lpage>2189</lpage>.<pub-id pub-id-type="pmid">20608959</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0006">
<label>6</label>
<mixed-citation id="epi412102-cit-0006" publication-type="journal">
<string-name>
<surname>Hrachovy</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Frost</surname>
<given-names>JD</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Infantile spasms</article-title>. <source xml:lang="en"/>Handb Clin Neurol
<year>2013</year>;<volume>111</volume>:<fpage>611</fpage>–<lpage>618</lpage>.<pub-id pub-id-type="pmid">23622208</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0007">
<label>7</label>
<mixed-citation id="epi412102-cit-0007" publication-type="journal">
<string-name>
<surname>Frost</surname>
<given-names>JD</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Hrachovy</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Pathogenesis of infantile spasms: a model based on developmental desynchronization</article-title>. <source xml:lang="en"/>J Clin Neurophysiol
<year>2005</year>;<volume>22</volume>:<fpage>25</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">15689710</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0008">
<label>8</label>
<mixed-citation id="epi412102-cit-0008" publication-type="journal">
<string-name>
<surname>Galanopoulou</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Moshe</surname>
<given-names>SL</given-names>
</string-name>. <article-title>Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: a view from preclinical studies</article-title>. <source xml:lang="en"/>Neurobiol Dis
<year>2015</year>;<volume>79</volume>:<fpage>135</fpage>–<lpage>149</lpage>.<pub-id pub-id-type="pmid">25968935</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0009">
<label>9</label>
<mixed-citation id="epi412102-cit-0009" publication-type="journal">
<string-name>
<surname>Wirrell</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>Shellhaas</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Joshi</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>How should children with West syndrome be efficiently and accurately investigated? Results from the National Infantile Spasms Consortium</article-title>. <source xml:lang="en"/>Epilepsia
<year>2015</year>;<volume>56</volume>:<fpage>617</fpage>–<lpage>625</lpage>.<pub-id pub-id-type="pmid">25779538</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0010">
<label>10</label>
<mixed-citation id="epi412102-cit-0010" publication-type="journal">
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, <string-name>
<surname>French</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hirsch</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Classification of the epilepsies: new concepts for discussion and debate—special report of the ILAE Classification Task Force of the Commission for Classification and Terminology</article-title>. <source xml:lang="en"/>Epilepsia Open
<year>2016</year>;<volume>1</volume>:<fpage>37</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">29588927</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0011">
<label>11</label>
<mixed-citation id="epi412102-cit-0011" publication-type="journal">
<collab collab-type="authors">Euro E‐RESC, Epilepsy Phenome/Genome P</collab>
, <string-name>
<surname>Epi</surname>
<given-names>KC</given-names>
</string-name>. <article-title>De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2014</year>;<volume>95</volume>:<fpage>360</fpage>–<lpage>370</lpage>.<pub-id pub-id-type="pmid">25262651</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0012">
<label>12</label>
<mixed-citation id="epi412102-cit-0012" publication-type="journal">
<string-name>
<surname>Pardo</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Nabbout</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Galanopoulou</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection‐related epilepsy syndrome (FIRES)</article-title>. <source xml:lang="en"/>Neurotherapeutics
<year>2014</year>;<volume>11</volume>:<fpage>297</fpage>–<lpage>310</lpage>.<pub-id pub-id-type="pmid">24639375</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0013">
<label>13</label>
<mixed-citation id="epi412102-cit-0013" publication-type="journal">
<string-name>
<surname>Jellinger</surname>
<given-names>K</given-names>
</string-name>. <article-title>Neuropathological aspects of infantile spasms</article-title>. <source xml:lang="en"/>Brain Dev
<year>1987</year>;<volume>9</volume>:<fpage>349</fpage>–<lpage>357</lpage>.<pub-id pub-id-type="pmid">3324792</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0014">
<label>14</label>
<mixed-citation id="epi412102-cit-0014" publication-type="journal">
<string-name>
<surname>Wolf</surname>
<given-names>NI</given-names>
</string-name>, <string-name>
<surname>Bast</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Surtees</surname>
<given-names>R</given-names>
</string-name>. <article-title>Epilepsy in inborn errors of metabolism</article-title>. <source xml:lang="en"/>Epileptic Disord
<year>2005</year>;<volume>7</volume>:<fpage>67</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">15929908</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0015">
<label>15</label>
<mixed-citation id="epi412102-cit-0015" publication-type="journal">
<string-name>
<surname>Gkampeta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pavlou</surname>
<given-names>E</given-names>
</string-name>. <article-title>Infantile spasms (West syndrome) in children with inborn errors of metabolism: a review of the literature</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2012</year>;<volume>27</volume>:<fpage>1295</fpage>–<lpage>1301</lpage>.<pub-id pub-id-type="pmid">22832779</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0016">
<label>16</label>
<mixed-citation id="epi412102-cit-0016" publication-type="journal">
<string-name>
<surname>Yu</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Pearl</surname>
<given-names>PL</given-names>
</string-name>. <article-title>Metabolic causes of epileptic encephalopathy</article-title>. <source xml:lang="en"/>Epilepsy Res Treat
<year>2013</year>;<volume>2013</volume>:<fpage>124934</fpage>.<pub-id pub-id-type="pmid">23762547</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0017">
<label>17</label>
<mixed-citation id="epi412102-cit-0017" publication-type="journal">
<string-name>
<surname>Rahman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Footitt</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Varadkar</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Inborn errors of metabolism causing epilepsy</article-title>. <source xml:lang="en"/>Dev Med Child Neurol
<year>2013</year>;<volume>55</volume>:<fpage>23</fpage>–<lpage>36</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0018">
<label>18</label>
<mixed-citation id="epi412102-cit-0018" publication-type="journal">
<string-name>
<surname>Van Hove</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Lohr</surname>
<given-names>NJ</given-names>
</string-name>. <article-title>Metabolic and monogenic causes of seizures in neonates and young infants</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2011</year>;<volume>104</volume>:<fpage>214</fpage>–<lpage>230</lpage>.<pub-id pub-id-type="pmid">21839663</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0019">
<label>19</label>
<mixed-citation id="epi412102-cit-0019" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>XM</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>SZ</given-names>
</string-name>, et al. <article-title>Screening of inherited metabolic disorders in infants with infantile spasms</article-title>. <source xml:lang="en"/>Cell Biochem Biophys
<year>2015</year>;<volume>72</volume>:<fpage>61</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">25417060</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0020">
<label>20</label>
<mixed-citation id="epi412102-cit-0020" publication-type="journal">
<string-name>
<surname>Alrifai</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>AlShaya</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Abulaban</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Hereditary neurometabolic causes of infantile spasms in 80 children presenting to a tertiary care center</article-title>. <source xml:lang="en"/>Pediatr Neurol
<year>2014</year>;<volume>51</volume>:<fpage>390</fpage>–<lpage>397</lpage>.<pub-id pub-id-type="pmid">25160544</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0021">
<label>21</label>
<mixed-citation id="epi412102-cit-0021" publication-type="journal">
<string-name>
<surname>Osborne</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Lux</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Edwards</surname>
<given-names>SW</given-names>
</string-name>, et al. <article-title>The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification</article-title>. <source xml:lang="en"/>Epilepsia
<year>2010</year>;<volume>51</volume>:<fpage>2168</fpage>–<lpage>2174</lpage>.<pub-id pub-id-type="pmid">20726878</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0022">
<label>22</label>
<mixed-citation id="epi412102-cit-0022" publication-type="journal">
<string-name>
<surname>Zhongshu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Weiming</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yukio</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Clinical analysis of West syndrome associated with phenylketonuria</article-title>. <source xml:lang="en"/>Brain Dev
<year>2001</year>;<volume>23</volume>:<fpage>552</fpage>–<lpage>557</lpage>.<pub-id pub-id-type="pmid">11701254</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0023">
<label>23</label>
<mixed-citation id="epi412102-cit-0023" publication-type="journal">
<string-name>
<surname>Malbora</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yuksel</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Aksoy</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Two infants with infantile spasms associated with vitamin B12 deficiency</article-title>. <source xml:lang="en"/>Pediatr Neurol
<year>2014</year>;<volume>51</volume>:<fpage>144</fpage>–<lpage>146</lpage>.<pub-id pub-id-type="pmid">24810877</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0024">
<label>24</label>
<mixed-citation id="epi412102-cit-0024" publication-type="journal">
<string-name>
<surname>Mercimek‐Mahmutoglu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cordeiro</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Diagnostic yield of genetic testing in epileptic encephalopathy in childhood</article-title>. <source xml:lang="en"/>Epilepsia
<year>2015</year>;<volume>56</volume>:<fpage>707</fpage>–<lpage>716</lpage>.<pub-id pub-id-type="pmid">25818041</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0025">
<label>25</label>
<mixed-citation id="epi412102-cit-0025" publication-type="journal">
<string-name>
<surname>Shellhaas</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Wusthoff</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Tsuchida</surname>
<given-names>TN</given-names>
</string-name>, et al. <article-title>Profile of neonatal epilepsies: characteristics of a prospective US cohort</article-title>. <source xml:lang="en"/>Neurology
<year>2017</year>;<volume>89</volume>:<fpage>893</fpage>–<lpage>899</lpage>.<pub-id pub-id-type="pmid">28733343</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0026">
<label>26</label>
<mixed-citation id="epi412102-cit-0026" publication-type="journal">
<string-name>
<surname>Folling</surname>
<given-names>I</given-names>
</string-name>. <article-title>The discovery of phenylketonuria</article-title>. <source xml:lang="en"/>Acta Paediatr Suppl
<year>1994</year>;<volume>407</volume>:<fpage>4</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">7766954</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0027">
<label>27</label>
<mixed-citation id="epi412102-cit-0027" publication-type="journal">
<string-name>
<surname>Blau</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>van Spronsen</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Levy</surname>
<given-names>HL</given-names>
</string-name>. <article-title>Phenylketonuria</article-title>. <source xml:lang="en"/>Lancet
<year>2010</year>;<volume>376</volume>:<fpage>1417</fpage>–<lpage>1427</lpage>.<pub-id pub-id-type="pmid">20971365</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0028">
<label>28</label>
<mixed-citation id="epi412102-cit-0028" publication-type="journal">
<string-name>
<surname>Blau</surname>
<given-names>N</given-names>
</string-name>. <article-title>Genetics of phenylketonuria: then and now</article-title>. <source xml:lang="en"/>Hum Mutat
<year>2016</year>;<volume>37</volume>:<fpage>508</fpage>–<lpage>515</lpage>.<pub-id pub-id-type="pmid">26919687</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0029">
<label>29</label>
<mixed-citation id="epi412102-cit-0029" publication-type="journal">
<string-name>
<surname>Crome</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pare</surname>
<given-names>CMB</given-names>
</string-name>. <article-title>Phenylketonuria: a review and a report of the pathological findings in four cases</article-title>. <source xml:lang="en"/>Br J Psychiatry
<year>1960</year>;<volume>106</volume>:<fpage>862</fpage>–<lpage>883</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0030">
<label>30</label>
<mixed-citation id="epi412102-cit-0030" publication-type="journal">
<string-name>
<surname>Crome</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tymms</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Woolf</surname>
<given-names>LI</given-names>
</string-name>. <article-title>A chemical investigation of the defects of myelination in phenylketonuria</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>1962</year>;<volume>25</volume>:<fpage>143</fpage>–<lpage>148</lpage>.<pub-id pub-id-type="pmid">13882314</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0031">
<label>31</label>
<mixed-citation id="epi412102-cit-0031" publication-type="journal">
<string-name>
<surname>Guthrie</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Susi</surname>
<given-names>A</given-names>
</string-name>. <article-title>A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants</article-title>. <source xml:lang="en"/>Pediatrics
<year>1963</year>;<volume>32</volume>:<fpage>338</fpage>–<lpage>343</lpage>.<pub-id pub-id-type="pmid">14063511</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0032">
<label>32</label>
<mixed-citation id="epi412102-cit-0032" publication-type="journal">
<string-name>
<surname>Al Hafid</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</string-name>. <article-title>Phenylketonuria: a review of current and future treatments</article-title>. <source xml:lang="en"/>Transl Pediatr
<year>2015</year>;<volume>4</volume>:<fpage>304</fpage>–<lpage>317</lpage>.<pub-id pub-id-type="pmid">26835392</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0033">
<label>33</label>
<mixed-citation id="epi412102-cit-0033" publication-type="journal">
<string-name>
<surname>Bilder</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Kobori</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Cohen‐Pfeffer</surname>
<given-names>JL</given-names>
</string-name>, et al. <article-title>Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2017</year>;<volume>121</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">28285739</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0034">
<label>34</label>
<mixed-citation id="epi412102-cit-0034" publication-type="journal">
<string-name>
<surname>Fois</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gibbs</surname>
<given-names>FA</given-names>
</string-name>. <article-title>The electroencephalogram in phenylpyruvic oligophrenia</article-title>. <source xml:lang="en"/>Electroencephalogr Clin Neurophysiol
<year>1955</year>;<volume>7</volume>:<fpage>569</fpage>–<lpage>572</lpage>.<pub-id pub-id-type="pmid">13270689</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0035">
<label>35</label>
<mixed-citation id="epi412102-cit-0035" publication-type="journal">
<string-name>
<surname>Low</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Bosma</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Armstrong</surname>
<given-names>MD</given-names>
</string-name>. <article-title>Studies on phenylketonuria. VI. EEG studies in phenylketonuria</article-title>. <source xml:lang="en"/>AMA Arch Neurol Psychiatry
<year>1957</year>;<volume>77</volume>:<fpage>359</fpage>–<lpage>365</lpage>.<pub-id pub-id-type="pmid">13410192</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0036">
<label>36</label>
<mixed-citation id="epi412102-cit-0036" publication-type="journal">
<string-name>
<surname>Bower</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Jeavons</surname>
<given-names>PM</given-names>
</string-name>. <article-title>Phenylketonuria presenting as infantile spasms with sudden mental deterioration</article-title>. <source xml:lang="en"/>Dev Med Child Neurol
<year>1963</year>;<volume>5</volume>:<fpage>577</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">14090616</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0037">
<label>37</label>
<mixed-citation id="epi412102-cit-0037" publication-type="journal">
<string-name>
<surname>Medici</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Varacchi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gonzalez</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Unusual case of phenylketonuria with atypical brain magnetic resonance imaging findings</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2013</year>;<volume>28</volume>:<fpage>1496</fpage>–<lpage>1499</lpage>.<pub-id pub-id-type="pmid">22965559</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0038">
<label>38</label>
<mixed-citation id="epi412102-cit-0038" publication-type="journal">
<string-name>
<surname>Ng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Heales</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Kurian</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders</article-title>. <source xml:lang="en"/>Paediatr Drugs
<year>2014</year>;<volume>16</volume>:<fpage>275</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">25011953</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0039">
<label>39</label>
<mixed-citation id="epi412102-cit-0039" publication-type="journal">
<string-name>
<surname>Kaufman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Holtzman</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Milstien</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Phenylketonuria due to a deficiency of dihydropteridine reductase</article-title>. <source xml:lang="en"/>N Engl J Med
<year>1975</year>;<volume>293</volume>:<fpage>785</fpage>–<lpage>790</lpage>.<pub-id pub-id-type="pmid">1160969</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0040">
<label>40</label>
<mixed-citation id="epi412102-cit-0040" publication-type="journal">
<string-name>
<surname>Dianzani</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>de Sanctis</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Smooker</surname>
<given-names>PM</given-names>
</string-name>, et al. <article-title>Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype‐phenotype correlations</article-title>. <source xml:lang="en"/>Hum Mutat
<year>1998</year>;<volume>12</volume>:<fpage>267</fpage>–<lpage>273</lpage>.<pub-id pub-id-type="pmid">9744478</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0041">
<label>41</label>
<mixed-citation id="epi412102-cit-0041" publication-type="journal">
<string-name>
<surname>Mikaeloff</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Plouin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dhondt</surname>
<given-names>JL</given-names>
</string-name>, et al. <article-title>Clinical and EEG video‐polygraphic features of epileptic spasms in a child with dihydropteridine reductase deficiency. Efficiency of hydrocortisone</article-title>. <source xml:lang="en"/>Epileptic Disord
<year>2000</year>;<volume>2</volume>:<fpage>213</fpage>–<lpage>217</lpage>.<pub-id pub-id-type="pmid">11174152</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0042">
<label>42</label>
<mixed-citation id="epi412102-cit-0042" publication-type="journal">
<string-name>
<surname>Coughlin</surname>
<given-names>CR</given-names>
<suffix>II</suffix>
</string-name>, <string-name>
<surname>Hyland</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Randall</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: a case report</article-title>. <source xml:lang="en"/>JIMD Rep
<year>2013</year>;<volume>10</volume>:<fpage>53</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">23430801</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0043">
<label>43</label>
<mixed-citation id="epi412102-cit-0043" publication-type="journal">
<string-name>
<surname>Tau</surname>
<given-names>GZ</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>BS</given-names>
</string-name>. <article-title>Normal development of brain circuits</article-title>. <source xml:lang="en"/>Neuropsychopharmacology
<year>2010</year>;<volume>35</volume>:<fpage>147</fpage>–<lpage>168</lpage>.<pub-id pub-id-type="pmid">19794405</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0044">
<label>44</label>
<mixed-citation id="epi412102-cit-0044" publication-type="journal">
<string-name>
<surname>Kwon</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Farrell</surname>
<given-names>PM</given-names>
</string-name>. <article-title>The magnitude and challenge of false‐positive newborn screening test results</article-title>. <source xml:lang="en"/>Arch Pediatr Adolesc Med
<year>2000</year>;<volume>154</volume>:<fpage>714</fpage>–<lpage>718</lpage>.<pub-id pub-id-type="pmid">10891024</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0045">
<label>45</label>
<mixed-citation id="epi412102-cit-0045" publication-type="journal">
<string-name>
<surname>Cornejo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Raimann</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Cabello</surname>
<given-names>JF</given-names>
</string-name>, et al. <article-title>Past, present and future of newborn screening in Chile</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2010</year>;<volume>33</volume>(<issue>Suppl. 3</issue>):<fpage>S301</fpage>–<lpage>S306</lpage>.<pub-id pub-id-type="pmid">20683669</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0046">
<label>46</label>
<mixed-citation id="epi412102-cit-0046" publication-type="journal">
<string-name>
<surname>Shedlovsky</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Symula</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Mouse models of human phenylketonuria</article-title>. <source xml:lang="en"/>Genetics
<year>1993</year>;<volume>134</volume>:<fpage>1205</fpage>–<lpage>1210</lpage>.<pub-id pub-id-type="pmid">8375656</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0047">
<label>47</label>
<mixed-citation id="epi412102-cit-0047" publication-type="journal">
<string-name>
<surname>Glushakov</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Dennis</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Morey</surname>
<given-names>TE</given-names>
</string-name>, et al. <article-title>Specific inhibition of N‐methyl‐D‐aspartate receptor function in rat hippocampal neurons by L‐phenylalanine at concentrations observed during phenylketonuria</article-title>. <source xml:lang="en"/>Mol Psychiatry
<year>2002</year>;<volume>7</volume>:<fpage>359</fpage>–<lpage>367</lpage>.<pub-id pub-id-type="pmid">11986979</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0048">
<label>48</label>
<mixed-citation id="epi412102-cit-0048" publication-type="journal">
<string-name>
<surname>Glushakov</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Glushakova</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Varshney</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Long‐term changes in glutamatergic synaptic transmission in phenylketonuria</article-title>. <source xml:lang="en"/>Brain
<year>2005</year>;<volume>128</volume>:<fpage>300</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="pmid">15634735</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0049">
<label>49</label>
<mixed-citation id="epi412102-cit-0049" publication-type="journal">
<string-name>
<surname>Martynyuk</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Ucar</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>DD</given-names>
</string-name>, et al. <article-title>Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels</article-title>. <source xml:lang="en"/>Epilepsia
<year>2007</year>;<volume>48</volume>:<fpage>1143</fpage>–<lpage>1150</lpage>.<pub-id pub-id-type="pmid">17484755</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0050">
<label>50</label>
<mixed-citation id="epi412102-cit-0050" publication-type="journal">
<string-name>
<surname>Martynyuk</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>van Spronsen</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Van der Zee</surname>
<given-names>EA</given-names>
</string-name>. <article-title>Animal models of brain dysfunction in phenylketonuria</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2010</year>;<volume>99</volume>(<issue>Suppl. 1</issue>):<fpage>S100</fpage>–<lpage>S105</lpage>.<pub-id pub-id-type="pmid">20123463</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0051">
<label>51</label>
<mixed-citation id="epi412102-cit-0051" publication-type="journal">
<string-name>
<surname>Dienel</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Cruz</surname>
<given-names>NF</given-names>
</string-name>. <article-title>Biochemical, metabolic, and behavioral characteristics of immature chronic hyperphenylalanemic rats</article-title>. <source xml:lang="en"/>Neurochem Res
<year>2016</year>;<volume>41</volume>:<fpage>16</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">26224289</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0052">
<label>52</label>
<mixed-citation id="epi412102-cit-0052" publication-type="journal">
<string-name>
<surname>Tada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kure</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takayanagi</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Non‐ketotic hyperglycinemia: a life‐threatening disorder in the neonate</article-title>. <source xml:lang="en"/>Early Hum Dev
<year>1992</year>;<volume>29</volume>:<fpage>75</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">1396281</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0053">
<label>53</label>
<mixed-citation id="epi412102-cit-0053" publication-type="journal">
<string-name>
<surname>Tada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kure</surname>
<given-names>S</given-names>
</string-name>. <article-title>Non‐ketotic hyperglycinaemia: molecular lesion, diagnosis and pathophysiology</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>1993</year>;<volume>16</volume>:<fpage>691</fpage>–<lpage>703</lpage>.<pub-id pub-id-type="pmid">8412015</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0054">
<label>54</label>
<mixed-citation id="epi412102-cit-0054" publication-type="journal">
<string-name>
<surname>Kure</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Dinopoulos</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia</article-title>. <source xml:lang="en"/>Hum Mutat
<year>2006</year>;<volume>27</volume>:<fpage>343</fpage>–<lpage>352</lpage>.<pub-id pub-id-type="pmid">16450403</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0055">
<label>55</label>
<mixed-citation id="epi412102-cit-0055" publication-type="journal">
<string-name>
<surname>Newell</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Barth</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ricciardi</surname>
<given-names>TN</given-names>
</string-name>, et al. <article-title>Glycine causes increased excitability and neurotoxicity by activation of NMDA receptors in the hippocampus</article-title>. <source xml:lang="en"/>Exp Neurol
<year>1997</year>;<volume>145</volume>:<fpage>235</fpage>–<lpage>244</lpage>.<pub-id pub-id-type="pmid">9184125</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0056">
<label>56</label>
<mixed-citation id="epi412102-cit-0056" publication-type="journal">
<string-name>
<surname>Turecek</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Trussell</surname>
<given-names>LO</given-names>
</string-name>. <article-title>Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse</article-title>. <source xml:lang="en"/>Nature
<year>2001</year>;<volume>411</volume>:<fpage>587</fpage>–<lpage>590</lpage>.<pub-id pub-id-type="pmid">11385573</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0057">
<label>57</label>
<mixed-citation id="epi412102-cit-0057" publication-type="journal">
<string-name>
<surname>Schiffmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kaye</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Willis</surname>
<given-names>JK</given-names>
<suffix>III</suffix>
</string-name>, et al. <article-title>Transient neonatal hyperglycinemia</article-title>. <source xml:lang="en"/>Ann Neurol
<year>1989</year>;<volume>25</volume>:<fpage>201</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="pmid">2919871</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0058">
<label>58</label>
<mixed-citation id="epi412102-cit-0058" publication-type="journal">
<string-name>
<surname>Luder</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Davidson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Goodman</surname>
<given-names>SI</given-names>
</string-name>, et al. <article-title>Transient nonketotic hyperglycinemia in neonates</article-title>. <source xml:lang="en"/>J Pediatr
<year>1989</year>;<volume>114</volume>:<fpage>1013</fpage>–<lpage>1015</lpage>.<pub-id pub-id-type="pmid">2723894</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0059">
<label>59</label>
<mixed-citation id="epi412102-cit-0059" publication-type="journal">
<string-name>
<surname>Zammarchi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Donati</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Ciani</surname>
<given-names>F</given-names>
</string-name>. <article-title>Transient neonatal nonketotic hyperglycinemia: a 13‐year follow‐up</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>1995</year>;<volume>26</volume>:<fpage>328</fpage>–<lpage>330</lpage>.<pub-id pub-id-type="pmid">8719751</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0060">
<label>60</label>
<mixed-citation id="epi412102-cit-0060" publication-type="journal">
<string-name>
<surname>Gerritsen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kaveggia</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Waisman</surname>
<given-names>HA</given-names>
</string-name>. <article-title>A new type of idiopathic hyperglycinemia with hypo‐oxaluria</article-title>. <source xml:lang="en"/>Pediatrics
<year>1965</year>;<volume>36</volume>:<fpage>882</fpage>–<lpage>891</lpage>.<pub-id pub-id-type="pmid">5846830</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0061">
<label>61</label>
<mixed-citation id="epi412102-cit-0061" publication-type="journal">
<string-name>
<surname>Perry</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Urquhart</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>MacLean</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain</article-title>. <source xml:lang="en"/>N Engl J Med
<year>1975</year>;<volume>292</volume>:<fpage>1269</fpage>–<lpage>1273</lpage>.<pub-id pub-id-type="pmid">1128590</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0062">
<label>62</label>
<mixed-citation id="epi412102-cit-0062" publication-type="journal">
<string-name>
<surname>Tada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Narisawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Hyperglycinemia: a defect in glycine cleavage reaction</article-title>. <source xml:lang="en"/>Tohoku J Exp Med
<year>1969</year>;<volume>98</volume>:<fpage>289</fpage>–<lpage>296</lpage>.<pub-id pub-id-type="pmid">5307488</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0063">
<label>63</label>
<mixed-citation id="epi412102-cit-0063" publication-type="journal">
<string-name>
<surname>Hoover‐Fong</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Shah</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Van Hove</surname>
<given-names>JL</given-names>
</string-name>, et al. <article-title>Natural history of nonketotic hyperglycinemia in 65 patients</article-title>. <source xml:lang="en"/>Neurology
<year>2004</year>;<volume>63</volume>:<fpage>1847</fpage>–<lpage>1853</lpage>.<pub-id pub-id-type="pmid">15557500</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0064">
<label>64</label>
<mixed-citation id="epi412102-cit-0064" publication-type="journal">
<string-name>
<surname>Campistol</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Plecko</surname>
<given-names>B</given-names>
</string-name>. <article-title>Treatable newborn and infant seizures due to inborn errors of metabolism</article-title>. <source xml:lang="en"/>Epileptic Disord
<year>2015</year>;<volume>17</volume>:<fpage>229</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">26234933</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0065">
<label>65</label>
<mixed-citation id="epi412102-cit-0065" publication-type="journal">
<string-name>
<surname>Seppalainen</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Simila</surname>
<given-names>S</given-names>
</string-name>. <article-title>Electroencephalographic findings in three patients with nonketotic hyperglycinemia</article-title>. <source xml:lang="en"/>Epilepsia
<year>1971</year>;<volume>12</volume>:<fpage>101</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">5282878</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0066">
<label>66</label>
<mixed-citation id="epi412102-cit-0066" publication-type="journal">
<string-name>
<surname>Markand</surname>
<given-names>ON</given-names>
</string-name>, <string-name>
<surname>Garg</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Brandt</surname>
<given-names>IK</given-names>
</string-name>. <article-title>Nonketotic hyperglycinemia: electroencephalographic and evoked potential abnormalities</article-title>. <source xml:lang="en"/>Neurology
<year>1982</year>;<volume>32</volume>:<fpage>151</fpage>–<lpage>156</lpage>.<pub-id pub-id-type="pmid">6798489</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0067">
<label>67</label>
<mixed-citation id="epi412102-cit-0067" publication-type="journal">
<string-name>
<surname>Mohamed</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>El Melegy</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Talaat</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Neurometabolic disorders‐related early childhood epilepsy: a single‐center experience in Saudi Arabia</article-title>. <source xml:lang="en"/>Pediatr Neonatol
<year>2015</year>;<volume>56</volume>:<fpage>393</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="pmid">26117549</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0068">
<label>68</label>
<mixed-citation id="epi412102-cit-0068" publication-type="journal">
<string-name>
<surname>Korman</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Wexler</surname>
<given-names>ID</given-names>
</string-name>, <string-name>
<surname>Gutman</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2006</year>;<volume>59</volume>:<fpage>411</fpage>–<lpage>415</lpage>.<pub-id pub-id-type="pmid">16404748</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0069">
<label>69</label>
<mixed-citation id="epi412102-cit-0069" publication-type="journal">
<string-name>
<surname>Pai</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>KY</given-names>
</string-name>, <string-name>
<surname>Savery</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Glycine decarboxylase deficiency causes neural tube defects and features of non‐ketotic hyperglycinemia in mice</article-title>. <source xml:lang="en"/>Nat Commun
<year>2015</year>;<volume>6</volume>:<fpage>6388</fpage>.<pub-id pub-id-type="pmid">25736695</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0070">
<label>70</label>
<mixed-citation id="epi412102-cit-0070" publication-type="journal">
<string-name>
<surname>Narisawa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Komatsuzaki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kikuchi</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2012</year>;<volume>21</volume>:<fpage>1496</fpage>–<lpage>1503</lpage>.<pub-id pub-id-type="pmid">22171071</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0071">
<label>71</label>
<mixed-citation id="epi412102-cit-0071" publication-type="journal">
<string-name>
<surname>Kojima‐ishii</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kure</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ichinohe</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Model mice for mild‐form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N‐methyl D‐aspartate receptor</article-title>. <source xml:lang="en"/>Pediatr Res
<year>2008</year>;<volume>64</volume>:<fpage>228</fpage>–<lpage>233</lpage>.<pub-id pub-id-type="pmid">18414141</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0072">
<label>72</label>
<mixed-citation id="epi412102-cit-0072" publication-type="journal">
<string-name>
<surname>Oda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kure</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sugawara</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system</article-title>. <source xml:lang="en"/>Stroke
<year>2007</year>;<volume>38</volume>:<fpage>2157</fpage>–<lpage>2164</lpage>.<pub-id pub-id-type="pmid">17510459</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0073">
<label>73</label>
<mixed-citation id="epi412102-cit-0073" publication-type="journal">
<string-name>
<surname>Gomeza</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hülsmann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ohno</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition</article-title>. <source xml:lang="en"/>Neuron
<year>2003</year>;<volume>40</volume>:<fpage>785</fpage>–<lpage>796</lpage>.<pub-id pub-id-type="pmid">14622582</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0074">
<label>74</label>
<mixed-citation id="epi412102-cit-0074" publication-type="journal">
<string-name>
<surname>Cubelos</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gimenez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zafra</surname>
<given-names>F</given-names>
</string-name>. <article-title>Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain</article-title>. <source xml:lang="en"/>Cereb Cortex
<year>2005</year>;<volume>15</volume>:<fpage>448</fpage>–<lpage>459</lpage>.<pub-id pub-id-type="pmid">15749988</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0075">
<label>75</label>
<mixed-citation id="epi412102-cit-0075" publication-type="journal">
<string-name>
<surname>Mayor</surname>
<given-names>F</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rodriguez‐Pombo</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Atypical nonketotic hyperglycinemia with a defective glycine transport system in nervous tissue</article-title>. <source xml:lang="en"/>Neurochem Pathol
<year>1984</year>;<volume>2</volume>:<fpage>233</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">6537469</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0076">
<label>76</label>
<mixed-citation id="epi412102-cit-0076" publication-type="journal">
<string-name>
<surname>Alfadhel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nashabat</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qahtani</surname>
<given-names>HA</given-names>
</string-name>, et al. <article-title>Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non‐ketotic hyperglycinemia in humans</article-title>. <source xml:lang="en"/>Hum Genet
<year>2016</year>;<volume>135</volume>:<fpage>1263</fpage>–<lpage>1268</lpage>.<pub-id pub-id-type="pmid">27481395</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0077">
<label>77</label>
<mixed-citation id="epi412102-cit-0077" publication-type="journal">
<string-name>
<surname>Gloyn</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Pearson</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Antcliff</surname>
<given-names>JF</given-names>
</string-name>, et al. <article-title>Activating mutations in the gene encoding the ATP‐sensitive potassium‐channel subunit Kir6.2 and permanent neonatal diabetes</article-title>. <source xml:lang="en"/>N Engl J Med
<year>2004</year>;<volume>350</volume>:<fpage>1838</fpage>–<lpage>1849</lpage>.<pub-id pub-id-type="pmid">15115830</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0078">
<label>78</label>
<mixed-citation id="epi412102-cit-0078" publication-type="journal">
<string-name>
<surname>Proks</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Antcliff</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Lippiat</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2004</year>;<volume>101</volume>:<fpage>17539</fpage>–<lpage>17544</lpage>.<pub-id pub-id-type="pmid">15583126</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0079">
<label>79</label>
<mixed-citation id="epi412102-cit-0079" publication-type="journal">
<string-name>
<surname>Gloyn</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Diatloff‐Zito</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Edghill</surname>
<given-names>EL</given-names>
</string-name>, et al. <article-title>KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features</article-title>. <source xml:lang="en"/>Eur J Hum Genet
<year>2006</year>;<volume>14</volume>:<fpage>824</fpage>–<lpage>830</lpage>.<pub-id pub-id-type="pmid">16670688</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0080">
<label>80</label>
<mixed-citation id="epi412102-cit-0080" publication-type="journal">
<string-name>
<surname>Bahi‐Buisson</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Eisermann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nivot</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2007</year>;<volume>22</volume>:<fpage>1147</fpage>–<lpage>1150</lpage>.<pub-id pub-id-type="pmid">17890419</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0081">
<label>81</label>
<mixed-citation id="epi412102-cit-0081" publication-type="journal">
<string-name>
<surname>Shimomura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Horster</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>de Wet</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain</article-title>. <source xml:lang="en"/>Neurology
<year>2007</year>;<volume>69</volume>:<fpage>1342</fpage>–<lpage>1349</lpage>.<pub-id pub-id-type="pmid">17652641</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0082">
<label>82</label>
<mixed-citation id="epi412102-cit-0082" publication-type="journal">
<string-name>
<surname>Singh</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Parikh</surname>
<given-names>R</given-names>
</string-name>. <article-title>Neonatal diabetes with intractable epilepsy: DEND syndrome</article-title>. <source xml:lang="en"/>Indian J Pediatr
<year>2014</year>;<volume>81</volume>:<fpage>1387</fpage>–<lpage>1388</lpage>.<pub-id pub-id-type="pmid">24912436</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0083">
<label>83</label>
<mixed-citation id="epi412102-cit-0083" publication-type="journal">
<string-name>
<surname>Ashcroft</surname>
<given-names>FM</given-names>
</string-name>. <article-title>Adenosine 5′‐triphosphate‐sensitive potassium channels</article-title>. <source xml:lang="en"/>Annu Rev Neurosci
<year>1988</year>;<volume>11</volume>:<fpage>97</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="pmid">2452599</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0084">
<label>84</label>
<mixed-citation id="epi412102-cit-0084" publication-type="journal">
<string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ji</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Protective role of ATP‐sensitive potassium channels in hypoxia‐induced generalized seizure</article-title>. <source xml:lang="en"/>Science
<year>2001</year>;<volume>292</volume>:<fpage>1543</fpage>–<lpage>1546</lpage>.<pub-id pub-id-type="pmid">11375491</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0085">
<label>85</label>
<mixed-citation id="epi412102-cit-0085" publication-type="journal">
<string-name>
<surname>Hernandez‐Sanchez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Basile</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Fedorova</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2001</year>;<volume>98</volume>:<fpage>3549</fpage>–<lpage>3554</lpage>.<pub-id pub-id-type="pmid">11248115</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0086">
<label>86</label>
<mixed-citation id="epi412102-cit-0086" publication-type="journal">
<string-name>
<surname>Ballanyi</surname>
<given-names>K</given-names>
</string-name>. <article-title>Protective role of neuronal KATP channels in brain hypoxia</article-title>. <source xml:lang="en"/>J Exp Biol
<year>2004</year>;<volume>207</volume>:<fpage>3201</fpage>–<lpage>3212</lpage>.<pub-id pub-id-type="pmid">15299041</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0087">
<label>87</label>
<mixed-citation id="epi412102-cit-0087" publication-type="journal">
<string-name>
<surname>Kumaran</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kapoor</surname>
<given-names>RR</given-names>
</string-name>, et al. <article-title>The clinical problem of hyperinsulinemic hypoglycemia and resultant infantile spasms</article-title>. <source xml:lang="en"/>Pediatrics
<year>2010</year>;<volume>126</volume>:<fpage>e1231</fpage>–<lpage>e1236</lpage>.<pub-id pub-id-type="pmid">20956428</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0088">
<label>88</label>
<mixed-citation id="epi412102-cit-0088" publication-type="journal">
<string-name>
<surname>Yang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Neonatal hypoglycemic brain injury is a cause of infantile spasms</article-title>. <source xml:lang="en"/>Exp Ther Med
<year>2016</year>;<volume>11</volume>:<fpage>2066</fpage>–<lpage>2070</lpage>.<pub-id pub-id-type="pmid">27168852</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0089">
<label>89</label>
<mixed-citation id="epi412102-cit-0089" publication-type="journal">
<string-name>
<surname>Riikonen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Donner</surname>
<given-names>M</given-names>
</string-name>. <article-title>Incidence and aetiology of infantile spasms from 1960 to 1976: a population study in Finland</article-title>. <source xml:lang="en"/>Dev Med Child Neurol
<year>1979</year>;<volume>21</volume>:<fpage>333</fpage>–<lpage>343</lpage>.<pub-id pub-id-type="pmid">467816</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0090">
<label>90</label>
<mixed-citation id="epi412102-cit-0090" publication-type="journal">
<string-name>
<surname>Riikonen</surname>
<given-names>R</given-names>
</string-name>. <article-title>A long‐term follow‐up study of 214 children with the syndrome of infantile spasms</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>1982</year>;<volume>13</volume>:<fpage>14</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">6281679</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0091">
<label>91</label>
<mixed-citation id="epi412102-cit-0091" publication-type="journal">
<string-name>
<surname>Udani</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Barrett</surname>
<given-names>ML</given-names>
</string-name>, et al. <article-title>Lowering the glycemic index of white bread using a white bean extract</article-title>. <source xml:lang="en"/>Nutr J
<year>2009</year>;<volume>8</volume>:<fpage>52</fpage>.<pub-id pub-id-type="pmid">19860922</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0092">
<label>92</label>
<mixed-citation id="epi412102-cit-0092" publication-type="journal">
<string-name>
<surname>Udani</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Munot</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ursekar</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Neonatal hypoglycemic brain ‐ injury a common cause of infantile onset remote symptomatic epilepsy</article-title>. <source xml:lang="en"/>Indian Pediatr
<year>2009</year>;<volume>46</volume>:<fpage>127</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">19242029</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0093">
<label>93</label>
<mixed-citation id="epi412102-cit-0093" publication-type="journal">
<string-name>
<surname>Wong</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Poskitt</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Chau</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Brain injury patterns in hypoglycemia in neonatal encephalopathy</article-title>. <source xml:lang="en"/>AJNR Am J Neuroradiol
<year>2013</year>;<volume>34</volume>:<fpage>1456</fpage>–<lpage>1461</lpage>.<pub-id pub-id-type="pmid">23436054</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0094">
<label>94</label>
<mixed-citation id="epi412102-cit-0094" publication-type="journal">
<string-name>
<surname>Vannucci</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Vannucci</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Hypoglycemic brain injury</article-title>. <source xml:lang="en"/>Semin Neonatol
<year>2001</year>;<volume>6</volume>:<fpage>147</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">11483020</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0095">
<label>95</label>
<mixed-citation id="epi412102-cit-0095" publication-type="book">
<string-name>
<surname>Carlen</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>. <chapter-title>Metabolic disturbances: hypo‐ and hyperglycemic seizures in vivo and in vitro</chapter-title> In <person-group person-group-type="editor"><name><surname>Pitkänen</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Buckmaster</surname><given-names>PS</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Galanopoulou</surname><given-names>AS</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Moshé</surname><given-names>SL</given-names></name></person-group> (Eds) <source xml:lang="en"/>Models of seizures and epilepsy. <edition>2</edition>nd Ed. <publisher-loc>London, UK</publisher-loc>: <publisher-name>Elsevier Inc.</publisher-name>; <year>2017</year>:<fpage>941</fpage>–<lpage>949</lpage>; ISBN: 78‐0‐12‐804066‐9.</mixed-citation>
</ref>
<ref id="epi412102-bib-0096">
<label>96</label>
<mixed-citation id="epi412102-cit-0096" publication-type="journal">
<string-name>
<surname>Auer</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Olsson</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Siesjo</surname>
<given-names>BK</given-names>
</string-name>. <article-title>Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study</article-title>. <source xml:lang="en"/>Diabetes
<year>1984</year>;<volume>33</volume>:<fpage>1090</fpage>–<lpage>1098</lpage>.<pub-id pub-id-type="pmid">6500189</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0097">
<label>97</label>
<mixed-citation id="epi412102-cit-0097" publication-type="journal">
<string-name>
<surname>Zhou</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>CX</given-names>
</string-name>, et al. <article-title>Repetitive and profound insulin‐induced hypoglycemia results in brain damage in newborn rats: an approach to establish an animal model of brain injury induced by neonatal hypoglycemia</article-title>. <source xml:lang="en"/>Eur J Pediatr
<year>2008</year>;<volume>167</volume>:<fpage>1169</fpage>–<lpage>1174</lpage>.<pub-id pub-id-type="pmid">18205012</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0098">
<label>98</label>
<mixed-citation id="epi412102-cit-0098" publication-type="journal">
<string-name>
<surname>Ennis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tran</surname>
<given-names>PV</given-names>
</string-name>, <string-name>
<surname>Seaquist</surname>
<given-names>ER</given-names>
</string-name>, et al. <article-title>Postnatal age influences hypoglycemia‐induced neuronal injury in the rat brain</article-title>. <source xml:lang="en"/>Brain Res
<year>2008</year>;<volume>1224</volume>:<fpage>119</fpage>–<lpage>126</lpage>.<pub-id pub-id-type="pmid">18582442</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0099">
<label>99</label>
<mixed-citation id="epi412102-cit-0099" publication-type="journal">
<string-name>
<surname>Yamada</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Rensing</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Thio</surname>
<given-names>LL</given-names>
</string-name>. <article-title>Ketogenic diet reduces hypoglycemia‐induced neuronal death in young rats</article-title>. <source xml:lang="en"/>Neurosci Lett
<year>2005</year>;<volume>385</volume>:<fpage>210</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">15975714</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0100">
<label>100</label>
<mixed-citation id="epi412102-cit-0100" publication-type="journal">
<string-name>
<surname>Maheandiran</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mylvaganam</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality</article-title>. <source xml:lang="en"/>PLoS ONE
<year>2013</year>;<volume>8</volume>:<fpage>e83168</fpage>.<pub-id pub-id-type="pmid">24386156</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0101">
<label>101</label>
<mixed-citation id="epi412102-cit-0101" publication-type="journal">
<string-name>
<surname>Abdelmalik</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Shannon</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Yiu</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Hypoglycemic seizures during transient hypoglycemia exacerbate hippocampal dysfunction</article-title>. <source xml:lang="en"/>Neurobiol Dis
<year>2007</year>;<volume>26</volume>:<fpage>646</fpage>–<lpage>660</lpage>.<pub-id pub-id-type="pmid">17459717</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0102">
<label>102</label>
<mixed-citation id="epi412102-cit-0102" publication-type="journal">
<string-name>
<surname>Yamada</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Rensing</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Izumi</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Repetitive hypoglycemia in young rats impairs hippocampal long‐term potentiation</article-title>. <source xml:lang="en"/>Pediatr Res
<year>2004</year>;<volume>55</volume>:<fpage>372</fpage>–<lpage>379</lpage>.<pub-id pub-id-type="pmid">14681492</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0103">
<label>103</label>
<mixed-citation id="epi412102-cit-0103" publication-type="journal">
<string-name>
<surname>Velisek</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Veliskova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chudomel</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Metabolic environment in substantia nigra reticulata is critical for the expression and control of hypoglycemia‐induced seizures</article-title>. <source xml:lang="en"/>J Neurosci
<year>2008</year>;<volume>28</volume>:<fpage>9349</fpage>–<lpage>9362</lpage>.<pub-id pub-id-type="pmid">18799669</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0104">
<label>104</label>
<mixed-citation id="epi412102-cit-0104" publication-type="journal">
<string-name>
<surname>De Vivo</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Trifiletti</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Jacobson</surname>
<given-names>RI</given-names>
</string-name>, et al. <article-title>Defective glucose transport across the blood‐brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay</article-title>. <source xml:lang="en"/>N Engl J Med
<year>1991</year>;<volume>325</volume>:<fpage>703</fpage>–<lpage>709</lpage>.<pub-id pub-id-type="pmid">1714544</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0105">
<label>105</label>
<mixed-citation id="epi412102-cit-0105" publication-type="journal">
<string-name>
<surname>Dick</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Harik</surname>
<given-names>SI</given-names>
</string-name>, <string-name>
<surname>Klip</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Identification and characterization of the glucose transporter of the blood‐brain barrier by cytochalasin B binding and immunological reactivity</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>1984</year>;<volume>81</volume>:<fpage>7233</fpage>–<lpage>7237</lpage>.<pub-id pub-id-type="pmid">6150484</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0106">
<label>106</label>
<mixed-citation id="epi412102-cit-0106" publication-type="journal">
<string-name>
<surname>Seidner</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Alvarez</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Yeh</surname>
<given-names>JI</given-names>
</string-name>, et al. <article-title>GLUT‐1 deficiency syndrome caused by haploinsufficiency of the blood‐brain barrier hexose carrier</article-title>. <source xml:lang="en"/>Nat Genet
<year>1998</year>;<volume>18</volume>:<fpage>188</fpage>–<lpage>191</lpage>.<pub-id pub-id-type="pmid">9462754</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0107">
<label>107</label>
<mixed-citation id="epi412102-cit-0107" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kranz‐Eble</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>De Vivo</surname>
<given-names>DC</given-names>
</string-name>. <article-title>Mutational analysis of GLUT1 (SLC2A1) in Glut‐1 deficiency syndrome</article-title>. <source xml:lang="en"/>Hum Mutat
<year>2000</year>;<volume>16</volume>:<fpage>224</fpage>–<lpage>231</lpage>.<pub-id pub-id-type="pmid">10980529</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0108">
<label>108</label>
<mixed-citation id="epi412102-cit-0108" publication-type="book">
<string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pascual</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>De Vivo</surname>
<given-names>D</given-names>
</string-name>. <chapter-title>Glucose transporter type 1 deficiency syndrome</chapter-title> In <person-group person-group-type="editor"><name><surname>Adam</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ardinger</surname><given-names>HH</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>RA</given-names></name></person-group>, et al. (Eds) <source xml:lang="en"/>GeneReviews®. <publisher-loc>[Internet]. Seattle, WA</publisher-loc>: <publisher-name>University of Washington</publisher-name>; <year>1993</year>‐2018. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK1430/">https://www.ncbi.nlm.nih.gov/books/NBK1430/</ext-link>
</mixed-citation>
</ref>
<ref id="epi412102-bib-0109">
<label>109</label>
<mixed-citation id="epi412102-cit-0109" publication-type="journal">
<string-name>
<surname>Leary</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nordli</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Seizure characterization and electroencephalographic features in glut‐1 deficiencysyndrome</article-title>. <source xml:lang="en"/>Epilepsia
<year>2003</year>;<volume>44</volume>:<fpage>701</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">12752470</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0110">
<label>110</label>
<mixed-citation id="epi412102-cit-0110" publication-type="journal">
<string-name>
<surname>Pong</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Geary</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Engelstad</surname>
<given-names>KM</given-names>
</string-name>, et al. <article-title>Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes</article-title>. <source xml:lang="en"/>Epilepsia
<year>2012</year>;<volume>53</volume>:<fpage>1503</fpage>–<lpage>1510</lpage>.<pub-id pub-id-type="pmid">22812641</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0111">
<label>111</label>
<mixed-citation id="epi412102-cit-0111" publication-type="journal">
<string-name>
<surname>Vykuntaraju</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Bhat</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sanjay</surname>
<given-names>KS</given-names>
</string-name>, et al. <article-title>Symptomatic west syndrome secondary to glucose transporter‐1(GLUT1) deficiency with complete response to 4:1 ketogenic diet</article-title>. <source xml:lang="en"/>Indian J Pediatr
<year>2014</year>;<volume>81</volume>:<fpage>934</fpage>–<lpage>936</lpage>.<pub-id pub-id-type="pmid">23604616</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0112">
<label>112</label>
<mixed-citation id="epi412102-cit-0112" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Hur</surname>
<given-names>YJ</given-names>
</string-name>. <article-title>Glucose transport 1 deficiency presenting as infantile spasms with a mutation identified in exon 9 of SLC2A1</article-title>. <source xml:lang="en"/>Korean J Pediatr
<year>2016</year>;<volume>59</volume>:<fpage>S29</fpage>–<lpage>S31</lpage>.<pub-id pub-id-type="pmid">28018440</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0113">
<label>113</label>
<mixed-citation id="epi412102-cit-0113" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pascual</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>A mouse model for Glut‐1 haploinsufficiency</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2006</year>;<volume>15</volume>:<fpage>1169</fpage>–<lpage>1179</lpage>.<pub-id pub-id-type="pmid">16497725</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0114">
<label>114</label>
<mixed-citation id="epi412102-cit-0114" publication-type="journal">
<string-name>
<surname>Magistretti</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Pellerin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Rothman</surname>
<given-names>DL</given-names>
</string-name>, et al. <article-title>Energy on demand</article-title>. <source xml:lang="en"/>Science
<year>1999</year>;<volume>283</volume>:<fpage>496</fpage>–<lpage>497</lpage>.<pub-id pub-id-type="pmid">9988650</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0115">
<label>115</label>
<mixed-citation id="epi412102-cit-0115" publication-type="journal">
<string-name>
<surname>Arsov</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mullen</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Rogers</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Glucose transporter 1 deficiency in the idiopathic generalized epilepsies</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2012</year>;<volume>72</volume>:<fpage>807</fpage>–<lpage>815</lpage>.<pub-id pub-id-type="pmid">23280796</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0116">
<label>116</label>
<mixed-citation id="epi412102-cit-0116" publication-type="journal">
<string-name>
<surname>van Maldegem</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Wanders</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Wijburg</surname>
<given-names>FA</given-names>
</string-name>. <article-title>Clinical aspects of short‐chain acyl‐CoA dehydrogenase deficiency</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2010</year>;<volume>33</volume>:<fpage>507</fpage>–<lpage>511</lpage>.<pub-id pub-id-type="pmid">20429031</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0117">
<label>117</label>
<mixed-citation id="epi412102-cit-0117" publication-type="journal">
<string-name>
<surname>Mikati</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Chaaban</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Karam</surname>
<given-names>PE</given-names>
</string-name>, et al. <article-title>Brain malformation and infantile spasms in a SCAD deficiency patient</article-title>. <source xml:lang="en"/>Pediatr Neurol
<year>2007</year>;<volume>36</volume>:<fpage>48</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">17162197</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0118">
<label>118</label>
<mixed-citation id="epi412102-cit-0118" publication-type="journal">
<string-name>
<surname>Wood</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Amendt</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Rhead</surname>
<given-names>WJ</given-names>
</string-name>, et al. <article-title>Short‐chain acyl‐coenzyme A dehydrogenase deficiency in mice</article-title>. <source xml:lang="en"/>Pediatr Res
<year>1989</year>;<volume>25</volume>:<fpage>38</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">2919115</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0119">
<label>119</label>
<mixed-citation id="epi412102-cit-0119" publication-type="journal">
<string-name>
<surname>Amendt</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Freneaux</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Reece</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Short‐chain acyl‐coenzyme A dehydrogenase activity, antigen, and biosynthesis are absent in the BALB/cByJ mouse</article-title>. <source xml:lang="en"/>Pediatr Res
<year>1992</year>;<volume>31</volume>:<fpage>552</fpage>–<lpage>556</lpage>.<pub-id pub-id-type="pmid">1635815</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0120">
<label>120</label>
<mixed-citation id="epi412102-cit-0120" publication-type="journal">
<string-name>
<surname>Armstrong</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Masiowski</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>PA</given-names>
</string-name>. <article-title>Pathologic characterization of short‐chain acyl‐CoA dehydrogenase deficiency in BALB/cByJ mice</article-title>. <source xml:lang="en"/>Am J Med Genet
<year>1993</year>;<volume>47</volume>:<fpage>884</fpage>–<lpage>892</lpage>.<pub-id pub-id-type="pmid">8279487</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0121">
<label>121</label>
<mixed-citation id="epi412102-cit-0121" publication-type="journal">
<string-name>
<surname>Guerra</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Koza</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation</article-title>. <source xml:lang="en"/>J Clin Invest
<year>1998</year>;<volume>102</volume>:<fpage>1724</fpage>–<lpage>1731</lpage>.<pub-id pub-id-type="pmid">9802886</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0122">
<label>122</label>
<mixed-citation id="epi412102-cit-0122" publication-type="journal">
<string-name>
<surname>Ritter</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kleemann</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hickmann</surname>
<given-names>FH</given-names>
</string-name>, et al. <article-title>Disturbance of energy and redox homeostasis and reduction of Na+, K + ‐ATPase activity provoked by in vivo intracerebral administration of ethylmalonic acid to young rats</article-title>. <source xml:lang="en"/>Biochim Biophys Acta
<year>2015</year>;<volume>1852</volume>:<fpage>759</fpage>–<lpage>767</lpage>.<pub-id pub-id-type="pmid">25583115</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0123">
<label>123</label>
<mixed-citation id="epi412102-cit-0123" publication-type="journal">
<string-name>
<surname>Kreuder</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Otten</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fuder</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Clinical and biochemical consequences of copper‐histidine therapy in Menkes disease</article-title>. <source xml:lang="en"/>Eur J Pediatr
<year>1993</year>;<volume>152</volume>:<fpage>828</fpage>–<lpage>832</lpage>.<pub-id pub-id-type="pmid">8223785</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0124">
<label>124</label>
<mixed-citation id="epi412102-cit-0124" publication-type="journal">
<string-name>
<surname>Chugani</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Conti</surname>
<given-names>JR</given-names>
</string-name>. <article-title>Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography</article-title>. <source xml:lang="en"/>J Child Neurol
<year>1996</year>;<volume>11</volume>:<fpage>44</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">8745385</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0125">
<label>125</label>
<mixed-citation id="epi412102-cit-0125" publication-type="journal">
<string-name>
<surname>Sfaello</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Castelnau</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Blanc</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Infantile spasms and Menkes disease</article-title>. <source xml:lang="en"/>Epileptic Disord
<year>2000</year>;<volume>2</volume>:<fpage>227</fpage>–<lpage>230</lpage>.<pub-id pub-id-type="pmid">11174154</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0126">
<label>126</label>
<mixed-citation id="epi412102-cit-0126" publication-type="journal">
<string-name>
<surname>Bahi‐Buisson</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kaminska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nabbout</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Epilepsy in Menkes disease: analysis of clinical stages</article-title>. <source xml:lang="en"/>Epilepsia
<year>2006</year>;<volume>47</volume>:<fpage>380</fpage>–<lpage>386</lpage>.<pub-id pub-id-type="pmid">16499764</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0127">
<label>127</label>
<mixed-citation id="epi412102-cit-0127" publication-type="journal">
<string-name>
<surname>Prasad</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Levin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rupar</surname>
<given-names>CA</given-names>
</string-name>, et al. <article-title>Menkes disease and infantile epilepsy</article-title>. <source xml:lang="en"/>Brain Dev
<year>2011</year>;<volume>33</volume>:<fpage>866</fpage>–<lpage>876</lpage>.<pub-id pub-id-type="pmid">21924848</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0128">
<label>128</label>
<mixed-citation id="epi412102-cit-0128" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>
<given-names>HW</given-names>
</string-name>, et al. <article-title>Identification of a novel mutation in the ATP7A gene in a Korean patient with Menkes disease</article-title>. <source xml:lang="en"/>J Korean Med Sci
<year>2011</year>;<volume>26</volume>:<fpage>951</fpage>–<lpage>953</lpage>.<pub-id pub-id-type="pmid">21738351</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0129">
<label>129</label>
<mixed-citation id="epi412102-cit-0129" publication-type="journal">
<string-name>
<surname>Verrotti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cusmai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Darra</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Epilepsy in Menkes disease: an electroclinical long‐term study of 28 patients</article-title>. <source xml:lang="en"/>Epilepsy Res
<year>2014</year>;<volume>108</volume>:<fpage>1597</fpage>–<lpage>1603</lpage>.<pub-id pub-id-type="pmid">25218893</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0130">
<label>130</label>
<mixed-citation id="epi412102-cit-0130" publication-type="journal">
<string-name>
<surname>Jain</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kannan</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chakrabarty</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Menkes disease ‐ an important cause of early onset refractory seizures</article-title>. <source xml:lang="en"/>J Pediatr Neurosci
<year>2014</year>;<volume>9</volume>:<fpage>11</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">24891895</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0131">
<label>131</label>
<mixed-citation id="epi412102-cit-0131" publication-type="journal">
<string-name>
<surname>Menkes</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Alter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Steigleder</surname>
<given-names>GK</given-names>
</string-name>, et al. <article-title>A sex‐linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration</article-title>. <source xml:lang="en"/>Pediatrics
<year>1962</year>;<volume>29</volume>:<fpage>764</fpage>–<lpage>779</lpage>.<pub-id pub-id-type="pmid">14472668</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0132">
<label>132</label>
<mixed-citation id="epi412102-cit-0132" publication-type="journal">
<string-name>
<surname>Danks</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>BJ</given-names>
</string-name>, et al. <article-title>Menkes's kinky hair syndrome. An inherited defect in copper absorption with widespread effects</article-title>. <source xml:lang="en"/>Pediatrics
<year>1972</year>;<volume>50</volume>:<fpage>188</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">5045349</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0133">
<label>133</label>
<mixed-citation id="epi412102-cit-0133" publication-type="journal">
<string-name>
<surname>Vulpe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Levinson</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Whitney</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper‐transporting ATPase</article-title>. <source xml:lang="en"/>Nat Genet
<year>1993</year>;<volume>3</volume>:<fpage>7</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">8490659</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0134">
<label>134</label>
<mixed-citation id="epi412102-cit-0134" publication-type="journal">
<string-name>
<surname>Harrison</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Dameron</surname>
<given-names>CT</given-names>
</string-name>. <article-title>Molecular mechanisms of copper metabolism and the role of the Menkes disease protein</article-title>. <source xml:lang="en"/>J Biochem Mol Toxicol
<year>1999</year>;<volume>13</volume>:<fpage>93</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="pmid">9890194</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0135">
<label>135</label>
<mixed-citation id="epi412102-cit-0135" publication-type="journal">
<string-name>
<surname>Verrotti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Carelli</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Coppola</surname>
<given-names>G</given-names>
</string-name>. <article-title>Epilepsy in children with Menkes disease: a systematic review of literature</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2014</year>;<volume>29</volume>:<fpage>1757</fpage>–<lpage>1764</lpage>.<pub-id pub-id-type="pmid">25038123</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0136">
<label>136</label>
<mixed-citation id="epi412102-cit-0136" publication-type="journal">
<string-name>
<surname>Levinson</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Vulpe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Elder</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>The mottled gene is the mouse homolog of the menkes disease gene</article-title>. <source xml:lang="en"/>Nat Genet
<year>1994</year>;<volume>6</volume>:<fpage>369</fpage>–<lpage>373</lpage>.<pub-id pub-id-type="pmid">8054976</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0137">
<label>137</label>
<mixed-citation id="epi412102-cit-0137" publication-type="journal">
<string-name>
<surname>Lenartowicz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Krzeptowski</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lipinski</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Mottled mice and non‐mammalian models of menkes disease</article-title>. <source xml:lang="en"/>Front Mol Neurosci
<year>2015</year>;<volume>8</volume>:<fpage>72</fpage>.<pub-id pub-id-type="pmid">26732058</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0138">
<label>138</label>
<mixed-citation id="epi412102-cit-0138" publication-type="journal">
<string-name>
<surname>Niciu</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>XM</given-names>
</string-name>, <string-name>
<surname>El Meskini</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease</article-title>. <source xml:lang="en"/>Neurobiol Dis
<year>2007</year>;<volume>27</volume>:<fpage>278</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">17588765</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0139">
<label>139</label>
<mixed-citation id="epi412102-cit-0139" publication-type="journal">
<string-name>
<surname>Llanos</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Ke</surname>
<given-names>BX</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Correction of a mouse model of Menkes disease by the human Menkes gene</article-title>. <source xml:lang="en"/>Biochim Biophys Acta
<year>2006</year>;<volume>1762</volume>:<fpage>485</fpage>–<lpage>493</lpage>.<pub-id pub-id-type="pmid">16488577</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0140">
<label>140</label>
<mixed-citation id="epi412102-cit-0140" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>KM</given-names>
</string-name>. <article-title>PCR‐cloning of tilapia ATP7A cDNA and its mRNA levels in tissues of tilapia following copper administrations</article-title>. <source xml:lang="en"/>Aquat Toxicol
<year>2011</year>;<volume>105</volume>:<fpage>717</fpage>–<lpage>727</lpage>.<pub-id pub-id-type="pmid">21996258</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0141">
<label>141</label>
<mixed-citation id="epi412102-cit-0141" publication-type="journal">
<string-name>
<surname>Sellami</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wegener</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Veenstra</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Functional significance of the copper transporter ATP7 in peptidergic neurons and endocrine cells in Drosophila melanogaster</article-title>. <source xml:lang="en"/>FEBS Lett
<year>2012</year>;<volume>586</volume>:<fpage>3633</fpage>–<lpage>3638</lpage>.<pub-id pub-id-type="pmid">22981378</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0142">
<label>142</label>
<mixed-citation id="epi412102-cit-0142" publication-type="journal">
<string-name>
<surname>Chick</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>El Sadr</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Worden</surname>
<given-names>AN</given-names>
</string-name>. <article-title>Occurrence of fits of an epileptiform nature in rats maintained for long periods on a diet deprived of vitamin B(6)</article-title>. <source xml:lang="en"/>Biochem J
<year>1940</year>;<volume>34</volume>:<fpage>595</fpage>–<lpage>600</lpage>.<pub-id pub-id-type="pmid">16747196</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0143">
<label>143</label>
<mixed-citation id="epi412102-cit-0143" publication-type="journal">
<string-name>
<surname>Daniel</surname>
<given-names>EP</given-names>
</string-name>, <string-name>
<surname>Kline</surname>
<given-names>OL</given-names>
</string-name>, <string-name>
<surname>Tolle</surname>
<given-names>CD</given-names>
</string-name>. <article-title>A convulsive syndrome in young rats associated with pyridoxine deficiency</article-title>. <source xml:lang="en"/>J Nutr
<year>1942</year>;<volume>23</volume>:<fpage>205</fpage>–<lpage>2016</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0144">
<label>144</label>
<mixed-citation id="epi412102-cit-0144" publication-type="journal">
<string-name>
<surname>Snyderman</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Holt</surname>
<given-names>LE</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Carretero</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Pyridoxine deficiency in the human infant</article-title>. <source xml:lang="en"/>J Clin Nutr
<year>1953</year>;<volume>1</volume>:<fpage>200</fpage>–<lpage>207</lpage>.<pub-id pub-id-type="pmid">13052721</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0145">
<label>145</label>
<mixed-citation id="epi412102-cit-0145" publication-type="journal">
<string-name>
<surname>Coursin</surname>
<given-names>DB</given-names>
</string-name>. <article-title>Convulsive seizures in infants with pyridoxine‐deficient diet</article-title>. <source xml:lang="en"/>J Am Med Assoc
<year>1954</year>;<volume>154</volume>:<fpage>406</fpage>.<pub-id pub-id-type="pmid">13117629</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0146">
<label>146</label>
<mixed-citation id="epi412102-cit-0146" publication-type="journal">
<string-name>
<surname>Hunt</surname>
<given-names>AD</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Stokes</surname>
<given-names>J</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Mc</surname>
<given-names>CW</given-names>
</string-name>, et al. <article-title>Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine</article-title>. <source xml:lang="en"/>Pediatrics
<year>1954</year>;<volume>13</volume>:<fpage>140</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">13133562</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0147">
<label>147</label>
<mixed-citation id="epi412102-cit-0147" publication-type="journal">
<string-name>
<surname>Ohtsuka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Matsuda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ogino</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Treatment of the west syndrome with high‐dose pyridoxal phosphate</article-title>. <source xml:lang="en"/>Brain Dev
<year>1987</year>;<volume>9</volume>:<fpage>418</fpage>–<lpage>421</lpage>.<pub-id pub-id-type="pmid">3434717</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0148">
<label>148</label>
<mixed-citation id="epi412102-cit-0148" publication-type="journal">
<string-name>
<surname>Ohtahara</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ohtsuka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamatogi</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Prenatal etiologies of west syndrome</article-title>. <source xml:lang="en"/>Epilepsia
<year>1993</year>;<volume>34</volume>:<fpage>716</fpage>–<lpage>722</lpage>.<pub-id pub-id-type="pmid">8330583</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0149">
<label>149</label>
<mixed-citation id="epi412102-cit-0149" publication-type="journal">
<string-name>
<surname>Pietz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Benninger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schafer</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Treatment of infantile spasms with high‐dosage vitamin B6</article-title>. <source xml:lang="en"/>Epilepsia
<year>1993</year>;<volume>34</volume>:<fpage>757</fpage>–<lpage>763</lpage>.<pub-id pub-id-type="pmid">8330589</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0150">
<label>150</label>
<mixed-citation id="epi412102-cit-0150" publication-type="journal">
<string-name>
<surname>Watanabe</surname>
<given-names>K</given-names>
</string-name>. <article-title>Medical treatment of West syndrome in Japan</article-title>. <source xml:lang="en"/>J Child Neurol
<year>1995</year>;<volume>10</volume>:<fpage>143</fpage>–<lpage>147</lpage>.<pub-id pub-id-type="pmid">7782606</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0151">
<label>151</label>
<mixed-citation id="epi412102-cit-0151" publication-type="journal">
<string-name>
<surname>Ito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Seki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takuma</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Current therapy for West syndrome in Japan</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2000</year>;<volume>15</volume>:<fpage>424</fpage>–<lpage>428</lpage>.<pub-id pub-id-type="pmid">10868790</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0152">
<label>152</label>
<mixed-citation id="epi412102-cit-0152" publication-type="journal">
<string-name>
<surname>Tsuji</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Okumura</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ozawa</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Current treatment of West syndrome in Japan</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2007</year>;<volume>22</volume>:<fpage>560</fpage>–<lpage>564</lpage>.<pub-id pub-id-type="pmid">17690062</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0153">
<label>153</label>
<mixed-citation id="epi412102-cit-0153" publication-type="journal">
<string-name>
<surname>Mackay</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Weiss</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Adams‐Webber</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society</article-title>. <source xml:lang="en"/>Neurology
<year>2004</year>;<volume>62</volume>:<fpage>1668</fpage>–<lpage>1681</lpage>.<pub-id pub-id-type="pmid">15159460</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0154">
<label>154</label>
<mixed-citation id="epi412102-cit-0154" publication-type="journal">
<string-name>
<surname>Tower</surname>
<given-names>DB</given-names>
</string-name>. <article-title>Neurochemical aspects of pyridoxine metabolism and function</article-title>. <source xml:lang="en"/>Am J Clin Nutr
<year>1956</year>;<volume>4</volume>:<fpage>329</fpage>–<lpage>345</lpage>.<pub-id pub-id-type="pmid">13339703</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0155">
<label>155</label>
<mixed-citation id="epi412102-cit-0155" publication-type="journal">
<string-name>
<surname>Kurlemann</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Loscher</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Dominick</surname>
<given-names>HC</given-names>
</string-name>, et al. <article-title>Disappearance of neonatal seizures and low CSF GABA levels after treatment with vitamin B6</article-title>. <source xml:lang="en"/>Epilepsy Res
<year>1987</year>;<volume>1</volume>:<fpage>152</fpage>–<lpage>154</lpage>.<pub-id pub-id-type="pmid">3504392</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0156">
<label>156</label>
<mixed-citation id="epi412102-cit-0156" publication-type="journal">
<string-name>
<surname>Kurlemann</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ziegler</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gruneberg</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Disturbance of GABA metabolism in pyridoxine‐dependent seizures</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>1992</year>;<volume>23</volume>:<fpage>257</fpage>–<lpage>259</lpage>.<pub-id pub-id-type="pmid">1454145</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0157">
<label>157</label>
<mixed-citation id="epi412102-cit-0157" publication-type="journal">
<string-name>
<surname>Mc Khann</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tower</surname>
<given-names>DB</given-names>
</string-name>. <article-title>gamma‐Aminobutyric acid: a substrate for oxidative metabolism of cerebral cortex</article-title>. <source xml:lang="en"/>Am J Physiol
<year>1959</year>;<volume>196</volume>:<fpage>36</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">13617432</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0158">
<label>158</label>
<mixed-citation id="epi412102-cit-0158" publication-type="journal">
<string-name>
<surname>Scriver</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Whelan</surname>
<given-names>DT</given-names>
</string-name>. <article-title>Glutamic acid decarboxylase (Gad) in mammalian tissue outside the central nervous system, and its possible relevance to hereditary vitamin b6dependency with seizures</article-title>. <source xml:lang="en"/>Ann N Y Acad Sci
<year>1969</year>;<volume>166</volume>:<fpage>83</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">5262035</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0159">
<label>159</label>
<mixed-citation id="epi412102-cit-0159" publication-type="journal">
<string-name>
<surname>Yoshida</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Arakawa</surname>
<given-names>T</given-names>
</string-name>. <article-title>Vitamin B6‐dependency of glutamic acid decarboxylase in the kidney from a patient with vitamin b6 dependent convulsion</article-title>. <source xml:lang="en"/>Tohoku J Exp Med
<year>1971</year>;<volume>104</volume>:<fpage>195</fpage>–<lpage>198</lpage>.<pub-id pub-id-type="pmid">5566248</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0160">
<label>160</label>
<mixed-citation id="epi412102-cit-0160" publication-type="journal">
<string-name>
<surname>Gospe</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Olin</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Keen</surname>
<given-names>CL</given-names>
</string-name>. <article-title>Reduced GABA synthesis in pyridoxine‐dependent seizures</article-title>. <source xml:lang="en"/>Lancet
<year>1994</year>;<volume>343</volume>:<fpage>1133</fpage>–<lpage>1134</lpage>.<pub-id pub-id-type="pmid">7910233</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0161">
<label>161</label>
<mixed-citation id="epi412102-cit-0161" publication-type="journal">
<string-name>
<surname>Kure</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sakata</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Miyabayashi</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Mutation and polymorphic marker analyses of 65K‐ and 67K‐glutamate decarboxylase genes in two families with pyridoxine‐dependent epilepsy</article-title>. <source xml:lang="en"/>J Hum Genet
<year>1998</year>;<volume>43</volume>:<fpage>128</fpage>–<lpage>131</lpage>.<pub-id pub-id-type="pmid">9621518</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0162">
<label>162</label>
<mixed-citation id="epi412102-cit-0162" publication-type="journal">
<string-name>
<surname>Battaglioli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rosen</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Gospe</surname>
<given-names>SMJ</given-names>
</string-name>, et al. <article-title>Glutamate decarboxylase is not genetically linked to pyridoxine‐dependent seizures</article-title>. <source xml:lang="en"/>Neurology
<year>2000</year>;<volume>55</volume>:<fpage>309</fpage>–<lpage>311</lpage>.<pub-id pub-id-type="pmid">10908915</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0163">
<label>163</label>
<mixed-citation id="epi412102-cit-0163" publication-type="journal">
<string-name>
<surname>Cormier‐Daire</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Dagoneau</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Nabbout</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>A gene for pyridoxine‐dependent epilepsy maps to chromosome 5q31</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2000</year>;<volume>67</volume>:<fpage>991</fpage>–<lpage>993</lpage>.<pub-id pub-id-type="pmid">10978228</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0164">
<label>164</label>
<mixed-citation id="epi412102-cit-0164" publication-type="journal">
<string-name>
<surname>Mills</surname>
<given-names>PB</given-names>
</string-name>, <string-name>
<surname>Surtees</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Champion</surname>
<given-names>MP</given-names>
</string-name>, et al. <article-title>Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′‐phosphate oxidase</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2005</year>;<volume>14</volume>:<fpage>1077</fpage>–<lpage>1086</lpage>.<pub-id pub-id-type="pmid">15772097</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0165">
<label>165</label>
<mixed-citation id="epi412102-cit-0165" publication-type="journal">
<string-name>
<surname>Michaud</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Lachance</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</string-name>, et al. <article-title>The genetic landscape of infantile spasms</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2014</year>;<volume>23</volume>:<fpage>4846</fpage>–<lpage>4858</lpage>.<pub-id pub-id-type="pmid">24781210</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0166">
<label>166</label>
<mixed-citation id="epi412102-cit-0166" publication-type="journal">
<string-name>
<surname>Mills</surname>
<given-names>PB</given-names>
</string-name>, <string-name>
<surname>Struys</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jakobs</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Mutations in antiquitin in individuals with pyridoxine‐dependent seizures</article-title>. <source xml:lang="en"/>Nat Med
<year>2006</year>;<volume>12</volume>:<fpage>307</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">16491085</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0167">
<label>167</label>
<mixed-citation id="epi412102-cit-0167" publication-type="journal">
<string-name>
<surname>Scharer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Brocker</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vasiliou</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>The genotypic and phenotypic spectrum of pyridoxine‐dependent epilepsy due to mutations in ALDH7A1</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2010</year>;<volume>33</volume>:<fpage>571</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">20814824</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0168">
<label>168</label>
<mixed-citation id="epi412102-cit-0168" publication-type="journal">
<string-name>
<surname>Kanno</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kure</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Narisawa</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Allelic and non‐allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2007</year>;<volume>91</volume>:<fpage>384</fpage>–<lpage>389</lpage>.<pub-id pub-id-type="pmid">17433748</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0169">
<label>169</label>
<mixed-citation id="epi412102-cit-0169" publication-type="journal">
<string-name>
<surname>Bennett</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hahn</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Prevalence of ALDH7A1 mutations in 18 North American pyridoxine‐dependent seizure (PDS) patients</article-title>. <source xml:lang="en"/>Epilepsia
<year>2009</year>;<volume>50</volume>:<fpage>1167</fpage>–<lpage>1175</lpage>.<pub-id pub-id-type="pmid">19128417</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0170">
<label>170</label>
<mixed-citation id="epi412102-cit-0170" publication-type="journal">
<string-name>
<surname>Gallagher</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Van Hove</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Scharer</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Folinic acid‐responsive seizures are identical to pyridoxine‐dependent epilepsy</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2009</year>;<volume>65</volume>:<fpage>550</fpage>–<lpage>556</lpage>.<pub-id pub-id-type="pmid">19142996</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0171">
<label>171</label>
<mixed-citation id="epi412102-cit-0171" publication-type="journal">
<string-name>
<surname>Lux</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Latest American and European updates on infantile spasms</article-title>. <source xml:lang="en"/>Curr Neurol Neurosci Rep
<year>2013</year>;<volume>13</volume>:<fpage>334</fpage>.<pub-id pub-id-type="pmid">23341252</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0172">
<label>172</label>
<mixed-citation id="epi412102-cit-0172" publication-type="journal">
<string-name>
<surname>Waymire</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Mahuren</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Jaje</surname>
<given-names>JM</given-names>
</string-name>, et al. <article-title>Mice lacking tissue non‐specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B‐6</article-title>. <source xml:lang="en"/>Nat Genet
<year>1995</year>;<volume>11</volume>:<fpage>45</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">7550313</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0173">
<label>173</label>
<mixed-citation id="epi412102-cit-0173" publication-type="journal">
<string-name>
<surname>Narisawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wennberg</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Luis</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Abnormal vitamin B6 metabolism in alkaline phosphatase knock‐out mice causes multiple abnormalities, but not the impaired bone mineralization</article-title>. <source xml:lang="en"/>J Pathol
<year>2001</year>;<volume>193</volume>:<fpage>125</fpage>–<lpage>133</lpage>.<pub-id pub-id-type="pmid">11169525</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0174">
<label>174</label>
<mixed-citation id="epi412102-cit-0174" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Sung</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>WN</given-names>
</string-name>, et al. <article-title>Zebrafish larvae exposed to ginkgotoxin exhibit seizure‐like behavior that is relieved by pyridoxal‐5′‐phosphate, GABA and anti‐epileptic drugs</article-title>. <source xml:lang="en"/>Dis Model Mech
<year>2012</year>;<volume>5</volume>:<fpage>785</fpage>–<lpage>795</lpage>.<pub-id pub-id-type="pmid">22736461</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0175">
<label>175</label>
<mixed-citation id="epi412102-cit-0175" publication-type="journal">
<string-name>
<surname>Brandt</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Brandt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rasmussen</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Letter: hyperglycericacidaemia with hyperglycinaemia: a new inborn error of metabolism</article-title>. <source xml:lang="en"/>Br Med J
<year>1974</year>;<volume>4</volume>:<fpage>344</fpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0176">
<label>176</label>
<mixed-citation id="epi412102-cit-0176" publication-type="journal">
<string-name>
<surname>Sass</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>D‐Glyceric aciduria is caused by genetic deficiency of D‐glycerate kinase (GLYCTK)</article-title>. <source xml:lang="en"/>Hum Mutat
<year>2010</year>;<volume>31</volume>:<fpage>1280</fpage>–<lpage>1285</lpage>.<pub-id pub-id-type="pmid">20949620</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0177">
<label>177</label>
<mixed-citation id="epi412102-cit-0177" publication-type="journal">
<string-name>
<surname>Duran</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Beemer</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Bruinvis</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>D‐glyceric acidemia: an inborn error associated with fructose metabolism</article-title>. <source xml:lang="en"/>Pediatr Res
<year>1987</year>;<volume>21</volume>:<fpage>502</fpage>–<lpage>506</lpage>.<pub-id pub-id-type="pmid">3588091</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0178">
<label>178</label>
<mixed-citation id="epi412102-cit-0178" publication-type="journal">
<string-name>
<surname>Bonham</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Stephenson</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Carpenter</surname>
<given-names>KH</given-names>
</string-name>, et al. <article-title>D(+)‐glyceric aciduria: etiology and clinical consequences</article-title>. <source xml:lang="en"/>Pediatr Res
<year>1990</year>;<volume>28</volume>:<fpage>38</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">2165585</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0179">
<label>179</label>
<mixed-citation id="epi412102-cit-0179" publication-type="journal">
<string-name>
<surname>Topcu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Saatci</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Haliloglu</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>D‐glyceric aciduria in a six‐month‐old boy presenting with West syndrome and autistic behaviour</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>2002</year>;<volume>33</volume>:<fpage>47</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">11930278</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0180">
<label>180</label>
<mixed-citation id="epi412102-cit-0180" publication-type="journal">
<string-name>
<surname>Lozano</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Van der Werf</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bietiger</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>High‐fructose and high‐fat diet‐induced disorders in rats: impact on diabetes risk, hepatic and vascular complications</article-title>. <source xml:lang="en"/>Nutr Metab (Lond)
<year>2016</year>;<volume>13</volume>:<fpage>15</fpage>.<pub-id pub-id-type="pmid">26918024</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0181">
<label>181</label>
<mixed-citation id="epi412102-cit-0181" publication-type="journal">
<string-name>
<surname>Oberholzer</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>Levin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Burgess</surname>
<given-names>EA</given-names>
</string-name>, et al. <article-title>Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis</article-title>. <source xml:lang="en"/>Arch Dis Child
<year>1967</year>;<volume>42</volume>:<fpage>492</fpage>–<lpage>504</lpage>.<pub-id pub-id-type="pmid">6061291</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0182">
<label>182</label>
<mixed-citation id="epi412102-cit-0182" publication-type="journal">
<string-name>
<surname>Kolhouse</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Utley</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fenton</surname>
<given-names>WA</given-names>
</string-name>, et al. <article-title>Immunochemical studies on cultured fibroblasts from patients with inherited methylmalonic acidemia</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>1981</year>;<volume>78</volume>:<fpage>7737</fpage>–<lpage>7741</lpage>.<pub-id pub-id-type="pmid">6121323</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0183">
<label>183</label>
<mixed-citation id="epi412102-cit-0183" publication-type="journal">
<string-name>
<surname>Matsui</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Mahoney</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <article-title>The natural history of the inherited methylmalonic acidemias</article-title>. <source xml:lang="en"/>N Engl J Med
<year>1983</year>;<volume>308</volume>:<fpage>857</fpage>–<lpage>861</lpage>.<pub-id pub-id-type="pmid">6132336</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0184">
<label>184</label>
<mixed-citation id="epi412102-cit-0184" publication-type="journal">
<string-name>
<surname>Gurnani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mistry</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>BC</given-names>
</string-name>. <article-title>Function of vitamin B12 in methylmalonate metabolism. I. Effect of a cofactor form of B12 on the activity of methylmalonyl‐CoA isomerase</article-title>. <source xml:lang="en"/>Biochim Biophys Acta
<year>1960</year>;<volume>38</volume>:<fpage>187</fpage>–<lpage>188</lpage>.<pub-id pub-id-type="pmid">13830365</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0185">
<label>185</label>
<mixed-citation id="epi412102-cit-0185" publication-type="journal">
<string-name>
<surname>Cox</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Methylmalonic acid excretion: an index of vitamin‐B12 deficiency</article-title>. <source xml:lang="en"/>Lancet
<year>1962</year>;<volume>2</volume>:<fpage>853</fpage>–<lpage>856</lpage>.<pub-id pub-id-type="pmid">14023552</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0186">
<label>186</label>
<mixed-citation id="epi412102-cit-0186" publication-type="journal">
<string-name>
<surname>Jansen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ledley</surname>
<given-names>FD</given-names>
</string-name>. <article-title>Heterozygous mutations at the mut locus in fibroblasts with Mut0 methylmalonic acidemia identified by polymerase‐chain‐reaction Cdna cloning</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1990</year>;<volume>47</volume>:<fpage>808</fpage>–<lpage>814</lpage>.<pub-id pub-id-type="pmid">1977311</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0187">
<label>187</label>
<mixed-citation id="epi412102-cit-0187" publication-type="journal">
<string-name>
<surname>Ledley</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Rosenblatt</surname>
<given-names>DS</given-names>
</string-name>. <article-title>Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations</article-title>. <source xml:lang="en"/>Hum Mutat
<year>1997</year>;<volume>9</volume>:<fpage>1</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">8990001</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0188">
<label>188</label>
<mixed-citation id="epi412102-cit-0188" publication-type="journal">
<string-name>
<surname>Gravel</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Mahoney</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Ruddle</surname>
<given-names>FH</given-names>
</string-name>, et al. <article-title>Genetic complementation in heterokaryons of human fibroblasts defective in cobalamin metabolism</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>1975</year>;<volume>72</volume>:<fpage>3181</fpage>–<lpage>3185</lpage>.<pub-id pub-id-type="pmid">1059104</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0189">
<label>189</label>
<mixed-citation id="epi412102-cit-0189" publication-type="journal">
<string-name>
<surname>Campeau</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Valayannopoulos</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Touati</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Management of West syndrome in a patient with methylmalonic aciduria</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2010</year>;<volume>25</volume>:<fpage>94</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">19700743</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0190">
<label>190</label>
<mixed-citation id="epi412102-cit-0190" publication-type="journal">
<string-name>
<surname>Erol</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Alehan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gumus</surname>
<given-names>A</given-names>
</string-name>. <article-title>West syndrome in an infant with vitamin B12 deficiency in the absence of macrocytic anaemia</article-title>. <source xml:lang="en"/>Dev Med Child Neurol
<year>2007</year>;<volume>49</volume>:<fpage>774</fpage>–<lpage>776</lpage>.<pub-id pub-id-type="pmid">17880648</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0191">
<label>191</label>
<mixed-citation id="epi412102-cit-0191" publication-type="journal">
<string-name>
<surname>Glaser</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Girschick</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Schropp</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Psychomotor development following early treatment of severe infantile vitamin B12 deficiency and West syndrome–is everything fine? A case report and review of literature</article-title>. <source xml:lang="en"/>Brain Dev
<year>2015</year>;<volume>37</volume>:<fpage>347</fpage>–<lpage>351</lpage>.<pub-id pub-id-type="pmid">24938481</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0192">
<label>192</label>
<mixed-citation id="epi412102-cit-0192" publication-type="journal">
<string-name>
<surname>Osborne</surname>
<given-names>LR</given-names>
</string-name>. <article-title>Animal models of Williams syndrome</article-title>. <source xml:lang="en"/>Am J Med Genet C Semin Med Genet
<year>2010</year>;<volume>154C</volume>:<fpage>209</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">20425782</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0193">
<label>193</label>
<mixed-citation id="epi412102-cit-0193" publication-type="journal">
<string-name>
<surname>Fighera</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Queiroz</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Stracke</surname>
<given-names>MP</given-names>
</string-name>, et al. <article-title>Ascorbic acid and alpha‐tocopherol attenuate methylmalonic acid‐induced convulsions</article-title>. <source xml:lang="en"/>NeuroReport
<year>1999</year>;<volume>10</volume>:<fpage>2039</fpage>–<lpage>2043</lpage>.<pub-id pub-id-type="pmid">10424671</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0194">
<label>194</label>
<mixed-citation id="epi412102-cit-0194" publication-type="journal">
<string-name>
<surname>de Mello</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Begnini</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jiménez‐Bernal</surname>
<given-names>RE</given-names>
</string-name>, et al. <article-title>Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms</article-title>. <source xml:lang="en"/>Brain Res
<year>1996</year>;<volume>721</volume>:<fpage>120</fpage>–<lpage>125</lpage>.<pub-id pub-id-type="pmid">8793091</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0195">
<label>195</label>
<mixed-citation id="epi412102-cit-0195" publication-type="journal">
<string-name>
<surname>Wyse</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Streck</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Barros</surname>
<given-names>SV</given-names>
</string-name>, et al. <article-title>Methylmalonate administration decreases Na+, K + ‐ATPase activity in cerebral cortex of rats</article-title>. <source xml:lang="en"/>NeuroReport
<year>2000</year>;<volume>11</volume>:<fpage>2331</fpage>–<lpage>2334</lpage>.<pub-id pub-id-type="pmid">10923695</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0196">
<label>196</label>
<mixed-citation id="epi412102-cit-0196" publication-type="journal">
<string-name>
<surname>Malfatti</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Perry</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Schweigert</surname>
<given-names>ID</given-names>
</string-name>, et al. <article-title>Convulsions induced by methylmalonic acid are associated with glutamic acid decarboxylase inhibition in rats: a role for GABA in the seizures presented by methylmalonic acidemic patients?</article-title>
<source xml:lang="en"/>Neuroscience
<year>2007</year>;<volume>146</volume>:<fpage>1879</fpage>–<lpage>1887</lpage>.<pub-id pub-id-type="pmid">17467181</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0197">
<label>197</label>
<mixed-citation id="epi412102-cit-0197" publication-type="journal">
<string-name>
<surname>Peng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Dreumont</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Coelho</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Genetic animal models to decipher the pathogenic effects of vitamin B12 and folate deficiency</article-title>. <source xml:lang="en"/>Biochimie
<year>2016</year>;<volume>126</volume>:<fpage>43</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">27178438</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0198">
<label>198</label>
<mixed-citation id="epi412102-cit-0198" publication-type="journal">
<string-name>
<surname>Arora</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sequeira</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>AI</given-names>
</string-name>, et al. <article-title>Behavioral alterations are associated with vitamin B12 deficiency in the transcobalamin receptor/CD320 KO mouse</article-title>. <source xml:lang="en"/>PLoS ONE
<year>2017</year>;<volume>12</volume>:<fpage>e0177156</fpage>.<pub-id pub-id-type="pmid">28545069</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0199">
<label>199</label>
<mixed-citation id="epi412102-cit-0199" publication-type="journal">
<string-name>
<surname>Lai</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Nakayama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sequeira</surname>
<given-names>JM</given-names>
</string-name>, et al. <article-title>The transcobalamin receptor knockout mouse: a model for vitamin B12 deficiency in the central nervous system</article-title>. <source xml:lang="en"/>FASEB J
<year>2013</year>;<volume>27</volume>:<fpage>2468</fpage>–<lpage>2475</lpage>.<pub-id pub-id-type="pmid">23430977</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0200">
<label>200</label>
<mixed-citation id="epi412102-cit-0200" publication-type="journal">
<string-name>
<surname>Gerritsen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Vaughn</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Waisman</surname>
<given-names>HA</given-names>
</string-name>. <article-title>The identification of homocystine in the urine</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun
<year>1962</year>;<volume>9</volume>:<fpage>493</fpage>–<lpage>496</lpage>.<pub-id pub-id-type="pmid">13960563</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0201">
<label>201</label>
<mixed-citation id="epi412102-cit-0201" publication-type="journal">
<string-name>
<surname>Harvey Mudd</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>William Uhlendorf</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Freeman</surname>
<given-names>JM</given-names>
</string-name>, et al. <article-title>Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun
<year>1972</year>;<volume>46</volume>:<fpage>905</fpage>–<lpage>912</lpage>.<pub-id pub-id-type="pmid">5057914</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0202">
<label>202</label>
<mixed-citation id="epi412102-cit-0202" publication-type="journal">
<string-name>
<surname>Goyette</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Sumner</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Milos</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification</article-title>. <source xml:lang="en"/>Nat Genet
<year>1994</year>;<volume>7</volume>:<fpage>195</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">7920641</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0203">
<label>203</label>
<mixed-citation id="epi412102-cit-0203" publication-type="journal">
<string-name>
<surname>Perla‐Kajan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Twardowski</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jakubowski</surname>
<given-names>H</given-names>
</string-name>. <article-title>Mechanisms of homocysteine toxicity in humans</article-title>. <source xml:lang="en"/>Amino Acids
<year>2007</year>;<volume>32</volume>:<fpage>561</fpage>–<lpage>572</lpage>.<pub-id pub-id-type="pmid">17285228</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0204">
<label>204</label>
<mixed-citation id="epi412102-cit-0204" publication-type="journal">
<string-name>
<surname>Prasad</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Rupar</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Prasad</surname>
<given-names>C</given-names>
</string-name>. <article-title>Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy</article-title>. <source xml:lang="en"/>Brain Dev
<year>2011</year>;<volume>33</volume>:<fpage>758</fpage>–<lpage>769</lpage>.<pub-id pub-id-type="pmid">21778025</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0205">
<label>205</label>
<mixed-citation id="epi412102-cit-0205" publication-type="journal">
<string-name>
<surname>Sprince</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Josephs</surname>
<given-names>JA</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Homocysteine‐induced convulsions in the rat: protection by homoserine, serine, betaine, glycine and glucose</article-title>. <source xml:lang="en"/>Agents Actions
<year>1969</year>;<volume>1</volume>:<fpage>9</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">5406120</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0206">
<label>206</label>
<mixed-citation id="epi412102-cit-0206" publication-type="journal">
<string-name>
<surname>Freed</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Luchins</surname>
<given-names>DJ</given-names>
</string-name>, et al. <article-title>Production of convulsions in mice by the combination of methionine and homocysteine</article-title>. <source xml:lang="en"/>Psychopharmacology
<year>1980</year>;<volume>69</volume>:<fpage>275</fpage>–<lpage>280</lpage>.<pub-id pub-id-type="pmid">6774367</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0207">
<label>207</label>
<mixed-citation id="epi412102-cit-0207" publication-type="journal">
<string-name>
<surname>Flott‐Rahmel</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schurmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schluff</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Homocysteic and homocysteine sulphinic acid exhibit excitotoxicity in organotypic cultures from rat brain</article-title>. <source xml:lang="en"/>Eur J Pediatr
<year>1998</year>;<volume>157</volume>(<issue>Suppl 2</issue>):<fpage>S112</fpage>–<lpage>S117</lpage>.<pub-id pub-id-type="pmid">9587037</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0208">
<label>208</label>
<mixed-citation id="epi412102-cit-0208" publication-type="journal">
<string-name>
<surname>Diaz‐Arrastia</surname>
<given-names>R</given-names>
</string-name>. <article-title>Homocysteine and neurologic disease</article-title>. <source xml:lang="en"/>Arch Neurol
<year>2000</year>;<volume>57</volume>:<fpage>1422</fpage>–<lpage>1427</lpage>.<pub-id pub-id-type="pmid">11030793</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0209">
<label>209</label>
<mixed-citation id="epi412102-cit-0209" publication-type="journal">
<collab collab-type="authors">Homocysteine Lowering Trialists' Collaboration</collab>
. <article-title>Lowering blood homocysteine with folic acid based supplements: meta‐analysis of randomised trials</article-title>. <source xml:lang="en"/>BMJ
<year>1998</year>;<volume>316</volume>:<fpage>894</fpage>–<lpage>898</lpage>.<pub-id pub-id-type="pmid">9569395</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0210">
<label>210</label>
<mixed-citation id="epi412102-cit-0210" publication-type="journal">
<string-name>
<surname>Kubova</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Folbergrova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mares</surname>
<given-names>P</given-names>
</string-name>. <article-title>Seizures induced by homocysteine in rats during ontogenesis</article-title>. <source xml:lang="en"/>Epilepsia
<year>1995</year>;<volume>36</volume>:<fpage>750</fpage>–<lpage>756</lpage>.<pub-id pub-id-type="pmid">7635093</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0211">
<label>211</label>
<mixed-citation id="epi412102-cit-0211" publication-type="journal">
<string-name>
<surname>Folbergrova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Haugvicova</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mares</surname>
<given-names>P</given-names>
</string-name>. <article-title>Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid: the protective effect of NMDA and non‐NMDA receptor antagonists</article-title>. <source xml:lang="en"/>Exp Neurol
<year>2000</year>;<volume>161</volume>:<fpage>336</fpage>–<lpage>345</lpage>.<pub-id pub-id-type="pmid">10683299</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0212">
<label>212</label>
<mixed-citation id="epi412102-cit-0212" publication-type="journal">
<string-name>
<surname>Streck</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Matte</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vieira</surname>
<given-names>PS</given-names>
</string-name>, et al. <article-title>Reduction of Na(+), K(+)‐ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia</article-title>. <source xml:lang="en"/>Neurochem Res
<year>2002</year>;<volume>27</volume>:<fpage>1593</fpage>–<lpage>1598</lpage>.<pub-id pub-id-type="pmid">12515310</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0213">
<label>213</label>
<mixed-citation id="epi412102-cit-0213" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Karaplis</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Ackerman</surname>
<given-names>SL</given-names>
</string-name>, et al. <article-title>Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2001</year>;<volume>10</volume>:<fpage>433</fpage>–<lpage>443</lpage>.<pub-id pub-id-type="pmid">11181567</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0214">
<label>214</label>
<mixed-citation id="epi412102-cit-0214" publication-type="journal">
<string-name>
<surname>Jadavji</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Malysheva</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Mthfr deficiency or reduced intake of folate or choline in pregnant mice results in impaired short‐term memory and increased apoptosis in the hippocampus of wild‐type offspring</article-title>. <source xml:lang="en"/>Neuroscience
<year>2015</year>;<volume>300</volume>:<fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">25956258</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0215">
<label>215</label>
<mixed-citation id="epi412102-cit-0215" publication-type="journal">
<string-name>
<surname>Childs</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Nyhan</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Borden</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. I</article-title>. <source xml:lang="en"/>Pediatrics
<year>1961</year>;<volume>27</volume>:<fpage>522</fpage>–<lpage>538</lpage>.<pub-id pub-id-type="pmid">13693094</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0216">
<label>216</label>
<mixed-citation id="epi412102-cit-0216" publication-type="journal">
<string-name>
<surname>Hsia</surname>
<given-names>YE</given-names>
</string-name>, <string-name>
<surname>Scully</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <article-title>Defective propionate carboxylation in ketotic hyperglycinÆmia</article-title>. <source xml:lang="en"/>Lancet
<year>1969</year>;<volume>293</volume>:<fpage>757</fpage>–<lpage>758</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0217">
<label>217</label>
<mixed-citation id="epi412102-cit-0217" publication-type="journal">
<string-name>
<surname>Hsia</surname>
<given-names>YE</given-names>
</string-name>, <string-name>
<surname>Scully</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <article-title>Inherited propionyl‐Coa carboxylase deficiency in “ketotic hyperglycinemia”</article-title>. <source xml:lang="en"/>J Clin Invest
<year>1971</year>;<volume>50</volume>:<fpage>127</fpage>–<lpage>130</lpage>.<pub-id pub-id-type="pmid">5101292</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0218">
<label>218</label>
<mixed-citation id="epi412102-cit-0218" publication-type="journal">
<string-name>
<surname>Lamhonwah</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Barankiewicz</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Willard</surname>
<given-names>HF</given-names>
</string-name>, et al. <article-title>Isolation of cDNA clones coding for the alpha and beta chains of human propionyl‐CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>1986</year>;<volume>83</volume>:<fpage>4864</fpage>–<lpage>4868</lpage>.<pub-id pub-id-type="pmid">3460076</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0219">
<label>219</label>
<mixed-citation id="epi412102-cit-0219" publication-type="journal">
<string-name>
<surname>Nyhan</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Bay</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Beyer</surname>
<given-names>EW</given-names>
</string-name>, et al. <article-title>Neurologic nonmetabolic presentation of propionic acidemia</article-title>. <source xml:lang="en"/>Arch Neurol
<year>1999</year>;<volume>56</volume>:<fpage>1143</fpage>–<lpage>1147</lpage>.<pub-id pub-id-type="pmid">10488817</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0220">
<label>220</label>
<mixed-citation id="epi412102-cit-0220" publication-type="journal">
<string-name>
<surname>North</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Korson</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Gopal</surname>
<given-names>YR</given-names>
</string-name>, et al. <article-title>Neonatal‐onset propionic acidemia: neurologic and developmental profiles, and implications for management</article-title>. <source xml:lang="en"/>J Pediatrics
<year>1995</year>;<volume>126</volume>:<fpage>916</fpage>–<lpage>922</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0221">
<label>221</label>
<mixed-citation id="epi412102-cit-0221" publication-type="journal">
<string-name>
<surname>Schreiber</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chapman</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Summar</surname>
<given-names>ML</given-names>
</string-name>, et al. <article-title>Neurologic considerations in propionic acidemia</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2011</year>;<volume>105</volume>:<fpage>10</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">22078457</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0222">
<label>222</label>
<mixed-citation id="epi412102-cit-0222" publication-type="journal">
<string-name>
<surname>Harris</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Propionyl coenzyme A carboxylase deficiency presenting as non‐ketotic hyperglycinaemia</article-title>. <source xml:lang="en"/>J Med Genet
<year>1981</year>;<volume>18</volume>:<fpage>156</fpage>–<lpage>157</lpage>.<pub-id pub-id-type="pmid">7241536</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0223">
<label>223</label>
<mixed-citation id="epi412102-cit-0223" publication-type="journal">
<string-name>
<surname>MacFabe</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Cain</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Rodriguez‐Capote</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders</article-title>. <source xml:lang="en"/>Behav Brain Res
<year>2007</year>;<volume>176</volume>:<fpage>149</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">16950524</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0224">
<label>224</label>
<mixed-citation id="epi412102-cit-0224" publication-type="journal">
<string-name>
<surname>Shultz</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>MacFabe</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Ossenkopp</surname>
<given-names>KP</given-names>
</string-name>, et al. <article-title>Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end‐product, impairs social behavior in the rat: implications for an animal model of autism</article-title>. <source xml:lang="en"/>Neuropharmacology
<year>2008</year>;<volume>54</volume>:<fpage>901</fpage>–<lpage>911</lpage>.<pub-id pub-id-type="pmid">18395759</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0225">
<label>225</label>
<mixed-citation id="epi412102-cit-0225" publication-type="journal">
<string-name>
<surname>Shultz</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Macfabe</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long‐Evans rat: further development of a rodent model of autism</article-title>. <source xml:lang="en"/>Behav Brain Res
<year>2009</year>;<volume>200</volume>:<fpage>33</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">19154758</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0226">
<label>226</label>
<mixed-citation id="epi412102-cit-0226" publication-type="journal">
<string-name>
<surname>El‐Ansary</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Ben Bacha</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kotb</surname>
<given-names>M</given-names>
</string-name>. <article-title>Etiology of autistic features: the persisting neurotoxic effects of propionic acid</article-title>. <source xml:lang="en"/>J Neuroinflam
<year>2012</year>;<volume>9</volume>:<fpage>74</fpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0227">
<label>227</label>
<mixed-citation id="epi412102-cit-0227" publication-type="journal">
<string-name>
<surname>Saemundsen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ludvigsson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rafnsson</surname>
<given-names>V</given-names>
</string-name>. <article-title>Risk of autism spectrum disorders after infantile spasms: a population‐based study nested in a cohort with seizures in the first year of life</article-title>. <source xml:lang="en"/>Epilepsia
<year>2008</year>;<volume>49</volume>:<fpage>1865</fpage>–<lpage>1870</lpage>.<pub-id pub-id-type="pmid">18557779</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0228">
<label>228</label>
<mixed-citation id="epi412102-cit-0228" publication-type="journal">
<string-name>
<surname>Patel</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Roche</surname>
<given-names>TE</given-names>
</string-name>. <article-title>Molecular biology and biochemistry of pyruvate dehydrogenase complexes</article-title>. <source xml:lang="en"/>FASEB J
<year>1990</year>;<volume>4</volume>:<fpage>3224</fpage>–<lpage>3233</lpage>.<pub-id pub-id-type="pmid">2227213</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0229">
<label>229</label>
<mixed-citation id="epi412102-cit-0229" publication-type="journal">
<string-name>
<surname>Dahl</surname>
<given-names>HHM</given-names>
</string-name>. <article-title>Pyruvate‐dehydrogenase E1‐alpha deficiency ‐ males and females differ yet again</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1995</year>;<volume>56</volume>:<fpage>553</fpage>–<lpage>557</lpage>.<pub-id pub-id-type="pmid">7887408</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0230">
<label>230</label>
<mixed-citation id="epi412102-cit-0230" publication-type="journal">
<string-name>
<surname>Endo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hasegawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Narisawa</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Defective gene in lactic acidosis: abnormal pyruvate dehydrogenase E1 alpha‐subunit caused by a frame shift</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1989</year>;<volume>44</volume>:<fpage>358</fpage>–<lpage>364</lpage>.<pub-id pub-id-type="pmid">2537010</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0231">
<label>231</label>
<mixed-citation id="epi412102-cit-0231" publication-type="journal">
<string-name>
<surname>Robinson</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>MacMillan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Petrova‐Benedict</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex</article-title>. <source xml:lang="en"/>J Pediatr
<year>1987</year>;<volume>111</volume>:<fpage>525</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">3116190</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0232">
<label>232</label>
<mixed-citation id="epi412102-cit-0232" publication-type="journal">
<string-name>
<surname>Brown</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Dahl</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>GK</given-names>
</string-name>. <article-title>X‐chromosome localization of the functional gene for the E1 alpha subunit of the human pyruvate dehydrogenase complex</article-title>. <source xml:lang="en"/>Genomics
<year>1989</year>;<volume>4</volume>:<fpage>174</fpage>–<lpage>181</lpage>.<pub-id pub-id-type="pmid">2737678</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0233">
<label>233</label>
<mixed-citation id="epi412102-cit-0233" publication-type="journal">
<string-name>
<surname>Naito</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yokota</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Concomitant administration of sodium dichloroacetate and thiamine in west syndrome caused by thiamine‐responsive pyruvate dehydrogenase complex deficiency</article-title>. <source xml:lang="en"/>J Neurol Sci
<year>1999</year>;<volume>171</volume>:<fpage>56</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">10567050</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0234">
<label>234</label>
<mixed-citation id="epi412102-cit-0234" publication-type="journal">
<string-name>
<surname>Naito</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yokota</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Gender‐specific occurrence of West syndrome in patients with pyruvate dehydrogenase complex deficiency</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>2001</year>;<volume>32</volume>:<fpage>295</fpage>–<lpage>298</lpage>.<pub-id pub-id-type="pmid">11870584</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0235">
<label>235</label>
<mixed-citation id="epi412102-cit-0235" publication-type="journal">
<string-name>
<surname>Wada</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Matsuishi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nonaka</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Pyruvate dehydrogenase E1alpha subunit deficiency in a female patient: evidence of antenatal origin of brain damage and possible etiology of infantile spasms</article-title>. <source xml:lang="en"/>Brain Dev
<year>2004</year>;<volume>26</volume>:<fpage>57</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">14729417</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0236">
<label>236</label>
<mixed-citation id="epi412102-cit-0236" publication-type="journal">
<string-name>
<surname>Otero</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Silver</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Association of cerebral dysgenesis and lactic acidemia with X‐linked PDH E1 alpha subunit mutations in females</article-title>. <source xml:lang="en"/>Pediatr Neurol
<year>1995</year>;<volume>13</volume>:<fpage>327</fpage>–<lpage>332</lpage>.<pub-id pub-id-type="pmid">8771169</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0237">
<label>237</label>
<mixed-citation id="epi412102-cit-0237" publication-type="journal">
<string-name>
<surname>Takakubo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Dahl</surname>
<given-names>HH</given-names>
</string-name>. <article-title>Analysis of pyruvate dehydrogenase expression in embryonic mouse brain: localization and developmental regulation</article-title>. <source xml:lang="en"/>Brain Res Dev Brain Res
<year>1994</year>;<volume>77</volume>:<fpage>63</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">7510589</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0238">
<label>238</label>
<mixed-citation id="epi412102-cit-0238" publication-type="journal">
<string-name>
<surname>Johnson</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Mahmood</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hyatt</surname>
<given-names>SL</given-names>
</string-name>, et al. <article-title>Inactivation of the murine pyruvate dehydrogenase (Pdha1) gene and its effect on early embryonic development</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2001</year>;<volume>74</volume>:<fpage>293</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">11708858</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0239">
<label>239</label>
<mixed-citation id="epi412102-cit-0239" publication-type="journal">
<string-name>
<surname>Pliss</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pentney</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>MT</given-names>
</string-name>, et al. <article-title>Biochemical and structural brain alterations in female mice with cerebral pyruvate dehydrogenase deficiency</article-title>. <source xml:lang="en"/>J Neurochem
<year>2004</year>;<volume>91</volume>:<fpage>1082</fpage>–<lpage>1091</lpage>.<pub-id pub-id-type="pmid">15569252</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0240">
<label>240</label>
<mixed-citation id="epi412102-cit-0240" publication-type="journal">
<string-name>
<surname>Ojano‐Dirain</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Glushakova</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>An animal model of PDH deficiency using AAV8‐siRNA vector‐mediated knockdown of pyruvate dehydrogenase E1alpha</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2010</year>;<volume>101</volume>:<fpage>183</fpage>–<lpage>191</lpage>.<pub-id pub-id-type="pmid">20685142</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0241">
<label>241</label>
<mixed-citation id="epi412102-cit-0241" publication-type="journal">
<string-name>
<surname>Ungerstedt</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Arbuthnott</surname>
<given-names>GW</given-names>
</string-name>. <article-title>Quantitative recording of rotational behavior in rats after 6‐hydroxy‐dopamine lesions of the nigrostriatal dopamine system</article-title>. <source xml:lang="en"/>Brain Res
<year>1970</year>;<volume>24</volume>:<fpage>485</fpage>–<lpage>493</lpage>.<pub-id pub-id-type="pmid">5494536</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0242">
<label>242</label>
<mixed-citation id="epi412102-cit-0242" publication-type="journal">
<string-name>
<surname>Pliss</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hausknecht</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Stachowiak</surname>
<given-names>MK</given-names>
</string-name>, et al. <article-title>Cerebral developmental abnormalities in a mouse with systemic pyruvate dehydrogenase deficiency</article-title>. <source xml:lang="en"/>PLoS ONE
<year>2013</year>;<volume>8</volume>:<fpage>e67473</fpage>.<pub-id pub-id-type="pmid">23840713</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0243">
<label>243</label>
<mixed-citation id="epi412102-cit-0243" publication-type="journal">
<string-name>
<surname>Taylor</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Hurley</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Van Epps</surname>
<given-names>HA</given-names>
</string-name>, et al. <article-title>A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2004</year>;<volume>101</volume>:<fpage>4584</fpage>–<lpage>4589</lpage>.<pub-id pub-id-type="pmid">15070761</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0244">
<label>244</label>
<mixed-citation id="epi412102-cit-0244" publication-type="journal">
<string-name>
<surname>Leigh</surname>
<given-names>D</given-names>
</string-name>. <article-title>Subacute necrotizing encephalomyelopathy in an infant</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>1951</year>;<volume>14</volume>:<fpage>216</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">14874135</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0245">
<label>245</label>
<mixed-citation id="epi412102-cit-0245" publication-type="journal">
<string-name>
<surname>Rahman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Blok</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Dahl</surname>
<given-names>HH</given-names>
</string-name>, et al. <article-title>Leigh syndrome: clinical features and biochemical and DNA abnormalities</article-title>. <source xml:lang="en"/>Ann Neurol
<year>1996</year>;<volume>39</volume>:<fpage>343</fpage>–<lpage>351</lpage>.<pub-id pub-id-type="pmid">8602753</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0246">
<label>246</label>
<mixed-citation id="epi412102-cit-0246" publication-type="journal">
<string-name>
<surname>Tsuji</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kuroki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Maeda</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Leigh syndrome associated with West syndrome</article-title>. <source xml:lang="en"/>Brain Dev
<year>2003</year>;<volume>25</volume>:<fpage>245</fpage>–<lpage>250</lpage>.<pub-id pub-id-type="pmid">12767455</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0247">
<label>247</label>
<mixed-citation id="epi412102-cit-0247" publication-type="journal">
<string-name>
<surname>Richter</surname>
<given-names>RB</given-names>
</string-name>. <article-title>Infantile subacute necrotizing encephalopathy (Leigh's disease). It relationship to Wernick's encephalopathy</article-title>. <source xml:lang="en"/>Neurology
<year>1968</year>;<volume>18</volume>:<fpage>1125</fpage>–<lpage>1132</lpage>.<pub-id pub-id-type="pmid">5751918</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0248">
<label>248</label>
<mixed-citation id="epi412102-cit-0248" publication-type="journal">
<string-name>
<surname>Kamoshita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mizutani</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Fukuyama</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Leigh's subacute necrotizing encephalomyelopathy in a child with infantile spasms and hypsarrhythmia</article-title>. <source xml:lang="en"/>Dev Med Child Neurol
<year>1970</year>;<volume>12</volume>:<fpage>430</fpage>–<lpage>435</lpage>.<pub-id pub-id-type="pmid">5457538</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0249">
<label>249</label>
<mixed-citation id="epi412102-cit-0249" publication-type="journal">
<string-name>
<surname>Muroi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Okuno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kuno</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>An MRI study of the myelination pattern in West syndrome</article-title>. <source xml:lang="en"/>Brain Dev
<year>1996</year>;<volume>18</volume>:<fpage>179</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">8836497</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0250">
<label>250</label>
<mixed-citation id="epi412102-cit-0250" publication-type="journal">
<string-name>
<surname>Tsao</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Luquette</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rusin</surname>
<given-names>JA</given-names>
</string-name>, et al. <article-title>Leigh syndrome, cytochrome C oxidase deficiency and hypsarrhythmia with infantile spasms</article-title>. <source xml:lang="en"/>Clin Electroencephalogr
<year>1997</year>;<volume>28</volume>:<fpage>214</fpage>–<lpage>217</lpage>.<pub-id pub-id-type="pmid">9343714</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0251">
<label>251</label>
<mixed-citation id="epi412102-cit-0251" publication-type="journal">
<string-name>
<surname>Desguerre</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Pinton</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nabbout</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>2003</year>;<volume>34</volume>:<fpage>265</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">14598233</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0252">
<label>252</label>
<mixed-citation id="epi412102-cit-0252" publication-type="journal">
<string-name>
<surname>Petruzzella</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Vergari</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Puzziferri</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>A nonsense mutation in the NDUFS4 gene encoding the 18 kDa (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh‐like syndrome</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2001</year>;<volume>10</volume>:<fpage>529</fpage>–<lpage>535</lpage>.<pub-id pub-id-type="pmid">11181577</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0253">
<label>253</label>
<mixed-citation id="epi412102-cit-0253" publication-type="journal">
<string-name>
<surname>Loeffen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Smeitink</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Triepels</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>The first nuclear‐encoded complex I mutation in a patient with Leigh syndrome</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1998</year>;<volume>63</volume>:<fpage>1598</fpage>–<lpage>1608</lpage>.<pub-id pub-id-type="pmid">9837812</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0254">
<label>254</label>
<mixed-citation id="epi412102-cit-0254" publication-type="journal">
<string-name>
<surname>Kruse</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Watt</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Marcinek</surname>
<given-names>DJ</given-names>
</string-name>, et al. <article-title>Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy</article-title>. <source xml:lang="en"/>Cell Metab
<year>2008</year>;<volume>7</volume>:<fpage>312</fpage>–<lpage>320</lpage>.<pub-id pub-id-type="pmid">18396137</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0255">
<label>255</label>
<mixed-citation id="epi412102-cit-0255" publication-type="journal">
<string-name>
<surname>Quintana</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kruse</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Kapur</surname>
<given-names>RP</given-names>
</string-name>, et al. <article-title>Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2010</year>;<volume>107</volume>:<fpage>10996</fpage>–<lpage>11001</lpage>.<pub-id pub-id-type="pmid">20534480</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0256">
<label>256</label>
<mixed-citation id="epi412102-cit-0256" publication-type="journal">
<string-name>
<surname>Ferrari</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>IH</given-names>
</string-name>, <string-name>
<surname>Goldberger</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2017</year>;<volume>114</volume>:<fpage>E4241</fpage>–<lpage>E4250</lpage>.<pub-id pub-id-type="pmid">28483998</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0257">
<label>257</label>
<mixed-citation id="epi412102-cit-0257" publication-type="journal">
<string-name>
<surname>Johnson</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Yanos</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Kayser</surname>
<given-names>EB</given-names>
</string-name>, et al. <article-title>mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome</article-title>. <source xml:lang="en"/>Science
<year>2013</year>;<volume>342</volume>:<fpage>1524</fpage>–<lpage>1528</lpage>.<pub-id pub-id-type="pmid">24231806</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0258">
<label>258</label>
<mixed-citation id="epi412102-cit-0258" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mouser</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pitt</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Rapamycin enhances survival in a Drosophila model of mitochondrial disease</article-title>. <source xml:lang="en"/>Oncotarget
<year>2016</year>;<volume>7</volume>:<fpage>80131</fpage>–<lpage>80139</lpage>.<pub-id pub-id-type="pmid">27741510</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0259">
<label>259</label>
<mixed-citation id="epi412102-cit-0259" publication-type="journal">
<string-name>
<surname>Boyd</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Harden</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Egger</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Progressive neuronal degeneration of childhood with liver‐disease (alpers disease) ‐ characteristic neurophysiological features</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>1986</year>;<volume>17</volume>:<fpage>75</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">3724991</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0260">
<label>260</label>
<mixed-citation id="epi412102-cit-0260" publication-type="journal">
<string-name>
<surname>Tulinius</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Holme</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kristiansson</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Mitochondrial encephalomyopathies in childhood. II. Clinical manifestations and syndromes</article-title>. <source xml:lang="en"/>J Pediatr
<year>1991</year>;<volume>119</volume>:<fpage>251</fpage>–<lpage>259</lpage>.<pub-id pub-id-type="pmid">1861210</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0261">
<label>261</label>
<mixed-citation id="epi412102-cit-0261" publication-type="journal">
<string-name>
<surname>Naviaux</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Nyhan</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Barshop</surname>
<given-names>BA</given-names>
</string-name>, et al. <article-title>Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome</article-title>. <source xml:lang="en"/>Ann Neurol
<year>1999</year>;<volume>45</volume>:<fpage>54</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">9894877</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0262">
<label>262</label>
<mixed-citation id="epi412102-cit-0262" publication-type="journal">
<string-name>
<surname>Cho</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>HY</given-names>
</string-name>, et al. <article-title>FARS2 mutation and epilepsy: possible link with early‐onset epileptic encephalopathy</article-title>. <source xml:lang="en"/>Epilepsy Res
<year>2017</year>;<volume>129</volume>:<fpage>118</fpage>–<lpage>124</lpage>.<pub-id pub-id-type="pmid">28043061</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0263">
<label>263</label>
<mixed-citation id="epi412102-cit-0263" publication-type="journal">
<string-name>
<surname>Raviglione</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Conte</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ghezzi</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Clinical findings in a patient with FARS2 mutations and early‐infantile‐encephalopathy with epilepsy</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2016</year>;<volume>170</volume>:<fpage>3004</fpage>–<lpage>3007</lpage>.<pub-id pub-id-type="pmid">27549011</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0264">
<label>264</label>
<mixed-citation id="epi412102-cit-0264" publication-type="journal">
<string-name>
<surname>Trifunovic</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wredenberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Falkenberg</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Premature ageing in mice expressing defective mitochondrial DNA polymerase</article-title>. <source xml:lang="en"/>Nature
<year>2004</year>;<volume>429</volume>:<fpage>417</fpage>–<lpage>423</lpage>.<pub-id pub-id-type="pmid">15164064</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0265">
<label>265</label>
<mixed-citation id="epi412102-cit-0265" publication-type="journal">
<string-name>
<surname>Kujoth</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Hiona</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pugh</surname>
<given-names>TD</given-names>
</string-name>, et al. <article-title>Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging</article-title>. <source xml:lang="en"/>Science
<year>2005</year>;<volume>309</volume>:<fpage>481</fpage>–<lpage>484</lpage>.<pub-id pub-id-type="pmid">16020738</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0266">
<label>266</label>
<mixed-citation id="epi412102-cit-0266" publication-type="journal">
<string-name>
<surname>Rahn</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Bestman</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Stackley</surname>
<given-names>KD</given-names>
</string-name>, et al. <article-title>Zebrafish lacking functional DNA polymerase gamma survive to juvenile stage, despite rapid and sustained mitochondrial DNA depletion, altered energetics and growth</article-title>. <source xml:lang="en"/>Nucleic Acids Res
<year>2015</year>;<volume>43</volume>:<fpage>10338</fpage>–<lpage>10352</lpage>.<pub-id pub-id-type="pmid">26519465</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0267">
<label>267</label>
<mixed-citation id="epi412102-cit-0267" publication-type="journal">
<string-name>
<surname>Hance</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ekstrand</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Trifunovic</surname>
<given-names>A</given-names>
</string-name>. <article-title>Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2005</year>;<volume>14</volume>:<fpage>1775</fpage>–<lpage>1783</lpage>.<pub-id pub-id-type="pmid">15888483</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0268">
<label>268</label>
<mixed-citation id="epi412102-cit-0268" publication-type="journal">
<string-name>
<surname>Staretz‐Chacham</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>LaMarca</surname>
<given-names>ME</given-names>
</string-name>, et al. <article-title>Lysosomal storage disorders in the newborn</article-title>. <source xml:lang="en"/>Pediatrics
<year>2009</year>;<volume>123</volume>:<fpage>1191</fpage>–<lpage>1207</lpage>.<pub-id pub-id-type="pmid">19336380</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0269">
<label>269</label>
<mixed-citation id="epi412102-cit-0269" publication-type="journal">
<string-name>
<surname>Gudino</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Campistol</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chavez</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Hurler's syndrome, West's syndrome, and vitamin D‐dependent rickets</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2002</year>;<volume>17</volume>:<fpage>149</fpage>–<lpage>151</lpage>.<pub-id pub-id-type="pmid">11952079</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0270">
<label>270</label>
<mixed-citation id="epi412102-cit-0270" publication-type="journal">
<string-name>
<surname>Chetta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guacci</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rizzo</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Infantile spasms in early‐onset Niemann–Pick disease with a novel compound heterozygous mutations in SMPD1 gene</article-title>. <source xml:lang="en"/>New Horizons Transl Med
<year>2015</year>;<volume>2</volume>:<fpage>155</fpage>–<lpage>158</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0271">
<label>271</label>
<mixed-citation id="epi412102-cit-0271" publication-type="journal">
<string-name>
<surname>Xu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Motabar</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ferrer</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Disease models for the development of therapies for lysosomal storage diseases</article-title>. <source xml:lang="en"/>Ann N Y Acad Sci
<year>2016</year>;<volume>1371</volume>:<fpage>15</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">27144735</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0272">
<label>272</label>
<mixed-citation id="epi412102-cit-0272" publication-type="journal">
<string-name>
<surname>Clarke</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Russell</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Pownall</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha‐L‐iduronidase gene</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>1997</year>;<volume>6</volume>:<fpage>503</fpage>–<lpage>511</lpage>.<pub-id pub-id-type="pmid">9097952</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0273">
<label>273</label>
<mixed-citation id="epi412102-cit-0273" publication-type="journal">
<string-name>
<surname>Desmaris</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Verot</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Puech</surname>
<given-names>JP</given-names>
</string-name>, et al. <article-title>Prevention of neuropathology in the mouse model of Hurler syndrome</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2004</year>;<volume>56</volume>:<fpage>68</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">15236403</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0274">
<label>274</label>
<mixed-citation id="epi412102-cit-0274" publication-type="journal">
<string-name>
<surname>Wolf</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Lenander</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Nan</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I</article-title>. <source xml:lang="en"/>Neurobiol Dis
<year>2011</year>;<volume>43</volume>:<fpage>123</fpage>–<lpage>133</lpage>.<pub-id pub-id-type="pmid">21397026</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0275">
<label>275</label>
<mixed-citation id="epi412102-cit-0275" publication-type="journal">
<string-name>
<surname>Horinouchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Erlich</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Perl</surname>
<given-names>DP</given-names>
</string-name>, et al. <article-title>Acid sphingomyelinase deficient mice: a model of types A and B Niemann‐Pick disease</article-title>. <source xml:lang="en"/>Nat Genet
<year>1995</year>;<volume>10</volume>:<fpage>288</fpage>–<lpage>293</lpage>.<pub-id pub-id-type="pmid">7670466</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0276">
<label>276</label>
<mixed-citation id="epi412102-cit-0276" publication-type="journal">
<string-name>
<surname>Jones</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Katouzian</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Characterization of common SMPD1 mutations causing types A and B Niemann‐Pick disease and generation of mutation‐specific mouse models</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2008</year>;<volume>95</volume>:<fpage>152</fpage>–<lpage>162</lpage>.<pub-id pub-id-type="pmid">18815062</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0277">
<label>277</label>
<mixed-citation id="epi412102-cit-0277" publication-type="journal">
<string-name>
<surname>Poser</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Low</surname>
<given-names>NL</given-names>
</string-name>. <article-title>Autopsy findings in three cases of hypsarhythmia (Infantile Spasms with Mental Retardation)1</article-title>. <source xml:lang="en"/>Acta Paediatr
<year>1960</year>;<volume>49</volume>:<fpage>695</fpage>–<lpage>706</lpage>.<pub-id pub-id-type="pmid">13737357</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0278">
<label>278</label>
<mixed-citation id="epi412102-cit-0278" publication-type="journal">
<string-name>
<surname>Bignami</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Maccagnani</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zappella</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Familial infantile spasms and hypsarrhytmia associated with leukodystrophy</article-title>. <source xml:lang="en"/>J Neurol Neurosurg Psychiatry
<year>1966</year>;<volume>29</volume>:<fpage>129</fpage>–<lpage>134</lpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0279">
<label>279</label>
<mixed-citation id="epi412102-cit-0279" publication-type="journal">
<string-name>
<surname>Meencke</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Gerhard</surname>
<given-names>C</given-names>
</string-name>. <article-title>Morphological aspects of aetiology and the course of infantile spasms (West‐syndrome)</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>1985</year>;<volume>16</volume>:<fpage>59</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">3925364</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0280">
<label>280</label>
<mixed-citation id="epi412102-cit-0280" publication-type="journal">
<string-name>
<surname>Gingold</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Bodensteiner</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Schochet</surname>
<given-names>SS</given-names>
</string-name>, et al. <article-title>Alexander's disease: unique presentation</article-title>. <source xml:lang="en"/>J Child Neurol
<year>1999</year>;<volume>14</volume>:<fpage>325</fpage>–<lpage>329</lpage>.<pub-id pub-id-type="pmid">10342600</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0281">
<label>281</label>
<mixed-citation id="epi412102-cit-0281" publication-type="journal">
<string-name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</string-name>. <article-title>Krabbe's disease: clinical presentation of neurological variants</article-title>. <source xml:lang="en"/>Neuropediatrics
<year>1984</year>;<volume>15</volume>(<issue>Suppl</issue>):<fpage>11</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">6546163</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0282">
<label>282</label>
<mixed-citation id="epi412102-cit-0282" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</string-name>, et al. <article-title>A case of infantile Alexander disease accompanied by infantile spasms diagnosed by DNA analysis</article-title>. <source xml:lang="en"/>J Korean Med Sci
<year>2006</year>;<volume>21</volume>:<fpage>954</fpage>–<lpage>957</lpage>.<pub-id pub-id-type="pmid">17043438</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0283">
<label>283</label>
<mixed-citation id="epi412102-cit-0283" publication-type="journal">
<string-name>
<surname>Brenner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Boespflug‐Tanguy</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease</article-title>. <source xml:lang="en"/>Nat Genet
<year>2001</year>;<volume>27</volume>:<fpage>117</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">11138011</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0284">
<label>284</label>
<mixed-citation id="epi412102-cit-0284" publication-type="journal">
<string-name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta‐galactosidase</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>1970</year>;<volume>66</volume>:<fpage>302</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">5271165</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0285">
<label>285</label>
<mixed-citation id="epi412102-cit-0285" publication-type="journal">
<string-name>
<surname>Sakai</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Inui</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Krabbe disease: isolation and characterization of a full‐length cDNA for human galactocerebrosidase</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun
<year>1994</year>;<volume>198</volume>:<fpage>485</fpage>–<lpage>491</lpage>.<pub-id pub-id-type="pmid">8297359</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0286">
<label>286</label>
<mixed-citation id="epi412102-cit-0286" publication-type="journal">
<string-name>
<surname>Tanaka</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Takebayashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamazaki</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance</article-title>. <source xml:lang="en"/>Glia
<year>2007</year>;<volume>55</volume>:<fpage>617</fpage>–<lpage>631</lpage>.<pub-id pub-id-type="pmid">17299771</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0287">
<label>287</label>
<mixed-citation id="epi412102-cit-0287" publication-type="journal">
<string-name>
<surname>Messing</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Head</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Galles</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice</article-title>. <source xml:lang="en"/>Am J Pathol
<year>1998</year>;<volume>152</volume>:<fpage>391</fpage>–<lpage>398</lpage>.<pub-id pub-id-type="pmid">9466565</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0288">
<label>288</label>
<mixed-citation id="epi412102-cit-0288" publication-type="journal">
<string-name>
<surname>Hagemann</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Gaeta</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>MA</given-names>
</string-name>, et al. <article-title>Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2005</year>;<volume>14</volume>:<fpage>2443</fpage>–<lpage>2458</lpage>.<pub-id pub-id-type="pmid">16014634</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0289">
<label>289</label>
<mixed-citation id="epi412102-cit-0289" publication-type="journal">
<string-name>
<surname>Wolf</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Grier</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Allen</surname>
<given-names>RJ</given-names>
</string-name>, et al. <article-title>Biotinidase deficiency: the enzymatic defect in late‐onset multiple carboxylase deficiency</article-title>. <source xml:lang="en"/>Clin Chim Acta
<year>1983</year>;<volume>131</volume>:<fpage>273</fpage>–<lpage>281</lpage>.<pub-id pub-id-type="pmid">6883721</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0290">
<label>290</label>
<mixed-citation id="epi412102-cit-0290" publication-type="journal">
<string-name>
<surname>Wolf</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Feldman</surname>
<given-names>GL</given-names>
</string-name>. <article-title>The biotin‐dependent carboxylase deficiencies</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1982</year>;<volume>34</volume>:<fpage>699</fpage>–<lpage>716</lpage>.<pub-id pub-id-type="pmid">6127031</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0291">
<label>291</label>
<mixed-citation id="epi412102-cit-0291" publication-type="journal">
<string-name>
<surname>Pomponio</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Reynolds</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Cole</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Mutational hotspot in the human serum biotinidase gene as a cause of biotinidase deficiency</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1995</year>;<volume>57</volume>:<fpage>28</fpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0292">
<label>292</label>
<mixed-citation id="epi412102-cit-0292" publication-type="journal">
<string-name>
<surname>Wolf</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Heard</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Weissbecker</surname>
<given-names>KA</given-names>
</string-name>, et al. <article-title>Biotinidase deficiency: initial clinical features and rapid diagnosis</article-title>. <source xml:lang="en"/>Ann Neurol
<year>1985</year>;<volume>18</volume>:<fpage>614</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">4073853</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0293">
<label>293</label>
<mixed-citation id="epi412102-cit-0293" publication-type="journal">
<string-name>
<surname>Kalayci</surname>
<given-names>Ö</given-names>
</string-name>, <string-name>
<surname>Coskun</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tokatli</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Infantile spasms as the initial symptom of biotinidase deficiency</article-title>. <source xml:lang="en"/>J Pediatr
<year>1994</year>;<volume>124</volume>:<fpage>103</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="pmid">8283357</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0294">
<label>294</label>
<mixed-citation id="epi412102-cit-0294" publication-type="journal">
<string-name>
<surname>Mikati</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Zalloua</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Karam</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Novel mutation causing partial biotinidase deficiency in a Syrian boy with infantile spasms and retardation</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2006</year>;<volume>21</volume>:<fpage>978</fpage>–<lpage>981</lpage>.<pub-id pub-id-type="pmid">17092467</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0295">
<label>295</label>
<mixed-citation id="epi412102-cit-0295" publication-type="journal">
<string-name>
<surname>Rybak</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Whitworth</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Weberg</surname>
<given-names>AD</given-names>
</string-name>, et al. <article-title>Rat as a potential model for hearing‐loss in biotinidase deficiency</article-title>. <source xml:lang="en"/>Ann Otol Rhinol Laryngol
<year>1991</year>;<volume>100</volume>:<fpage>294</fpage>–<lpage>300</lpage>.<pub-id pub-id-type="pmid">2018287</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0296">
<label>296</label>
<mixed-citation id="epi412102-cit-0296" publication-type="journal">
<string-name>
<surname>Pindolia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jordan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Development and characterization of a mouse with profound biotinidase deficiency: a biotin‐responsive neurocutaneous disorder</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2011</year>;<volume>102</volume>:<fpage>161</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">21051254</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0297">
<label>297</label>
<mixed-citation id="epi412102-cit-0297" publication-type="journal">
<string-name>
<surname>Pindolia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cardwell</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Neurological deficits in mice with profound biotinidase deficiency are associated with demylination and axonal degeneration</article-title>. <source xml:lang="en"/>Neurobiol Dis
<year>2012</year>;<volume>47</volume>:<fpage>428</fpage>–<lpage>435</lpage>.<pub-id pub-id-type="pmid">22579707</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0298">
<label>298</label>
<mixed-citation id="epi412102-cit-0298" publication-type="journal">
<string-name>
<surname>van Grunsven</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>van Berkel</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ijlst</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Peroxisomal D‐hydroxyacyl‐CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>1998</year>;<volume>95</volume>:<fpage>2128</fpage>–<lpage>2133</lpage>.<pub-id pub-id-type="pmid">9482850</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0299">
<label>299</label>
<mixed-citation id="epi412102-cit-0299" publication-type="journal">
<string-name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Souri</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>D‐3‐hydroxyacyl‐CoA dehydratase/D‐3‐hydroxyacyl‐CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1997</year>;<volume>61</volume>:<fpage>1153</fpage>–<lpage>1162</lpage>.<pub-id pub-id-type="pmid">9345094</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0300">
<label>300</label>
<mixed-citation id="epi412102-cit-0300" publication-type="journal">
<string-name>
<surname>Huyghe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mannaerts</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Baes</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Peroxisomal multifunctional protein‐2: the enzyme, the patients and the knockout mouse model</article-title>. <source xml:lang="en"/>Biochim Biophys Acta
<year>2006</year>;<volume>1761</volume>:<fpage>973</fpage>–<lpage>994</lpage>.<pub-id pub-id-type="pmid">16766224</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0301">
<label>301</label>
<mixed-citation id="epi412102-cit-0301" publication-type="journal">
<string-name>
<surname>Möller</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>van Grunsven</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>Wanders</surname>
<given-names>RJA</given-names>
</string-name>, et al. <article-title>Molecular basis of d‐bifunctional protein deficiency</article-title>. <source xml:lang="en"/>Mol Cell Endocrinol
<year>2001</year>;<volume>171</volume>:<fpage>61</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">11165012</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0302">
<label>302</label>
<mixed-citation id="epi412102-cit-0302" publication-type="journal">
<string-name>
<surname>Buoni</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zannolli</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Waterham</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>D‐bifunctional protein deficiency associated with drug resistant infantile spasms</article-title>. <source xml:lang="en"/>Brain Dev
<year>2007</year>;<volume>29</volume>:<fpage>51</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">16919904</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0303">
<label>303</label>
<mixed-citation id="epi412102-cit-0303" publication-type="journal">
<string-name>
<surname>Baes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Huyghe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Carmeliet</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Inactivation of the peroxisomal multifunctional protein‐2 in mice impedes the degradation of not only 2‐methyl‐branched fatty acids and bile acid intermediates but also of very long chain fatty acids</article-title>. <source xml:lang="en"/>J Biol Chem
<year>2000</year>;<volume>275</volume>:<fpage>16329</fpage>–<lpage>16336</lpage>.<pub-id pub-id-type="pmid">10748062</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0304">
<label>304</label>
<mixed-citation id="epi412102-cit-0304" publication-type="journal">
<string-name>
<surname>Huyghe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Schmalbruch</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hulshagen</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Peroxisomal multifunctional protein‐2 deficiency causes motor deficits and glial lesions in the adult central nervous system</article-title>. <source xml:lang="en"/>Am J Pathol
<year>2006</year>;<volume>168</volume>:<fpage>1321</fpage>–<lpage>1334</lpage>.<pub-id pub-id-type="pmid">16565505</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0305">
<label>305</label>
<mixed-citation id="epi412102-cit-0305" publication-type="journal">
<string-name>
<surname>Verheijden</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bottelbergs</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Krysko</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Peroxisomal multifunctional protein‐2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation</article-title>. <source xml:lang="en"/>Neurobiol Dis
<year>2013</year>;<volume>58</volume>:<fpage>258</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">23777740</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0306">
<label>306</label>
<mixed-citation id="epi412102-cit-0306" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>YI</given-names>
</string-name>, <string-name>
<surname>Bhandari</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JN</given-names>
</string-name>, et al. <article-title>Developmental roles of D‐bifunctional protein‐A zebrafish model of peroxisome dysfunction</article-title>. <source xml:lang="en"/>Mol Cells
<year>2014</year>;<volume>37</volume>:<fpage>74</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">24552713</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0307">
<label>307</label>
<mixed-citation id="epi412102-cit-0307" publication-type="journal">
<string-name>
<surname>Pober</surname>
<given-names>BR</given-names>
</string-name>. <article-title>Williams‐Beuren syndrome</article-title>. <source xml:lang="en"/>N Engl J Med
<year>2010</year>;<volume>362</volume>:<fpage>239</fpage>–<lpage>252</lpage>.<pub-id pub-id-type="pmid">20089974</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0308">
<label>308</label>
<mixed-citation id="epi412102-cit-0308" publication-type="journal">
<string-name>
<surname>Palacios‐Verdu</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Segura‐Puimedon</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Borralleras</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Metabolic abnormalities in Williams‐Beuren syndrome</article-title>. <source xml:lang="en"/>J Med Genet
<year>2015</year>;<volume>52</volume>:<fpage>248</fpage>–<lpage>255</lpage>.<pub-id pub-id-type="pmid">25663682</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0309">
<label>309</label>
<mixed-citation id="epi412102-cit-0309" publication-type="journal">
<string-name>
<surname>Williams</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Barratt‐Boyes</surname>
<given-names>BG</given-names>
</string-name>, <string-name>
<surname>Lowe</surname>
<given-names>JB</given-names>
</string-name>. <article-title>Supravalvular aortic stenosis</article-title>. <source xml:lang="en"/>Circulation
<year>1961</year>;<volume>24</volume>:<fpage>1311</fpage>–<lpage>1318</lpage>.<pub-id pub-id-type="pmid">14007182</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0310">
<label>310</label>
<mixed-citation id="epi412102-cit-0310" publication-type="journal">
<string-name>
<surname>Tsao</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Westman</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Infantile spasms in two children with Williams syndrome</article-title>. <source xml:lang="en"/>Am J Med Genet
<year>1997</year>;<volume>71</volume>:<fpage>54</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">9215769</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0311">
<label>311</label>
<mixed-citation id="epi412102-cit-0311" publication-type="journal">
<string-name>
<surname>Morimoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ogami</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Infantile spasms in a patient with williams syndrome and craniosynostosis</article-title>. <source xml:lang="en"/>Epilepsia
<year>2003</year>;<volume>44</volume>:<fpage>1459</fpage>–<lpage>1462</lpage>.<pub-id pub-id-type="pmid">14636357</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0312">
<label>312</label>
<mixed-citation id="epi412102-cit-0312" publication-type="journal">
<string-name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Pani</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23‐q21.11</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2008</year>;<volume>83</volume>:<fpage>106</fpage>–<lpage>111</lpage>.<pub-id pub-id-type="pmid">18565486</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0313">
<label>313</label>
<mixed-citation id="epi412102-cit-0313" publication-type="journal">
<string-name>
<surname>Noebels</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Qiao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Bronson</surname>
<given-names>RT</given-names>
</string-name>, et al. <article-title>Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures</article-title>. <source xml:lang="en"/>Epilepsy Res
<year>1990</year>;<volume>7</volume>:<fpage>129</fpage>–<lpage>135</lpage>.<pub-id pub-id-type="pmid">2289471</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0314">
<label>314</label>
<mixed-citation id="epi412102-cit-0314" publication-type="journal">
<string-name>
<surname>Komoike</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nishimura</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegaly</article-title>. <source xml:lang="en"/>Genesis
<year>2010</year>;<volume>48</volume>:<fpage>233</fpage>–<lpage>243</lpage>.<pub-id pub-id-type="pmid">20146355</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0315">
<label>315</label>
<mixed-citation id="epi412102-cit-0315" publication-type="journal">
<string-name>
<surname>Zhao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Aviles</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Abel</surname>
<given-names>RA</given-names>
</string-name>, et al. <article-title>Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval</article-title>. <source xml:lang="en"/>Development
<year>2005</year>;<volume>132</volume>:<fpage>2917</fpage>–<lpage>2927</lpage>.<pub-id pub-id-type="pmid">15930120</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0316">
<label>316</label>
<mixed-citation id="epi412102-cit-0316" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Roy</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kuscuoglu</surname>
<given-names>U</given-names>
</string-name>, et al. <article-title>Induced chromosome deletions cause hypersociability and other features of Williams‐Beuren syndrome in mice</article-title>. <source xml:lang="en"/>EMBO Mol Med
<year>2009</year>;<volume>1</volume>:<fpage>50</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">20049703</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0317">
<label>317</label>
<mixed-citation id="epi412102-cit-0317" publication-type="journal">
<string-name>
<surname>Segura‐Puimedon</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sahun</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Velot</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Heterozygous deletion of the Williams‐Beuren syndrome critical interval in mice recapitulates most features of the human disorder</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2014</year>;<volume>23</volume>:<fpage>6481</fpage>–<lpage>6494</lpage>.<pub-id pub-id-type="pmid">25027326</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0318">
<label>318</label>
<mixed-citation id="epi412102-cit-0318" publication-type="journal">
<string-name>
<surname>Borralleras</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Amedee</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams‐Beuren syndrome</article-title>. <source xml:lang="en"/>Mol Brain
<year>2016</year>;<volume>9</volume>:<fpage>76</fpage>.<pub-id pub-id-type="pmid">27485321</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0319">
<label>319</label>
<mixed-citation id="epi412102-cit-0319" publication-type="journal">
<string-name>
<surname>Thiel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schwarz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>A new type of congenital disorders of glycosylation (CDG‐Ii) provides new insights into the early steps of dolichol‐linked oligosaccharide biosynthesis</article-title>. <source xml:lang="en"/>J Biol Chem
<year>2003</year>;<volume>278</volume>:<fpage>22498</fpage>–<lpage>22505</lpage>.<pub-id pub-id-type="pmid">12684507</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0320">
<label>320</label>
<mixed-citation id="epi412102-cit-0320" publication-type="journal">
<string-name>
<surname>Jaeken</surname>
<given-names>J</given-names>
</string-name>. <article-title>Congenital disorders of glycosylation</article-title>. <source xml:lang="en"/>Handb Clin Neurol
<year>2013</year>;<volume>113</volume>:<fpage>1737</fpage>–<lpage>1743</lpage>.<pub-id pub-id-type="pmid">23622397</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0321">
<label>321</label>
<mixed-citation id="epi412102-cit-0321" publication-type="journal">
<string-name>
<surname>Thiel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Korner</surname>
<given-names>C</given-names>
</string-name>. <article-title>Mouse models for congenital disorders of glycosylation</article-title>. <source xml:lang="en"/>J Inherit Metab Dis
<year>2011</year>;<volume>34</volume>:<fpage>879</fpage>–<lpage>889</lpage>.<pub-id pub-id-type="pmid">21347588</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0322">
<label>322</label>
<mixed-citation id="epi412102-cit-0322" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sutton‐Smith</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine‐linked glycan‐dependent functions in mammalian physiology and insights into disease pathogenesis</article-title>. <source xml:lang="en"/>Glycobiology
<year>2001</year>;<volume>11</volume>:<fpage>1051</fpage>–<lpage>1070</lpage>.<pub-id pub-id-type="pmid">11805078</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0323">
<label>323</label>
<mixed-citation id="epi412102-cit-0323" publication-type="journal">
<string-name>
<surname>El‐Hattab</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Scaglia</surname>
<given-names>F</given-names>
</string-name>. <article-title>Disorders of carnitine biosynthesis and transport</article-title>. <source xml:lang="en"/>Mol Genet Metab
<year>2015</year>;<volume>116</volume>:<fpage>107</fpage>–<lpage>112</lpage>.<pub-id pub-id-type="pmid">26385306</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0324">
<label>324</label>
<mixed-citation id="epi412102-cit-0324" publication-type="journal">
<string-name>
<surname>Reiss</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hahnewald</surname>
<given-names>R</given-names>
</string-name>. <article-title>Molybdenum cofactor deficiency: mutations in GPHN, MOCS1, and MOCS2</article-title>. <source xml:lang="en"/>Hum Mutat
<year>2011</year>;<volume>32</volume>:<fpage>10</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">21031595</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0325">
<label>325</label>
<mixed-citation id="epi412102-cit-0325" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Adham</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Schwarz</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Molybdenum cofactor‐deficient mice resemble the phenotype of human patients</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2002</year>;<volume>11</volume>:<fpage>3309</fpage>–<lpage>3317</lpage>.<pub-id pub-id-type="pmid">12471057</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0326">
<label>326</label>
<mixed-citation id="epi412102-cit-0326" publication-type="journal">
<string-name>
<surname>Hahnewald</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wegner</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Reiss</surname>
<given-names>J</given-names>
</string-name>. <article-title>AAV‐mediated gene therapy for metabolic diseases: dosage and reapplication studies in the molybdenum cofactor deficiency model</article-title>. <source xml:lang="en"/>Genet Vaccines Ther
<year>2009</year>;<volume>7</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">19538746</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0327">
<label>327</label>
<mixed-citation id="epi412102-cit-0327" publication-type="journal">
<string-name>
<surname>Jakubiczka‐Smorag</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Santamaria‐Araujo</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Metz</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients</article-title>. <source xml:lang="en"/>Hum Genet
<year>2016</year>;<volume>135</volume>:<fpage>813</fpage>–<lpage>826</lpage>.<pub-id pub-id-type="pmid">27138983</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0328">
<label>328</label>
<mixed-citation id="epi412102-cit-0328" publication-type="journal">
<string-name>
<surname>Heinonen</surname>
<given-names>OJ</given-names>
</string-name>, <string-name>
<surname>Takala</surname>
<given-names>J</given-names>
</string-name>. <article-title>Moderate carnitine depletion and long‐chain fatty acid oxidation, exercise capacity, and nitrogen balance in the rat</article-title>. <source xml:lang="en"/>Pediatr Res
<year>1994</year>;<volume>36</volume>:<fpage>288</fpage>–<lpage>292</lpage>.<pub-id pub-id-type="pmid">7808823</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0329">
<label>329</label>
<mixed-citation id="epi412102-cit-0329" publication-type="journal">
<string-name>
<surname>Spaniol</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Auer</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Development and characterization of an animal model of carnitine deficiency</article-title>. <source xml:lang="en"/>Eur J Biochem
<year>2001</year>;<volume>268</volume>:<fpage>1876</fpage>–<lpage>1887</lpage>.<pub-id pub-id-type="pmid">11248709</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0330">
<label>330</label>
<mixed-citation id="epi412102-cit-0330" publication-type="journal">
<string-name>
<surname>Nasca</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Xenos</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Barone</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>L‐acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2013</year>;<volume>110</volume>:<fpage>4804</fpage>–<lpage>4809</lpage>.<pub-id pub-id-type="pmid">23382250</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0331">
<label>331</label>
<mixed-citation id="epi412102-cit-0331" publication-type="journal">
<string-name>
<surname>Pettegrew</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McClure</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Acetyl‐L‐carnitine physical‐chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression</article-title>. <source xml:lang="en"/>Mol Psychiatry
<year>2000</year>;<volume>5</volume>:<fpage>616</fpage>–<lpage>632</lpage>.<pub-id pub-id-type="pmid">11126392</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0332">
<label>332</label>
<mixed-citation id="epi412102-cit-0332" publication-type="journal">
<string-name>
<surname>Wainwright</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Mannix</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>L‐carnitine reduces brain injury after hypoxia‐ischemia in newborn rats</article-title>. <source xml:lang="en"/>Pediatr Res
<year>2003</year>;<volume>54</volume>:<fpage>688</fpage>–<lpage>695</lpage>.<pub-id pub-id-type="pmid">12904603</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0333">
<label>333</label>
<mixed-citation id="epi412102-cit-0333" publication-type="journal">
<string-name>
<surname>Jones</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Borum</surname>
<given-names>PR</given-names>
</string-name>. <article-title>Acylcarnitines: role in brain</article-title>. <source xml:lang="en"/>Prog Lipid Res
<year>2010</year>;<volume>49</volume>:<fpage>61</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">19720082</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0334">
<label>334</label>
<mixed-citation id="epi412102-cit-0334" publication-type="journal">
<string-name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: a hypothesis</article-title>. <source xml:lang="en"/>BioEssays
<year>2017</year>;<volume>39</volume>:<fpage>1700012‐n/a</fpage>.</mixed-citation>
</ref>
<ref id="epi412102-bib-0335">
<label>335</label>
<mixed-citation id="epi412102-cit-0335" publication-type="journal">
<string-name>
<surname>Sezer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Balci</surname>
<given-names>O</given-names>
</string-name>. <article-title>Infantile spasms during acute metabolic decompensation in an infant with isovaleric acidemia</article-title>. <source xml:lang="en"/>J Clin Neurol
<year>2016</year>;<volume>12</volume>:<fpage>376</fpage>–<lpage>377</lpage>.<pub-id pub-id-type="pmid">27165427</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0336">
<label>336</label>
<mixed-citation id="epi412102-cit-0336" publication-type="journal">
<string-name>
<surname>Vockley</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ensenauer</surname>
<given-names>R</given-names>
</string-name>. <article-title>Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity</article-title>. <source xml:lang="en"/>Am J Med Genet C Semin Med Genet
<year>2006</year>;<volume>142C</volume>:<fpage>95</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">16602101</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0337">
<label>337</label>
<mixed-citation id="epi412102-cit-0337" publication-type="journal">
<string-name>
<surname>Ribeiro</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Balestro</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Grando</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Isovaleric acid reduces Na+, K + ‐ATPase activity in synaptic membranes from cerebral cortex of young rats</article-title>. <source xml:lang="en"/>Cell Mol Neurobiol
<year>2007</year>;<volume>27</volume>:<fpage>529</fpage>–<lpage>540</lpage>.<pub-id pub-id-type="pmid">17394058</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0338">
<label>338</label>
<mixed-citation id="epi412102-cit-0338" publication-type="journal">
<string-name>
<surname>Solano</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Leipnitz</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>De Bortoli</surname>
<given-names>GM</given-names>
</string-name>, et al. <article-title>Induction of oxidative stress by the metabolites accumulating in isovaleric acidemia in brain cortex of young rats</article-title>. <source xml:lang="en"/>Free Radic Res
<year>2008</year>;<volume>42</volume>:<fpage>707</fpage>–<lpage>715</lpage>.<pub-id pub-id-type="pmid">18661426</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0339">
<label>339</label>
<mixed-citation id="epi412102-cit-0339" publication-type="journal">
<string-name>
<surname>Dulac</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Plecko</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gataullina</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Occasional seizures, epilepsy, and inborn errors of metabolism</article-title>. <source xml:lang="en"/>Lancet Neurol
<year>2014</year>;<volume>13</volume>:<fpage>727</fpage>–<lpage>739</lpage>.<pub-id pub-id-type="pmid">24943345</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0340">
<label>340</label>
<mixed-citation id="epi412102-cit-0340" publication-type="journal">
<string-name>
<surname>Vernon</surname>
<given-names>HJ</given-names>
</string-name>. <article-title>Inborn errors of metabolism: advances in diagnosis and therapy</article-title>. <source xml:lang="en"/>JAMA Pediatr
<year>2015</year>;<volume>169</volume>:<fpage>778</fpage>–<lpage>782</lpage>.<pub-id pub-id-type="pmid">26075348</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0341">
<label>341</label>
<mixed-citation id="epi412102-cit-0341" publication-type="journal">
<string-name>
<surname>Sharma</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Prasad</surname>
<given-names>AN</given-names>
</string-name>. <article-title>Inborn errors of metabolism and epilepsy: current understanding, diagnosis, and treatment approaches</article-title>. <source xml:lang="en"/>Int J Mol Sci
<year>2017</year>;<volume>18</volume>:<fpage>E1384</fpage>.<pub-id pub-id-type="pmid">28671587</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0342">
<label>342</label>
<mixed-citation id="epi412102-cit-0342" publication-type="journal">
<string-name>
<surname>Mohammad</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Abdelkhalek</surname>
<given-names>HS</given-names>
</string-name>. <article-title>Nonketotic hyperglycinemia: spectrum of imaging findings with emphasis on diffusion‐weighted imaging</article-title>. <source xml:lang="en"/>Neuroradiology
<year>2017</year>;<volume>59</volume>:<fpage>1155</fpage>–<lpage>1163</lpage>.<pub-id pub-id-type="pmid">28864914</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0343">
<label>343</label>
<mixed-citation id="epi412102-cit-0343" publication-type="journal">
<string-name>
<surname>Tekgul</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Serdaroglu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Karapinar</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2006</year>;<volume>21</volume>:<fpage>82</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">16551461</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0344">
<label>344</label>
<mixed-citation id="epi412102-cit-0344" publication-type="journal">
<string-name>
<surname>Camurdan</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>Cinaz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Serdaroglu</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Persistent hyperinsulinemic hypoglycemia presenting with a rare complication: West syndrome</article-title>. <source xml:lang="en"/>J Pediatr Endocrinol Metab
<year>2004</year>;<volume>17</volume>:<fpage>1465</fpage>–<lpage>1468</lpage>.<pub-id pub-id-type="pmid">15526728</pub-id></mixed-citation>
</ref>
<ref id="epi412102-bib-0345">
<label>345</label>
<mixed-citation id="epi412102-cit-0345" publication-type="journal">
<string-name>
<surname>Basura</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Hagland</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Wiltse</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>Clinical features and the management of pyridoxine‐dependent and pyridoxine‐responsive seizures: review of 63 North American cases submitted to a patient registry</article-title>. <source xml:lang="en"/>Eur J Pediatr. <year>2009</year>;<volume>168</volume>:<fpage>697</fpage>–<lpage>704</lpage>.<pub-id pub-id-type="pmid">18762976</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>